
<html lang="en"     class="pb-page"  data-request-id="d75c0bfe-beb9-4f35-85fa-1bb8b8e4354f"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;issue:issue:10.1021/jmcmar.2017.60.issue-20;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.7b01231;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Methyl 3-(3-(4-(2,4,4-Trimethylpentan-2-yl)phenoxy)-propanamido)benzoate as a Novel and Dual Malate Dehydrogenase (MDH) 1/2 Inhibitor Targeting Cancer Metabolism" /></meta><meta name="dc.Creator" content="Ravi  Naik" /></meta><meta name="dc.Creator" content="Hyun Seung  Ban" /></meta><meta name="dc.Creator" content="Kyusic  Jang" /></meta><meta name="dc.Creator" content="Inhyub  Kim" /></meta><meta name="dc.Creator" content="Xuezhen  Xu" /></meta><meta name="dc.Creator" content="Dipesh  Harmalkar" /></meta><meta name="dc.Creator" content="Seong-Ah  Shin" /></meta><meta name="dc.Creator" content="Minkyoung  Kim" /></meta><meta name="dc.Creator" content="Bo-Kyung  Kim" /></meta><meta name="dc.Creator" content="Jaehyung  Park" /></meta><meta name="dc.Creator" content="Bonsu  Ku" /></meta><meta name="dc.Creator" content="Sujin  Oh" /></meta><meta name="dc.Creator" content="Misun  Won" /></meta><meta name="dc.Creator" content="Kyeong  Lee" /></meta><meta name="dc.Description" content="Previously, we reported a hypoxia-inducible factor (HIF)-1 inhibitor LW6 containing an (aryloxyacetylamino)benzoic acid moiety inhibits malate dehydrogenase 2 (MDH2) using a chemical biology approa..." /></meta><meta name="Description" content="Previously, we reported a hypoxia-inducible factor (HIF)-1 inhibitor LW6 containing an (aryloxyacetylamino)benzoic acid moiety inhibits malate dehydrogenase 2 (MDH2) using a chemical biology approa..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 16, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b01231" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01231" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b01231" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01231" /></link>
        
    
    

<title>Methyl 3-(3-(4-(2,4,4-Trimethylpentan-2-yl)phenoxy)-propanamido)benzoate as a Novel and Dual Malate Dehydrogenase (MDH) 1/2 Inhibitor Targeting Cancer Metabolism | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b01231" /></meta><meta property="og:title" content="Methyl 3-(3-(4-(2,4,4-Trimethylpentan-2-yl)phenoxy)-propanamido)benzoate as a Novel and Dual Malate Dehydrogenase (MDH) 1/2 Inhibitor Targeting Cancer Metabolism" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/large/jm-2017-01231h_0018.jpeg" /></meta><meta property="og:description" content="Previously, we reported a hypoxia-inducible factor (HIF)-1 inhibitor LW6 containing an (aryloxyacetylamino)benzoic acid moiety inhibits malate dehydrogenase 2 (MDH2) using a chemical biology approach. Structure–activity relationship studies on a series of (aryloxyacetylamino)benzoic acids identified selective MDH1, MDH2, and dual inhibitors, which were used to study the relationship between MDH enzyme activity and HIF-1 inhibition. We hypothesized that dual inhibition of MDH1 and MDH2 might be a powerful approach to target cancer metabolism and selected methyl-3-(3-(4-(2,4,4-trimethylpentan-2-yl)phenoxy)propanamido)-benzoate (16c) as the most potent dual inhibitor. Kinetic studies revealed that compound 16c competitively inhibited MDH1 and MDH2. Compound 16c inhibited mitochondrial respiration and hypoxia-induced HIF-1α accumulation. In xenograft assays using HCT116 cells, compound 16c demonstrated significant in vivo antitumor efficacy. This finding provides concrete evidence that inhibition of both MDH1 and MDH2 may provide a valuable platform for developing novel therapeutics that target cancer metabolism and tumor growth." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b01231"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b01231">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b01231&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b01231&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b01231&amp;href=/doi/10.1021/acs.jmedchem.7b01231" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 20</span><span class="cit-fg-pageRange">, 8631-8646</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/20" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b01189" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b01332" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Methyl 3-(3-(4-(2,4,4-Trimethylpentan-2-yl)phenoxy)-propanamido)benzoate as a Novel and Dual Malate Dehydrogenase (MDH) 1/2 Inhibitor Targeting Cancer Metabolism</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ravi++Naik">Ravi Naik</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hyun+Seung++Ban">Hyun Seung Ban</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-2698-6037" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kyusic++Jang">Kyusic Jang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Inhyub++Kim">Inhyub Kim</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xuezhen++Xu">Xuezhen Xu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dipesh++Harmalkar">Dipesh Harmalkar</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Seong-Ah++Shin">Seong-Ah Shin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Minkyoung++Kim">Minkyoung Kim</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bo-Kyung++Kim">Bo-Kyung Kim</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jaehyung++Park">Jaehyung Park</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bonsu++Ku">Bonsu Ku</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sujin++Oh">Sujin Oh</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∇</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Misun++Won">Misun Won</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kyeong++Lee">Kyeong Lee</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-5455-9956" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">College of Pharmacy, Dongguk University, Goyang 10326, Korea</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Metabolic Regulation Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon 34141, Korea</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Biomolecular Science, University of Science and Technology, Daejeon 34113, Korea</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Personalized Genomic Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon 34141, Korea</span></div><div class="aff-info" id="aff5"><span class="aff-symbol">⊥</span> <span class="aff-text">Functional Genomics, University of Science and Technology, Daejeon 34113, Korea</span></div><div class="aff-info" id="aff6"><span class="aff-symbol">#</span> <span class="aff-text">Disease Target Structure Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon 34141, Korea</span></div><div class="aff-info" id="aff7"><span class="aff-symbol">∇</span> <span class="aff-text">New Drug Development Center, Asan Medical Center, Seoul 05505, Korea</span></div><div class="corresp-info"><strong>*</strong>For K.L.: phone, 82-31-961-5214; fax, 82-31-961-5206; E-mail, <a href="/cdn-cgi/l/email-protection#452e243c29202005212a2b2222302e6b202130"><span class="__cf_email__" data-cfemail="79121800151c1c391d16171e1e0c12571c1d0c">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>For M.W.: phone, 82-42-860-4174; E-mail, <a href="/cdn-cgi/l/email-protection#c7aaaeb4b2a987acb5aea5a5e9b5a2e9acb5"><span class="__cf_email__" data-cfemail="5b3632282e351b302932393975293e753029">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01231&amp;href=/doi/10.1021%2Facs.jmedchem.7b01231" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 20</span><span class="cit-pageRange">, 8631–8646</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 9, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>1 September 2017</li><li><span class="item_label"><b>Published</b> online</span>16 October 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 26 October 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b01231" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01231</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D8631%26pageCount%3D16%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DRavi%2BNaik%252C%2BHyun%2BSeung%2BBan%252C%2BKyusic%2BJang%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D20%26contentID%3Dacs.jmedchem.7b01231%26title%3DMethyl%2B3-%25283-%25284-%25282%252C4%252C4-Trimethylpentan-2-yl%2529phenoxy%2529-propanamido%2529benzoate%2Bas%2Ba%2BNovel%2Band%2BDual%2BMalate%2BDehydrogenase%2B%2528MDH%2529%2B1%252F2%2BInhibitor%2BTargeting%2BCancer%2BMetabolism%26numPages%3D16%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D8646%26publicationDate%3DOctober%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b01231"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2089</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">11</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b01231" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Methyl 3-(3-(4-(2,4,4-Trimethylpentan-2-yl)phenoxy)-propanamido)benzoate as a Novel and Dual Malate Dehydrogenase (MDH) 1/2 Inhibitor Targeting Cancer Metabolism&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Ravi&quot;,&quot;last_name&quot;:&quot;Naik&quot;},{&quot;first_name&quot;:&quot;Hyun&quot;,&quot;last_name&quot;:&quot;Seung Ban&quot;},{&quot;first_name&quot;:&quot;Kyusic&quot;,&quot;last_name&quot;:&quot;Jang&quot;},{&quot;first_name&quot;:&quot;Inhyub&quot;,&quot;last_name&quot;:&quot;Kim&quot;},{&quot;first_name&quot;:&quot;Xuezhen&quot;,&quot;last_name&quot;:&quot;Xu&quot;},{&quot;first_name&quot;:&quot;Dipesh&quot;,&quot;last_name&quot;:&quot;Harmalkar&quot;},{&quot;first_name&quot;:&quot;Seong-Ah&quot;,&quot;last_name&quot;:&quot;Shin&quot;},{&quot;first_name&quot;:&quot;Minkyoung&quot;,&quot;last_name&quot;:&quot;Kim&quot;},{&quot;first_name&quot;:&quot;Bo-Kyung&quot;,&quot;last_name&quot;:&quot;Kim&quot;},{&quot;first_name&quot;:&quot;Jaehyung&quot;,&quot;last_name&quot;:&quot;Park&quot;},{&quot;first_name&quot;:&quot;Bonsu&quot;,&quot;last_name&quot;:&quot;Ku&quot;},{&quot;first_name&quot;:&quot;Sujin&quot;,&quot;last_name&quot;:&quot;Oh&quot;},{&quot;first_name&quot;:&quot;Misun&quot;,&quot;last_name&quot;:&quot;Won&quot;},{&quot;first_name&quot;:&quot;Kyeong&quot;,&quot;last_name&quot;:&quot;Lee&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;16&quot;,&quot;issue&quot;:&quot;20&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;8631-8646&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b01231&quot;},&quot;abstract&quot;:&quot;Previously, we reported a hypoxia-inducible factor (HIF)-1 inhibitor LW6 containing an (aryloxyacetylamino)benzoic acid moiety inhibits malate dehydrogenase 2 (MDH2) using a chemical biology approach. Structure–activity relationship studies on a series of (aryloxyacetylamino)benzoic acids identified selective MDH1, MDH2, and dual inhibitors, which were used to study the relationship between MDH enzyme activity and HIF-1 inhibition. We hypothesized that dual inhibition of MDH1 and MDH2 might be a powerful approach to target cancer metabolism and selected methyl-3-(3-(4-(2,4,4-trimethylpentan-2-yl)phenoxy)propanamido)-benzoate (16c) as the most potent dual inhibitor. Kinetic studies revealed that compound 16c competitively inhibited MDH1 and MDH2. Compound 16c inhibited mitochondrial respiration and hypoxia-induced HIF-1α accumulation. In xenograft assays using HCT116 cells, compound 16c demonstrated significant in vivo antitumor efficacy. This finding provides concrete evidence that inhibition of both MDH1 and&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01231&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01231" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01231&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01231" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01231&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01231" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01231&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01231&amp;href=/doi/10.1021/acs.jmedchem.7b01231" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b01231" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b01231" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b01231%26sid%3Dliteratum%253Aachs%26pmid%3D28991459%26genre%3Darticle%26aulast%3DNaik%26date%3D2017%26atitle%3DMethyl%2B3-%25283-%25284-%25282%252C4%252C4-Trimethylpentan-2-yl%2529phenoxy%2529-propanamido%2529benzoate%2Bas%2Ba%2BNovel%2Band%2BDual%2BMalate%2BDehydrogenase%2B%2528MDH%2529%2B1%252F2%2BInhibitor%2BTargeting%2BCancer%2BMetabolism%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D20%26spage%3D8631%26epage%3D8646%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292349" title="Alkyls">Alkyls</a>,</li><li><a href="/action/doSearch?ConceptID=291774" title="Nuclear magnetic resonance spectroscopy">Nuclear magnetic resonance spectroscopy</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/20" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/jmcmar.2017.60.issue-20/20171026/jmcmar.2017.60.issue-20.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/medium/jm-2017-01231h_0018.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/large/jm-2017-01231h_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01231&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Previously, we reported a hypoxia-inducible factor (HIF)-1 inhibitor LW6 containing an (aryloxyacetylamino)benzoic acid moiety inhibits malate dehydrogenase 2 (MDH2) using a chemical biology approach. Structure–activity relationship studies on a series of (aryloxyacetylamino)benzoic acids identified selective MDH1, MDH2, and dual inhibitors, which were used to study the relationship between MDH enzyme activity and HIF-1 inhibition. We hypothesized that dual inhibition of MDH1 and MDH2 might be a powerful approach to target cancer metabolism and selected methyl-3-(3-(4-(2,4,4-trimethylpentan-2-yl)phenoxy)propanamido)-benzoate (<b>16c</b>) as the most potent dual inhibitor. Kinetic studies revealed that compound <b>16c</b> competitively inhibited MDH1 and MDH2. Compound <b>16c</b> inhibited mitochondrial respiration and hypoxia-induced HIF-1α accumulation. In xenograft assays using HCT116 cells, compound <b>16c</b> demonstrated significant in vivo antitumor efficacy. This finding provides concrete evidence that inhibition of both MDH1 and MDH2 may provide a valuable platform for developing novel therapeutics that target cancer metabolism and tumor growth.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31857" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31857" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Metabolic alterations, including aerobic glycolysis, high fatty acid synthesis, and rapid glutamine metabolism, are characteristics of cancer cells.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Notably, a high glycolysis rate is important for ATP production, biosynthesis, and redox control in cancer cells. In addition, the malate–aspartate shuttle has been demonstrated to be crucial for the net transfer of cytosolic NADH produced during glycolysis into the mitochondria.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2, 3)</a> The malate–aspartate shuttle is operated by two pairs of enzymes, malate dehydrogenases (MDHs) and glutamate oxaloacetate transaminases (GOTs), which are localized to the mitochondria and cytoplasm (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>).<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Amino-oxyacetic acid (AOA), a specific inhibitor of the malate–aspartate shuttle, impairs the conversion of glucose into tricarboxylic acid (TCA) cycle products and decreases the proliferation of breast adenocarcinoma cells.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Moreover, mitochondrial GOT2 acetylation stimulates the malate–aspartate NADH shuttle activity to support ATP production needed for pancreatic tumor growth.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Knockdown of the <i>GOT1/2</i> genes inhibits cell proliferation and colony formation of pancreatic cancer cells.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/medium/jm-2017-01231h_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/large/jm-2017-01231h_0019.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Schematic overview of the malate–aspartate shuttle. The malate–aspartate shuttle is operated by malate dehydrogenases (MDHs) and glutamate oxaloacetate transaminases (GOTs). MDH1 in the cytoplasm reduces oxaloacetate to malate while oxidizing NADH to NAD<sup>+</sup>. Then, malate is transported to the interior of the mitochondrion and oxidized once again to oxaloacetate by mitochondrial MDH2, thereby generating NADH to produce ATP in the electron transport chain (ETC).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/large/jm-2017-01231h_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01231&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The two essential MDH isoenzymes, MDH1 and MDH2, are encoded by distinct <i>MDH</i> genes in humans and are localized in the cytosol and mitochondrial matrix, respectively. MDH1 and MDH2 catalyze the reversible conversion of malate and oxaloacetate (OAA) using the NAD/NADH cofactor system.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7, 8)</a> In the cytoplasm, MDH1 reduces OAA to malate while oxidizing NADH to NAD<sup>+</sup>. In the malate–aspartate shuttle, malate is transported to the interior of the mitochondrion and oxidized once again to OAA by mitochondrial MDH2, thereby generating NADH, which enters the ETC to produce ATP. Notably, MDH2 is also involved in the TCA cycle which is needed for energy production through respiration.</div><div class="NLM_p">Although the involvement of MDH in cancer is not currently a major focus in the field of cancer metabolism, there are evidence for the cancer-associated functions of MDH1 and MDH2. Glutamine-dependent pancreatic ductal adenocarcinoma (PDAC) cells require MDH1 to maintain their cellular redox state by reprograming glutamine metabolism, and MDH1 knockdown inhibited the viability of PDAC cells.<a onclick="showRef(event, 'ref7 ref9'); return false;" href="javascript:void(0);" class="ref ref7 ref9">(7, 9)</a> In addition, knockdown of MDH1 decreased the viability of BT474, Erb-B2 receptor tyrosine kinase 2 (<i>ERBB2</i>)-positive breast cancer cells, by suppressing the fatty acid synthesis pathway.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> In another study, MDH1 stabilized by glucose depletion translocates to the nucleus and interacts with p53 to regulate the transcription of the p53-dependent metabolic checkpoint.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> It has also been shown that high expression of MDH2 is associated with shorter relapse-free survival and chemoresistance in prostate cancer patients.<a onclick="showRef(event, 'ref6 ref8'); return false;" href="javascript:void(0);" class="ref ref6 ref8">(6, 8)</a> MDH2 knockdown suppresses proliferation and enhances docetaxel sensitivity via induced metabolic inefficiency of prostate cancer cells.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a></div><div class="NLM_p">Homology analysis of MDH1 and MDH2 reveals 26% identity and 43% similarity as measured by Protein–Protein Blast (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01231/suppl_file/jm7b01231_si_001.pdf" class="ext-link">Figure S1</a>, Supporting Information). Of note, the substrate-associated residues of human MDH1 were well-matched to those of MDH2 in a sequence alignment as they showed 63% similarity (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01231/suppl_file/jm7b01231_si_001.pdf" class="ext-link">Figure S2</a>, Supporting Information), which is greater than the homology between the entire regions of the two proteins. Considering that the structures of the substrate binding and active sites of MDH1 and MDH2 are very similar, we hypothesized that the development of an MDH1/2 dual inhibitor might be an achievable and attractive approach to target cancer metabolism. Recently, we identified mitochondrial MDH2 as a target molecule of methyl 3-(2-(4-((3<i>r</i>,5<i>r</i>,7<i>r</i>)-adamantan-1-yl)phenoxy)acetamido)-4-hydroxybenzoate (LW6, <b>1</b>),<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> a hypoxia-inducible factor (HIF)-1α inhibitor, using its chemical probe, prop-2-yn-1-yl 3-(2-(4-((3<i>r</i>,5<i>r</i>,7<i>r</i>)-adamantan-1-yl)-2-(3-(trifluoromethyl)-3<i>H</i>-diazirin-3-yl)phenoxy)acetamido)-4-hydroxybenzoate (<b>2</b>, <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>).<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a><b>1</b> inhibits MDH2 activity by binding the NAD-binding site in a competitive fashion. Cancer cells treated with <b>1</b> showed reduced oxygen consumption and increased local cellular oxygen tension, thereby promoting HIF-1α degradation under hypoxic conditions.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> HIF-1α correlates with the aggressive growth of solid tumors, resistance to radiation and chemotherapy, and poor clinical outcomes.<a onclick="showRef(event, 'ref14 ref15 ref16 ref17 ref18 ref19 ref20 ref21 ref22 ref23 ref24 ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref14 ref15 ref16 ref17 ref18 ref19 ref20 ref21 ref22 ref23 ref24 ref25 ref26">(14-26)</a> The HIF-1α/β complex binds to hypoxia-responsive elements (<i>HRE</i>s) in the promoter of hypoxia-responsive genes, including vascular endothelial growth factor (<i>VEGF</i>) and glucose transporter 1 (<i>GLUT1</i>).<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/medium/jm-2017-01231h_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/large/jm-2017-01231h_0020.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Malate dehydrogenase (MDH) inhibitor design.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/large/jm-2017-01231h_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01231&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Although the functional importance of MDH1 and MDH2 has been elucidated, the rationale for the development of MDH inhibitors as anticancer agents has not yet been reported. Therefore, in this study, we attempted to develop potent MDH inhibitors based on the structure–activity relationship (SAR) of compound <b>1</b>. We then determined the inhibitory activity of these derivatives against MDH and evaluated the relationship between their activity and inhibition of HIF-1 and cancer cell metabolism. Finally, we identified a methyl 3-(3-(4-(2,4,4-trimethylpentan-2-yl)phenoxy)propanamido)benzoate (<b>16c</b>) as a dual inhibitor of MDH1/2 that showed significant tumor reduction in a colorectal cancer xenograft model.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53680" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53680" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Chemistry</h3><div class="NLM_p">To develop novel MDH inhibitors, compound <b>1</b> derivatives were synthesized as indicated in <a class="ref internalNav" href="#sch1" aria-label="Schemes 1">Schemes 1</a>–<a class="ref internalNav" href="#sch4" aria-label="4">4</a>. The carboxylic acid derivatives <b>4a</b>–<b>l</b> were prepared using a two-step synthesis. The hydroxyl groups of phenols <b>3a</b>–<b>l</b> were subjected to alkylation using ethyl chloroacetate in the presence of potassium carbonate (K<sub>2</sub>CO<sub>3</sub>) in dimethylformamide (DMF), and the resulting ethyl ester was hydrolyzed with lithium hydroxide to obtain <b>4a</b>–<b>l</b>.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> These resulting carboxylic acids were subsequently used to prepare amide derivatives (<b>5a</b>–<b>l</b>) using the standard amide coupling method (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/medium/jm-2017-01231h_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/large/jm-2017-01231h_0006.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Amide Derivatives <b>5a</b>–<b>l</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/large/jm-2017-01231h_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01231&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) EDC·HCl, <i>N</i>-(3-(dimethylamino)propyl)-<i>N</i>′-ethylcarbonate hydrochloride; HOBT, 1-hydroxybenzotriazole; DIPEA, <i>N</i>,<i>N</i>-diisopropylethylamine; DMF, dimethylformamide.</p></p></figure><div class="NLM_p">Coupling of the commercially available methyl 3-amino-4-hydroxybenzoate with 4-adamantyl phenoxyacetic (<b>4a</b>) or 2-(4-(2,4,4-trimethylpentan-2-yl)phenoxy)acetic acid (<b>4l</b>) in the presence of <i>N</i>-(3-(dimethylamino)propyl)-<i>N</i>′-ethylcarbonate hydrochloride (EDC·HCl), 1-hydroxybenzotriazole (HOBT), and <i>N</i>,<i>N</i>-diisopropylethylamine (DIPEA) yielded the hydroxylated analogues, <b>1</b> or <b>6</b>, respectively. <i>O</i>-Alkylation of <b>1</b> and <b>6</b> with alkyl or aryl halide produced 4-adamantyl and trimethylpentanyl derivatives (<b>7a</b>–<b>f</b>, <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). Additionally, <b>4l</b> was coupled with various amines to produce the respective amide derivatives (<b>8a</b>–<b>f</b>), as shown in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/medium/jm-2017-01231h_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/large/jm-2017-01231h_0007.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of 4-Adamantyl and Trimethylpentane Derivatives <b>7a</b>–<b>f</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/large/jm-2017-01231h_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01231&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) methyl 3-amino-4-hydroxybenzoate EDC·HCl, <i>N</i>-(3-(dimethylamino)propyl)-<i>N</i>′-ethylcarbonate hydrochloride; HOBT, 1-hydroxybenzotriazole; DIPEA, <i>N</i>,<i>N</i>-di-isopropylethylamine; DMF, dimethylformamide; (b) alkyl or aryl halide, potassium carbonate (K<sub>2</sub>CO<sub>3</sub>), DMF.</p></p></figure><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/medium/jm-2017-01231h_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/large/jm-2017-01231h_0008.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Trimethylpentane Derivatives <b>8a</b>–<b>f</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/large/jm-2017-01231h_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01231&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) amines, EDC·HCl, <i>N</i>-(3-(dimethylamino)propyl)-<i>N</i>′-ethylcarbonate hydrochloride; HOBT, 1-hydroxybenzotriazole; DIPEA, <i>N</i>,<i>N</i>-diisopropylethylamine; DMF, dimethylformamide.</p></p></figure><div class="NLM_p">Some of the key intermediate (<i>E</i>)-phenoxyacrylic acid derivatives (<b>12a</b> and <b>12b</b>) were synthesized from phenols <b>3a</b> and <b>3l</b> using previously described procedures<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>). The hydroxyl groups of phenols <b>3a</b> and <b>3l</b> were alkylated with methyl propiolate in the presence of triphenylphosphine (PPh<sub>3</sub>) in toluene, and the resulting (<i>E</i>)-phenoxyacrylic methyl esters (<b>9a</b> and <b>9b</b>) were hydrolyzed with lithium hydroxide to form <b>12a</b> and <b>12b</b>. Other key intermediates, such as the propionic acids (<b>13a</b> and <b>13b</b>) and butanoic acids (<b>11a</b> and <b>11c</b>), and the branched propanoic acids (<b>11b</b> and <b>11d</b>) were also synthesized from <b>3a</b> or <b>3l</b>, respectively (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>). The phenoxyacrylic portions of <b>9a</b> and <b>9b</b> were saturated using palladium on carbon (Pd/C) catalyzed hydrogenation to generate <b>10a</b> and <b>10b</b>. To prepare the three-carbon linker part, phenols <b>3a</b> and <b>3l</b> were alkylated with methyl 4-bromobutanoate in the presence of K<sub>2</sub>CO<sub>3</sub> in DMF followed by hydrolysis to obtain <b>11a</b> and <b>11c</b>. A series of carboxylic acid derivatives were coupled with methyl 3-amino benzoate or methyl 3-amino-4-hydroxybenzoate in the presence of EDC, HOBT, and DIPEA to produce the amide derivatives <b>14a</b>–<b>f</b>, <b>15a</b>–<b>b</b>, and <b>16a</b>–<b>c</b>, as shown in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>.</div><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/medium/jm-2017-01231h_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/large/jm-2017-01231h_0009.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of 4-Adamantyl and Trimethylpentane Derivatives <b>14a</b>–<b>f</b>, <b>15a</b>–<b>b</b>, and <b>16a</b>–<b>c</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/large/jm-2017-01231h_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01231&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) K<sub>2</sub>CO<sub>3</sub>, methyl 4-bromobutanoate for <b>11a</b> and <b>11c</b> and methyl 2-bromo-2-methylpropanoate for <b>11b</b> and <b>11d</b>, DMF, (ii) LiOH, THF/H<sub>2</sub>O; (b) PPh<sub>3</sub>, methyl propiolate, toluene; (c) Pd/C, H<sub>2</sub>, MeOH; (d,e) LiOH, THF/H<sub>2</sub>O; (f,g,h) EDC·HCl, HOBT, DIPEA, DMF, methyl 3-amino-4-hydroxybenzoate for <b>14c</b>, <b>14f</b>, and <b>16b</b> and methyl 3-aminobenzoate for <b>14a</b>,<b>b</b>, <b>14d</b>,<b>e</b>, <b>15a</b>,<b>b</b>, and <b>16a</b>,<b>c</b>.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> MDH Enzyme Assay</h3><div class="NLM_p">The newly synthesized compounds were evaluated for their ability to inhibit human recombinant MDH1 and MDH2 enzymatic activity using an oxaloacetate-dependent NADH oxidation assay (<a class="ref internalNav" href="#tbl1" aria-label="Tables 1">Tables 1</a>–<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). Compound <b>1</b> showed good inhibitory activities toward both enzymes. To define the key structural requirements for biological activity of the aryloxyacetylamino benzoic acid derivatives, our optimization strategy focused on three discrete areas: (A) the 4-adamantyl phenyl ring, which could be replaced by a phenyl ring containing various substituents, (B) the aminophenyl ring, and (C) modifications that included replacing the oxyacetylamide linker portion (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>).</div><div class="NLM_p">For SAR for part A, we started with a 4-adamantyl (aryloxyacetylamino)benzoic ester analogue <b>5a</b>, which induced mild inhibitory activity against both MDH1 and MDH2 enzymes (IC<sub>50</sub> = 23.48 ± 1.64 and 15.97 ± 2.02 μM, respectively). Substitution of 4-adamantyl group with electron withdrawing groups, such as NO<sub>2</sub> and CF<sub>3</sub> (<b>5b</b> and <b>5c</b>), did not yield any MDH1/MDH2 inhibitory activity (>40 μM). Then, the 4-adamantyl group of <b>5a</b> was modified with a similar lipophilic group (<i>t</i>-butyl) to yield <b>5d</b>, which exhibited moderate inhibitory activity (IC<sub>50</sub> = 10.74 ± 1.31) against MDH1 but not against MDH2. The compounds substituted with a simple alkyl chain (methyl to <i>n</i>-propyl chain) <b>5e</b>–<b>g</b> failed to inhibit MDH enzymes up to 40 μM. Interestingly, <b>5h</b> and <b>5i</b> with <i>n</i>-butyl or <i>n</i>-pentyl moiety exhibited medium inhibitory activity against MDH1 (IC<sub>50</sub> = 9.58 ± 0.23, 6.79 ± 0.21 μM, respectively). Compounds <b>5d</b>, <b>5h</b>, and <b>5i</b> showed some selectivity to MDH1 over MDH2. For cyclopentyl <b>5j</b> and cyclohexyl <b>5k</b>, potent effects was not observed in the MDH enzyme assay. Similar to <b>5a</b>, <b>5l</b> with 2,4,4-trimethylpentanyl substituent showed dual inhibition against both MDH1 and MDH2. As listed in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>, compound <b>5l</b> demonstrated considerable inhibition against MDH1 and MDH2 with IC<sub>50</sub> values of 6.65 ± 0.65 and 8.92 ± 1.39 μM, respectively. The presence of a trimethylpentanyl moiety may be more beneficial for MDH inhibition than an adamantyl group for the phenoxyacetamido platform (<b>5a</b> vs <b>5l</b>). These findings suggested that the presence of a 2,4,4-trimethylpentanyl substituent or an equivalent for part A is important for the effective inhibition of MDH enzymes (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. In Vitro MDH1 and MDH2 Inhibitory Activity of Amide Derivatives <b>5a</b>–<b>l</b><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/medium/jm-2017-01231h_0010.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/medium/jm-2017-01231h_0011.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Values are the means of three experiments.</p></div></div><div></div></div><div class="NLM_p">On the basis of the encouraging results for compound <b>5l</b>, a further optimization study focused on analogues with an adamantly or trimethylpentanyl moiety. In addition, we observed that the introduction of a hydroxyl group into the phenyl ring at part B (<b>5a</b> vs <b>1</b>) resulted in increased potency against both MDH1 and MDH2. Notably, in this study, we found that a known MDH2 inhibitor <b>1</b><a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> showed better activity against MDH1 (IC<sub>50</sub> = 1.10 ± 1.10 μM) than MDH2, whereas the corresponding trimethylpentanyl compound <b>6</b> exhibited more potency and dual inhibitory activity against MDH1 and MDH2 (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). Interestingly, compound <b>5</b> (with phenolic OH at part B) exhibited greater inhibitory activity than <b>5l</b> against both MDH1 and MDH2 enzymes (IC<sub>50</sub> = 1.14 ± 0.09 and 1.89 ± 0.18 μM, respectively). This finding suggested that OH-containing compounds (i.e., <b>1</b> and <b>6</b>) with an oxyacetamide linker shows better feasibility for MDH enzyme inhibition. The alkylation of the hydroxyl group (<b>1</b> or <b>6</b>) with cyclic amine-substituted alkyl groups or a methoxy-substituted alkyl group led to analogues <b>7a</b>,<b>b</b> and <b>7d</b>,<b>e</b>, which resulted in the loss of activity. Methoxy compound <b>7c</b> with 2,4,4-trimethylpentane scaffold showed 12-fold selective MDH1 activity over MDH2 (IC<sub>50</sub> = 2.27 ± 0.32 and 27.47 ± 0.16 μM, respectively). By contrast, the propargylated compound <b>7f</b> maintained its relative inhibitory activity against both MDH1 and MDH2. This finding suggests that the free OH group in <b>1</b> or <b>6</b> is important for its interaction with the protein (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. In Vitro MDH1 and MDH2 Inhibitory Activity of Amide Derivatives <b>1</b>, <b>6</b>, and <b>7a</b>–<b>f</b><a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/medium/jm-2017-01231h_0012.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/medium/jm-2017-01231h_0013.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>Table a</sup><p class="last">Values are the means of three experiments.</p></div></div><div></div></div><div class="NLM_p">Using the best analogue, <b>6</b>, among the compounds shown in <a class="ref internalNav" href="#tbl1" aria-label="Tables 1">Tables 1</a>–<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, we explored part B with further modifications using a variety of amines (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>, <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). The trifluoromethyl group will pull or withdraw electrons through either resonance or induction to the aromatic group, as shown for compound <b>8a</b>. Adjacent functional groups, as well as the presence or absence of direct attachment to an aromatic ring, will determine the relative involvement of these two processes. CF<sub>3</sub>-phenyl compound <b>8a</b> exhibited less activity than <b>6</b> against both MDH1 and MDH 2 with IC<sub>50</sub> values of 3.44 ± 0.43 and 1.53 ± 0.08 μM, respectively. Notably, 2-(4-(adamantan-1-yl)phenoxy)-1-(4-methylpiperazin-1-yl)ethanone (IDF-11774) is a potent HIF-1 inhibitor that is approved as a clinical candidate for cancer therapy.<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28, 29)</a> A number of piperazine compounds showed various biological activities with favorable properties. Herewith, we prepared amide derivatives with various piperazine groups in different positions. However, piperazine-containing compounds <b>8b</b> and <b>8c</b> showed moderate activity against both MDH1 and MDH2. Compound <b>8d</b>, with 1-(prop-2-ynyl)piperazine, completely lost activity. Interestingly, propargyl ester (<b>8e</b>) showed potency against MDH1 with an IC<sub>50</sub> value of 0.92 ± 0.28 μM. The hydroxyl-adamantane containing amide <b>8f</b> showed weak inhibitory activity against both MDH1 and MDH2 (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. In Vitro MDH1 and MDH2 Inhibitory Activity of Amide Derivatives <b>8a</b>–<b>f</b><a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/medium/jm-2017-01231h_0014.gif" alt="" id="fx5" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/medium/jm-2017-01231h_0015.gif" alt="" id="fx6" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">Values are the means of three experiments.</p></div></div><div></div></div><div class="NLM_p">As summarized in <a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>, our SAR study showed that altering the carbon linker (part C) between the alkyl substituted phenyl ring (part A) and amino phenyl (part B) of the phenoxyacetamides was a useful strategy for inducing MDH inhibition. Notably, the addition of branched carbons (<b>14d</b> and <b>14e</b>) to the corresponding acetamides apparently increased potency against both MDH1 and MDH2. Interestingly, the 2,4,4-trimethylpentanyl derivative with branched carbon and hydroxyl groups in the phenyl ring (<b>14f</b>) was more selective to MDH1 than MDH2 (IC<sub>50</sub> = 3.00 ± 0.03 and 10.98 ± 0.79 μM, respectively). One- to two-carbon homologations (<b>14a</b>,<b>b</b>, <b>16a</b>, and <b>16c</b>) to the acetamide <b>5a</b> and <b>5l</b> resulted in a significant increase in MDH1 and MDH2 enzyme potency, as shown in <a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>. In contrast, one- to two-carbon homologations (<b>14c</b> and <b>16b</b>) to the OH containing acetamide <b>6</b> was not helpful for improvement of activity. Among the series, compound <b>16c</b> showed the most potent and dual inhibitory activity against both MDH enzymes (IC<sub>50</sub> = 1.07 ± 0.07 and 1.06 ± 0.03 μM, respectively). It was found that homologation (<b>14a</b> and <b>16a</b>) for the 4-adamantyl derivatives resulted in lower potency than that of the trimethylpentane derivatives (<b>14a</b> and <b>16c</b>). According to previous studies, various compounds with 4-(2,4,4-trimethylpentan-2-yl)phenoxy pendent groups were reported to be useful for the treatment of some chronic diseases, including inflammation, diabetes, hyperglycemia, and cancers.<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30, 31)</a> For the 2,4,4-trimethylpentane-based compounds, the introduction of a more conformationally constrained oxyacrylic amide linker, as represented by <b>15b</b>, induced better MDH inhibitory activity. By contrast, the corresponding 4-adamantyl compound (<b>15a</b>) showed MDH2-selectivity (6-fold) over MDH1. For compounds that contained OH groups with a modified linker (<b>14c</b>, <b>14f</b>, and <b>16b</b>), the MDH1 and MDH2 enzymes inhibitory activity profiles were different for acetamide scaffold with OH groups (i.e., <b>1</b> and <b>6</b>). The one-carbon homologated compound <b>16b</b> (with OH group) was less potent than <b>16c</b> (without OH) against MDH1 and MDH2 enzymes with IC<sub>50</sub> = 1.54 ± 0.02 and 4.60 ± 0.32 μM, respectively. Similarly, compound <b>14c</b> containing two carbon homologated linkers with OH group was less active against MDH1 and MDH2 enzymes compared to compound <b>14b</b> (IC<sub>50</sub> = 1.18 ± 0.08 and 1.11 ± 0.04 μM, respectively). This pattern did not change for branched carbon linker compounds with or without a OH group (<b>14e</b> vs <b>14f</b>). Compound <b>14f</b> (with −OH group) lost some potency against MDH1 and MDH2 enzymes with IC<sub>50</sub> = 3.00 ± 0.03 and 10.98 ± 0.79 μM, respectively, than the corresponding OH-free compound <b>14e</b>. This finding suggests that the MDH1 and MDH2 inhibitory activities for compounds with or without a OH group at part B was dependent on the carbon linker.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. In Vitro MDH1 and MDH2 Inhibitory Activity of Linker Modified Derivatives <b>14a</b>–<b>f</b>, <b>15a</b>–<b>c</b>, and <b>16a</b>–<b>c</b><a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/medium/jm-2017-01231h_0016.gif" alt="" id="fx7" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/medium/jm-2017-01231h_0017.gif" alt="" id="fx8" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>Table a</sup><p class="last">Values are the means of three experiments.</p></div></div><div></div></div><div class="NLM_p">To date, several MDH inhibitors have been reported. A thyroid hormone thyroxine (T4) was described to suppresses MDH2 activity with an IC<sub>50</sub> value of 43.6 μM.<a onclick="showRef(event, 'ref8 ref32'); return false;" href="javascript:void(0);" class="ref ref8 ref32">(8, 32)</a> A staurosporine aglycone K252c also inhibits MDH activity with an IC<sub>50</sub> value of 8 μM.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> However, this compound mainly suppresses PKC and PKA with IC<sub>50</sub> values of 2.45 and 25.7 μM, respectively. Considering the importance of MDH enzymes in cancer metabolism, more potent and selective inhibitors are required for in-depth mechanistic studies and drug development. However, we cannot exclude the possibility of off-target effects of MDH inhibitors because compounds may have multitargeting properties. It may affect the activity of metabolic enzymes involving NADH–NAD conversion. Additionally, it is not easy to increase the selectivity of the compound toward MHD1 or MDH2 because they share common NADH binding sites of 63% similarity based on structural superimposition (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01231/suppl_file/jm7b01231_si_001.pdf" class="ext-link">Figure S2</a>, Supporting Information). Therefore, on the basis of these considerations, compounds such as <b>5i</b>,<b>7</b>, <b>16a</b>, <b>14b</b>, and <b>16c</b> may have advantages in both activity and selectivity as MDH inhibitors. As listed in <a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>, compounds <b>5i</b> and <b>7c</b> were categorized as selective MDH1 inhibitors, while most compounds that inhibited MDH2 activity also inhibited MDH1, as demonstrated by <b>14b</b> and <b>16c</b>, which were termed dual MDH1/2 inhibitors. The phenoxyacrylic linker-containing <b>15a</b> was selected as a selective MDH2 inhibitor. According to a docking study using X-ray crystal data for MDH1 (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5MDH">5MDH</a>) and MDH2 (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2DFD">2DFD</a>), the flexible nature of the homologated linker domain of <b>16c</b> may be helpful for binding both NAD sites of the enzymes (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01231/suppl_file/jm7b01231_si_001.pdf" class="ext-link">Figure S3</a>, Supporting Information).</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Cell-Based HRE-Luc Inhibitory Activity by the Representative Compounds<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" align="center">HRE</th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">MDH selectivity</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5i</b></td><td class="colsep0 rowsep0" align="center">>40</td><td class="colsep0 rowsep0" align="center">selective MDH1 inhibitor</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7c</b></td><td class="colsep0 rowsep0" align="center">>40</td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="left">     </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15a</b></td><td class="colsep0 rowsep0" align="center">0.74 ± 0.06</td><td class="colsep0 rowsep0" align="center">selective MDH2 inhibitor</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="left">     </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14b</b></td><td class="colsep0 rowsep0" align="center">1.40 ± 0.38</td><td class="colsep0 rowsep0" align="center">dual MDH1/2 inhibitor</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16c</b></td><td class="colsep0 rowsep0" align="center">1.08 ± 0.06</td><td class="colsep0 rowsep0" align="center"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Values are the means of three experiments.</p></div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Cell-Based HRE Reporter Assay</h3><div class="NLM_p">Next, we assessed whether the inhibition of MDH1 or MDH2 enzymes was related to the outputs of the HRE-luciferase activity, which indicates HIF-1α inhibition (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>). The hypoxia-induced HIF-1 activities of the representative compounds were determined using a cell-based HRE reporter assay in HCT116. We followed a previously described assay protocol under standard hypoxic assay conditions (1% O<sub>2</sub>, 94% N<sub>2</sub>, and 5% CO<sub>2</sub>).<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Cell viability, as measured using the methylene blue assay, showed that all of the compounds had no significant cytotoxicity at concentrations at which they effectively inhibited HIF-1 activation (>40 μM). The MDH1 inhibitors <b>5i</b> and <b>7c</b> did not show potent effects in the HRE assay. However, the MDH2-selective inhibitor <b>15a</b> and the dual MDH1/2 inhibitors <b>14b</b> and <b>16c</b> strongly suppressed HRE-luciferase activity. This finding is consistent with the previous report that inhibition of MDH2 suppresses mitochondrial respiration and increases oxygen content, thereby stimulating HIF-1α degradation in cancer cells.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Then, to further confirm the role of MDH1, MDH2, or both MDH1 and MDH2 activity in HIF-1α accumulation, intracellular oxygen content was determined using a mono azo rhodamine (MAR) fluorescent hypoxia probe, (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01231/suppl_file/jm7b01231_si_001.pdf" class="ext-link">Figure S4</a>, Supporting Information). On the basis of the MDH enzyme and cell-based HRE assays results, the MDH1 selective agents (<b>5i</b> and <b>7c</b>) did not affect the fluorescence of MAR. However, <b>14b</b> and <b>16c</b> that showed MDH2 inhibitory activity significantly reduced MAR fluorescence, indicating increased intracellular oxygen contents.</div><div class="NLM_p">As previously reported, the roles of MDH1 and MDH2 are related to cancer cell metabolism. MDH1 and ME1 convert malate to pyruvate for palmitate synthesis to generate NADH, which supplies the NADPH required for the synthesis and elongation of fatty acids.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> It has been reported that the inhibition of MDH1 induced anticancer activity by suppressing fatty acid synthesis. Moreover, MDH2 inhibition reduced the loss of NADH and inhibited mitochondrial respiration, resulting in increased oxygen contents and stimulation of HIF-1α degradation. MDH2 knockdown may induce anticancer activity by reducing HIF-1α accumulation and sensitizing chemoresistant cancer cells.</div><div class="NLM_p">In addition to the specific roles of MDH1 and MDH2, both enzymes are associated with the malate–aspartate shuttle. This process involves a reaction between NADH and oxaloacetate in the cytosol, and the malate is transported into the mitochondria and subsequently reoxidized by the electron transfer chain. The malate–aspartate shuttle facilitates the translocation of electrons across the mitochondrial membrane, thereby regulating metabolic coordination between the cytosol and mitochondria. Indeed, the malate–aspartate shuttle is crucial for the net transfer of cytosolic NADH into mitochondria to maintain a high rate of glycolysis to support rapid tumor cell growth. Therefore, compounds that inhibit both MDH1 and MDH2, such as <b>14b</b> and <b>16c</b>, are expected to have considerable anticancer activity. Among the series described in this study, we discovered that compound <b>16c</b> exhibited the strongest inhibition of both MDH1 and MDH2 and showed potent inhibition against HIF-1. To elucidate the inhibitory mechanism of compound <b>16c</b> on MDH1 and MDH2 activity, an enzyme kinetics study was performed using various NADH concentrations. Double-reciprocal plots of enzyme kinetics revealed a competitive mode of MDH1 and MDH2 inhibition by compound <b>16c</b> with <i>K</i><sub>i</sub> values of 0.74 and 0.95 μM, respectively (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A,B). Additionally, we found that the trimethylpentane derivative <b>16c</b> showed reasonable water solubility (94.4 ± 0.50 μM at pH 7.4), which was superior to that of another dual MDH1/2 inhibitor, <b>14b</b> (45.8 ± 1.45 μM at pH 7.4, <a href="/doi/suppl/10.1021/acs.jmedchem.7b01231/suppl_file/jm7b01231_si_001.pdf" class="ext-link">Table S1</a>, Supporting Information) and, therefore, merits further evaluation as a novel anticancer agent for targeting cancer cell metabolism.</div><figure id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/medium/jm-2017-01231h_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/large/jm-2017-01231h_0001.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Mode of malate dehydrogenase (MDH) inhibition by compound <b>16c</b>. Enzyme kinetics of (A) MDH1 and (B) MDH2 were performed at various concentrations of NADH. Concentrations of compound <b>16c</b>: 0 μM (●), 0.625 μM (○), 1.25 μM (▼closed triangle), and 2.5 μM (▽).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/large/jm-2017-01231h_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01231&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Effects on HIF-1α Pathway and Oxygen Tension</h3><div class="NLM_p">Following the identification of a novel MDH1/2 dual inhibitor, we examined the effects of compound <b>16c</b> on HIF-1α signaling in HCT116 cells. Under hypoxic conditions, treatment with compound <b>16c</b> suppressed hypoxia-induced HIF-1α accumulation in a concentration-dependent manner (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>A). As expected, compound <b>16c</b> inhibited the expression of HIF-1α target genes, including <i>VEGF</i>, <i>GLUT1</i>, and pyruvate dehydrogenase kinase 1 (<i>PDK1</i>), without affecting the levels of HIF-1α mRNA (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>B).</div><figure id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/medium/jm-2017-01231h_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/large/jm-2017-01231h_0002.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Inhibition of hypoxia-induced hypoxia-inducible factor-1 (HIF-1)-α activation by compound <b>16c</b>. (A) Effects of compound <b>16c</b> on hypoxia-induced HIF-1α accumulation. After treatment of HCT116 cells with compound <b>16c</b> under hypoxic conditions, proteins were detected using immunoblot analysis in HCT116 cells. (B) Effects of compound <b>16c</b> on mRNA expression levels of HIF-1α target genes were detected using reverse transcription–polymerase chain reaction (RT-PCR) analysis.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/large/jm-2017-01231h_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01231&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To characterize the inhibitory mechanism of compound <b>16c</b> against HIF-1α accumulation, we further examined its effects on mitochondrial respiration using an XF24 extracellular flux analyzer. Compound <b>16c</b> reduced the oxygen consumption rate (OCR), indicating the inhibition of mitochondrial respiration (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>A). In the presence of compound <b>16c</b>, the reduction of intracellular ATP levels resulted in the phosphorylation of adenosine monophosphate (AMP)-activated protein kinase (AMPK), which inactivated acetyl-CoA carboxylase (ACC), a downstream target of AMPK (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>B,C). Furthermore, staining with the hypoxia-detecting probe MAR showed that compound <b>16c</b> increased intracellular oxygen tension, presumably because of reduced OCR, resulting in HIF-1α degradation under hypoxic conditions (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>D).</div><figure id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/medium/jm-2017-01231h_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/large/jm-2017-01231h_0003.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Inhibition of mitochondrial respiration by compound <b>16c</b>. (A) Oxygen consumption rate (OCR) was measured using XF24 extracellular flux analyzer by adding oligomycin (1 μM), carbonyl cyanide <i>p</i>-trifluoromethoxy-phenylhydrazone (FCCP, 0.5 μM), and rotenone (1 μM)/antimycin A (1 μM) to compound <b>16c</b>-treated HCT116 cells. (B) Adenosine monophosphate (AMP)-activated protein kinase (AMPK) activation was determined using immunoblot analysis with each specific antibody. (C) The intracellular adenosine triphosphate (ATP) content of compound <b>16c</b>-treated HCT116 cells was measured using a luciferase-based assay system. (D) Intracellular oxygen tension was determined using a hypoxia-sensitive probe mono azo rhodamine (MAR, 0.5 μM). Scale bar, 100 μm. Fluorescence intensity of the MAR probe is shown by vertical bars; *<i>P</i> < 0.05 and **<i>P</i> < 0.01, compared with hypoxic control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/large/jm-2017-01231h_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01231&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We next examined sequential electron flow of the electron transport chain (ETC) to further understand the inhibitory mechanism of mitochondrial respiration of compound <b>16c</b>. Each complex-linked respiratory process was regulated by the addition of specific substrates and inhibitors (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>A). Under these experimental conditions, compound <b>16c</b> significantly inhibited complex I-dependent respiration (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>B) without affecting complex II/III- and IV-dependent respiration (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01231/suppl_file/jm7b01231_si_001.pdf" class="ext-link">Figure S5</a>, Supporting Information). These findings suggest that the inhibition of MDHs by compound <b>16c</b> reduced complex I-dependent mitochondrial respiration.</div><figure id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/medium/jm-2017-01231h_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/large/jm-2017-01231h_0004.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Inhibition of mitochondria complex I activity by compound <b>16c</b>. (A) The exogenous substrate-dependent mitochondrial respiration rate was measured in digitonin-permeabilized HCT116 cells by adding a substrate and inhibitor of each complex. Substrates and inhibitors used were as follows: pyruvate (5 mM), malate (5 mM), rotenone (1 μM), succinate (5 mM), antimycin A (1 μM), ascorbate (5 mM), and tetramethyl-<i>p</i>-phenylenediamine (TMPD, 2 mM). (B) Inhibitory activity of compound <b>16c</b> against mitochondria complex I was determined by adding compound <b>16c</b> (30 μM) after treatment with complex I substrates.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/large/jm-2017-01231h_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01231&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> In Vivo Growth Inhibition</h3><div class="NLM_p">The in vivo antitumor efficacy of compound <b>16c</b> was analyzed using a xenograft assay of an HCT116 cell mouse model. Compound <b>16c</b> was administered intraperitoneally (20 mg/kg, once daily [qd]) for 14 days, and significant tumor growth inhibition (63.4%) was observed (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>). Moreover, compound <b>16c</b> did not cause significant adverse effects in mice, including changes in body weight and abnormalities of internal organs and behavior (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01231/suppl_file/jm7b01231_si_001.pdf" class="ext-link">Figure S6</a>, Supporting Information). In addition, we examined the combined effect of MDH1-selective compound <b>5i</b> and MDH2-selective compound <b>15a</b> on the growth of HCT116 cell xenografts (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01231/suppl_file/jm7b01231_si_001.pdf" class="ext-link">Figure S7</a>, Supporting Information). Treatment with <b>5i</b> (10 mg/kg) and <b>15a</b> (10 mg/kg) showed 34.9% and 26.2% antitumor efficacy, respectively. However, combined treatment with <b>6i</b> (10 mg/kg) and <b>15a</b> (10 mg/kg) demonstrated 79.7% inhibition of tumor growth, indicating a combination of <b>5i</b> and <b>15a</b> was more efficient than single compounds. This finding suggests that the inhibition of both MDH1 and MDH2 may induce greater efficacy of anticancer therapeutics.</div><figure id="fig7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/medium/jm-2017-01231h_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/large/jm-2017-01231h_0005.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. In vivo antitumor effects of compound <b>16c</b> in a HCT116 cell xenograft model. (A) HCT116 cells (5 × 10<sup>6</sup>) were subcutaneously inoculated into the right flank of female nude mice. Drugs were administered intraperitoneally once a day for 14 days after the tumor reached a volume of 80–100 mm<sup>3</sup>. (B) Image and weight of tumors at the end of the experiment; *<i>P</i> < 0.05 and **<i>P</i> < 0.01, compared with vehicle control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/large/jm-2017-01231h_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01231&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54345" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54345" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">This study reported a trimethylpentane derivative as a novel scaffold that exhibited MDH1 and MDH2 dual inhibitory activity. A series of trimethylpentane derivatives were newly synthesized and evaluated as potential MDH1 or MDH2 inhibitors or dual inhibitors. The SAR study of this series identified both MDH1- and MDH2-selective and MDH1/MDH2 dual inhibitors. We demonstrated that MDH2, but not MDH1 inhibitors, suppressed HRE-luciferase activity and the growth of cancer cells. Considering that dual inhibition of MDH enzymes may be a potent approach to target cancer cell metabolism, the trimethylpentane-containing ester compound <b>16c</b> was identified as a potent and dual inhibitor of MDH1/MDH2. Measurements of OCR revealed that compound <b>16c</b> inhibited mitochondrial respiration, thereby reducing APT production. Therefore, the phosphorylation of AMPK was activated to down-regulate mechanistic target of rapamycin (mTOR) signaling. In addition, decreased respiration increased cellular oxygen tension, as shown by the hypoxia probe MAR. Expectedly, compound <b>16c</b> suppressed hypoxia-induced HIF-1α accumulation and the expression of HIF-1α target genes. We also discovered that compound <b>16c</b> significantly suppressed the activity of complex I in the ETC. Moreover, in the mouse xenograft assay, compound <b>16c</b> showed strong in vivo antitumor efficacy in an HCT116 cell model. Therefore, the dual MDH1 and MDH2 inhibitor compound <b>16c</b> was demonstrated to be a potential tumor-suppressing agent, suggesting that the simultaneous inhibition of both MDH1 and MDH2 enzymes could be a crucial therapeutic strategy.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81544" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81544" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Chemistry: General</h3><div class="NLM_p last">All the commercial chemicals were of reagent grade and were used without further purification. Solvents were dried with standard procedures. All the reactions were carried out under an atmosphere of dried argon in flame-dried glassware. The proton nuclear magnetic resonance (<sup>1</sup>H NMR) spectra were determined on a Varian (300, 400, or 500 MHz) spectrometer (Varian Medical Systems, Inc., Palo Alto, CA, USA). <sup>13</sup>C NMR spectra were recorded on a Varian (100 MHz) spectrometer. The chemical shifts are provided in parts per million (ppm) downfield with coupling constants in hertz (Hz). The mass spectra were recorded using high-resolution mass spectrometry (HRMS) (electron ionization MS) obtained on a JMS-700 mass spectrometer (Jeol, Japan) or using HRMS (electrospray ionization MS) obtained on a G2 QTOF mass spectrometer. The products from all the reactions were purified by flash column chromatography using silica gel 60 (230–400 mesh Kieselgel 60). Additionally, thin-layer chromatography on 0.25 mm silica plates (E. Merck; silica gel 60 F254) was used to monitor reactions. Final product purity was checked by reversed phase high-pressure liquid chromatography (RP-HPLC), performed on a Waters Corp. HPLC system equipped with an ultraviolet (UV) detector set at 254 nm. The mobile phases used were: (A) H<sub>2</sub>O containing 0.05% trifluoroacetic acid, and (B) CH<sub>3</sub>CN. HPLC employed a YMC Hydrosphere C18 (HS-302) column (5 μm particle size, 12 nm pore size) that was 4.6 mm in diameter × 150 mm in size with a flow rate of 1.0 mL/min. Some of the starting chemicals (i.e., <b>3a</b>–<b>l</b>) were purchased from Sigma aldrich, TCI, Ark Pharma, and Combi Blocks. The compound purity was assessed using method A, a gradient of 25% B to 100% B in 35 min. The purity of all biologically evaluated compounds was >95% in method A.</div></div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> General Procedure for the Synthesis of <b>5a</b>–<b>l</b></h3><div class="NLM_p">EDCI (1.2 equiv) and HOBt (1.2 equiv) were added to a solution of appropriate phenoxyacetic acid <b>4a</b>–<b>l</b> (1.0 equiv), methyl 3-aminobenzoate (1.0 equiv), and DIPEA (2.5 equiv) in DMF, and the reaction mixture was stirred at room temperature until completion as monitored by TLC. The reaction mixture was diluted with EtOAc brine. The organic layer was separated, dried over anhydrous MgSO<sub>4</sub>, filtered, and concentrated in vacuo. The resulting residue was purified by silica gel column chromatography.</div><div id="sec4_1_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> Methyl 3-(2-(4-Adamantan-1-yl-phenoxy)acetamido)benzoate (<b>5a</b>)<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></h4><div class="NLM_p last">See ref <a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">21</a>.</div></div><div id="sec4_1_1_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> Methyl 3-(2-(4-Nitrophenoxy)acetamido)benzoate (<b>5b</b>)</h4><div class="NLM_p last">Obtained as a white solid (0.21 g, 64.2% yield). <sup>1</sup>H NMR (400 MHz, DMSO) δ 10.5 (brs, 1H), 8.33 (t, <i>J</i> = 1.8 Hz, 1H), 8.25 (d, <i>J</i> = 9.4 Hz, 2H), 7.89 (m, 1H), 7.69 (d, <i>J</i> = 7.8 Hz, 1H), 7.50 (t, <i>J</i> = 8.0 Hz, 1H), 7.23 (d, <i>J</i> = 9.0 Hz, 2H), 4.95 (s, 2H), 3.86 (s, 3H). <sup>13</sup>C NMR (100 MHz, DMSO) δ 166.4, 163.5, 141.7, 139.1, 130.6, 129.7, 126.3, 124.8, 124.5, 120.5, 115.7, 67.6, 52.7. HRMS [M + H] calcd [C<sub>16</sub>H<sub>15</sub>N<sub>2</sub>O<sub>6</sub>] 329.0852, found 329.0676. Purity 97.3% (as determined by RP-HPLC, method A, <i>t</i><sub>R</sub> = 14.62 min).</div></div><div id="sec4_1_1_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> Methyl 3-(2-(4-(Trifluoromethyl)phenoxy)acetamido)benzoate (<b>5c</b>)</h4><div class="NLM_p last">Obtained as a white solid (0.01g, 40.8% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 8.32 (s, 1H), 8.07 (s, 1H), 8.01 (d, <i>J</i> = 8.0 Hz, 1H), 7.85 (d, <i>J</i> = 7.2 Hz, 1H), 7.64 (d, <i>J</i> = 8.4 Hz, 2H), 7.46 (t, <i>J</i> = 7.8 Hz, 1H), 7.09 (d, <i>J</i> = 8.4 Hz, 2H), 4.68 (s, 2H), 3.93 (s, 3H), 1.62 (s, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 166.5, 159.1, 136.8, 131.0, 129.4, 127.5, 127.4, 127.4, 126.1, 124.6, 120.9, 114.9, 67.4, 52.3. HRMS [M + H] calcd [C<sub>17</sub>H<sub>15</sub>F<sub>3</sub>NO<sub>4</sub>] 354.0875, found 354.0929. Purity 99.99% (as determined by RP-HPLC, method A, <i>t</i><sub>R</sub> = 17.70 min).</div></div><div id="sec4_1_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> Methyl 3-(2-(4-<i>tert</i>-Butylphenoxy)acetamido)benzoate (<b>5d</b>)<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></h4><div class="NLM_p last">See ref <a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">21</a>.</div></div><div id="sec4_1_1_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> Methyl 3-(2-(<i>p</i>-Tolyloxy)acetamido)benzoate (<b>5e</b>)</h4><div class="NLM_p last">Obtained as a white solid (0.10 g, 40.4% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.51 (s, 1H), 8.09 (t, <i>J</i> = 8.0 Hz, 1H), 7.99 (m, 1H), 7.80 (d, <i>J</i> = 7.4 Hz, 1H), 7.40 (t, <i>J</i> = 8.0 Hz, 1H), 7.12 (d, <i>J</i> = 8.2 Hz, 2H), 6.87 (m, 2H), 4.56 (s, 2H), 3.89 (s, 3H), 2.29 (s, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 166.7, 166.5, 154.9, 137.2, 131.8, 130.9, 130.3, 129.2, 125.8, 124.5, 120.9, 114.6, 67.7, 52.3, 20.5. HRMS [M + H] calcd [C<sub>17</sub>H<sub>18</sub>NO<sub>4</sub>] 300.1158, found 300.1232. Purity 100% (as determined by RP-HPLC, method A, <i>t</i><sub>R</sub> = 16.29 min).</div></div><div id="sec4_1_1_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> Methyl 3-(2-(4-Ethylphenoxy)acetamido)benzoate (<b>5f</b>)</h4><div class="NLM_p last">Obtained as a white solid (0.34 g, 97.4% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.48 (brs, 1H), 8.00 (m, 1H), 7.81 (m, 1H), 7.42 (t, <i>J</i> = 7.8 Hz, 1H), 7.16 (d, <i>J</i> = 8.0 Hz, 2H), 6.91 (m, 2H), 4.59 (s, 2H), 3.90 (s, 3H), 2.61 (q, <i>J</i> = 7.4 Hz, 2H), 1.23 (m, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 166.7, 166.5, 155.0, 138.3, 137.1, 13.9, 129.2, 129.1, 125.8, 124.5, 120.9, 114.7, 67.7, 52.2, 28.0, 15.8. HRMS [M + H] calcd [C<sub>18</sub>H<sub>20</sub>NO<sub>4</sub>] 314.1314, found 314.1379. Purity 100% (as determined by RP-HPLC, method A, <i>t</i><sub>R</sub> = 18.06 min).</div></div><div id="sec4_1_1_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> Methyl 3-(2-(4-Propylphenoxy)acetamido)benzoate (<b>5g</b>)</h4><div class="NLM_p last">Obtained as a white solid (0.31 g, 90.5% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.46 (brs, 1H), 8.09 (t, <i>J</i> = 1.8 Hz, 1H), 8.00 (dd, <i>J</i> = 8.2 Hz, 1H), 7.82 (dd, <i>J</i> = 7.8 Hz, 1H), 7.42 (t, <i>J</i> = 8.0 Hz, 1H), 7.14 (d, <i>J</i> = 8.6 Hz, 2H), 6.90 (m, 2H), 4.59 (s, 2H), 3.91 (s, 3H), 2.54 (m, 2H), 1.61 (m, 2H), 0.93 (t, <i>J</i> = 7.2 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 166.7, 166.6, 155.0, 137.1, 136.8, 131.0, 129.7, 129.2, 125.8, 124.5, 120.9, 114.6, 67.7, 52.3, 37.1, 24.7, 13.7. HRMS [M + H] calcd [C<sub>19</sub>H<sub>22</sub>NO<sub>4</sub>] 328.2471, found 328.1546. Purity 100% (as determined by RP-HPLC, method A, <i>t</i><sub>R</sub> = 19.92 min).</div></div><div id="sec4_1_1_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> Methyl 3-(2-(4-Butylphenoxy)acetamido)benzoate (<b>5h</b>)</h4><div class="NLM_p last">Obtained as a white solid (0.32 g, 98.4% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.52 (brs, 1H), 8.10 (s, 1H), 7.99 (dd, <i>J</i> = 8.2, 1.2 Hz, 1H), 7.80 (d, <i>J</i> = 7.8 Hz, 1H), 7.40 (t, <i>J</i> = 7.8 Hz, 1H), 7.13 (d, <i>J</i> = 8.6 Hz, 2H), 6.89 (d, <i>J</i> = 8.6 Hz, 2H), 4.57 (s, 2H), 3.89 (s, 3H), 2.56 (t, <i>J</i> = 7.6 Hz, 2H), 1.56 (m, 2H), 1.34 (m, 2H), 0.92 (t, <i>J</i> = 7.4 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 166.8, 166.5, 155.0, 137.2, 137.0, 130.9, 129.6, 129.2, 125.8, 124.5, 120.9, 114.6, 67.7, 52.2, 34.7, 33.8, 22.3, 14.0. HRMS [M + H] calcd [C<sub>20</sub>H<sub>24</sub>NO<sub>4</sub>] 342.1627, found 342.1694. Purity 100% (as determined by RP-HPLC, method A, <i>t</i><sub>R</sub> = 21.59 min).</div></div><div id="sec4_1_1_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> Methyl 3-(2-(4-Pentylphenoxy)acetamido)benzoate (<b>5i</b>)</h4><div class="NLM_p last">Obtained as a yellow solid (0.13 g, 81.2% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.40 (s, 1H), 8.07 (s, 1H), 8.01 (d, <i>J</i> = 8.0 Hz, 1H), 7.82 (d, <i>J</i> = 8.0 Hz, 1H), 7.44 (t, <i>J</i> = 12.0 Hz, 1H), 7.15 (d, <i>J</i> = 8.0 Hz, 2H), 6.91 (d, <i>J</i> = 8.0 Hz, 2H), 4.60 (s, 2H), 3.92 (s, 3H), 2.56 (t, <i>J</i> = 8.0 Hz, 2H), 1.61–1.57 (m, 2H), 1.34–1.29 (m, 4H), 0.89 (t, <i>J</i> = 4.0 Hz, 1H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 166.7, 166.6, 155.0, 137.2, 137.1, 131.1, 129.7, 129.3, 125.9, 124.5, 120.9, 114.7, 67.8, 52.3, 35.0, 31.4, 31.3, 22.5, 14.0. HRMS [M + H] calcd [C<sub>21</sub>H<sub>26</sub>NO<sub>4</sub>] 356.1862, found 356.1842. Purity 100% (as determined by RP-HPLC, method A, <i>t</i><sub>R</sub> = 23.53 min).</div></div><div id="sec4_1_1_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> Methyl 3-(2-(4-Cyclopentylphenoxy)acetamido)benzoate (<b>5j</b>)</h4><div class="NLM_p last">Obtained as a yellow solid (0.10 g, 62.5% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.39 (s, 1H), 8.07 (s, 1H), 8.01 (d, <i>J</i> = 8.0 Hz, 1H), 7.83 (d, <i>J</i> = 8.0 Hz, 1H), 7.45 (t, <i>J</i> = 12.0 Hz, 1H), 7.22 (d, <i>J</i> = 8.0 Hz, 2H), 6.92 (d, <i>J</i> = 8.0 Hz, 2H), 4.61 (s, 2H), 3.93 (s, 3H), 2.98–2.94 (m, 1H), 2.06–2.05 (m, 2H), 1.82–1.77 (m, 2H), 1.70–1.67 (m, 2H), 1.57–1.52 (m, 4H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 166.7, 166.6, 155.1, 140.8, 137.1, 131.1, 129.3, 128.4, 125.9, 124.5, 120.9, 114.7, 67.9, 52.3, 45.2, 34.7, 25.4. HRMS [M + H] calcd [C<sub>21</sub>H<sub>24</sub>NO<sub>4</sub>] 354.1705, found 354.1682. Purity 100% (as determined by RP-HPLC, method A, <i>t</i><sub>R</sub> = 22.03 min).</div></div><div id="sec4_1_1_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> Methyl 3-(2-(4-Cyclohexylphenoxy)acetamido)benzoate (<b>5k</b>)</h4><div class="NLM_p last">Obtained as a yellow solid (0.11 g, 70.5% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.39 (s, 1H), 8.07 (s, 1H), 8.00 (d, <i>J</i> = 8.0 Hz, 1H), 7.82 (d, <i>J</i> = 8.0 Hz, 1H), 7.45 (t, <i>J</i> = 12.0 Hz, 1H), 7.19 (d, <i>J</i> = 8.0 Hz, 2H), 6.92 (d, <i>J</i> = 8.0 Hz, 2H), 4.60 (s, 2H), 3.92 (s, 3H), 2.50–2.46 (m, 1H), 1.84–1.76 (m, 4H), 1.73–1.58 (m, 2H), 1.44–1.38 (m, 4H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 166.7, 166.6, 155.1, 142.4, 137.1, 131.1, 129.3, 128.1, 125.9, 124.5, 120.9, 114.7, 67.8, 52.3, 43.3, 34.6, 26.9, 26.1. HRMS [M + H] calcd [C<sub>22</sub>H<sub>26</sub>NO<sub>4</sub>] 368.1862, found 368.1842. Purity 100% (as determined by RP-HPLC, method A, <i>t</i><sub>R</sub> = 23.62 min).</div></div><div id="sec4_1_1_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> Methyl 3-(2-(4-(2,4,4-Trimethylpentan-2-yl)phenoxy)acetamido)benzoate (<b>5l</b>)</h4><div class="NLM_p last">Obtained as a white solid (0.10 g, 64.1% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.46 (s, 1H), 8.08 (s, 1H), 7.79 (d, <i>J</i> = 8.0 Hz, 1H), 7.81 (d, <i>J</i> = 8.0 Hz, 1H), 7.44–7.32 (m, 1H), 7.33 (d, <i>J</i> = 8.0 Hz, 2H), 6.90 (d, <i>J</i> = 8.0 Hz, 2H), 4.60 (s, 2H), 3.91 (s, 3H) 1.71 (s, 2H), 1.35 (s, 6H), 0.71 (s, 9H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 166.7, 166.6, 154.6, 144.3, 137.1, 131.0, 129.3, 127.5, 125.8, 124.5, 120.9, 114.0, 67.6, 56.9, 52.3, 30.1, 32.3, 31.8, 31.6. HRMS [M + H] calcd [C<sub>24</sub>H<sub>32</sub>NO<sub>4</sub>] 398.2331, found 398.2345. Purity 100% (as determined by RP-HPLC, method A, <i>t</i><sub>R</sub> = 26.11 min).</div></div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> General Procedure for the Synthesis of <b>1</b> and <b>6</b></h3><div class="NLM_p">EDCI (1.2 equiv) and HOBt (1.2 equiv) were added to a solution of appropriate phenoxyacetic acid <b>4a</b> or <b>4l</b> (1.0 equiv), methyl 3-amino-4-hydroxybenzoate (1.0 equiv), and DIPEA (2.5 equiv) in DMF, and the reaction mixture was stirred at room temperature until completion as monitored by TLC. The reaction mixture was diluted with EtOAc brine. The organic layer was separated, dried over anhydrous MgSO<sub>4</sub>, filtered, and concentrated in vacuo. The resulting residue was purified by silica gel column chromatography.</div><div id="sec4_1_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> Methyl 3-(2-(4-Adamantan-1-yl-phenoxy)acetamido)-4-hydroxybenzoate (<b>1</b>)<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a></h4><div class="NLM_p last">See ref <a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">8</a>.</div></div><div id="sec4_1_2_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> Methyl 4-Hydroxy-3-(2-(4-(2,4,4-trimethylpentan-2-yl)phenoxy)acetamido)benzoate (<b>6</b>)</h4><div class="NLM_p last">Obtained as a white solid (1.00 g, 64.1% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.75 (s, 1H), 8.60 (s, 1H), 7.85–7.83 (m, 1H), 7.73 (s, 1H), 7.38–7.34 (m, 2H), 7.06 (d, <i>J</i> = 8.0 Hz, 1H), 6.94–6.90 (m, 2H), 4.68 (s, 2H), 3.89 (s, 3H), 1.73 (s, 2H), 1.36 (s, 6H), 0.72 (s, 9H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 168.2, 166.7, 154.5, 147.2, 144.6, 129.2, 128.0, 127.6, 122.3, 121.3, 119.5, 114.2, 67.5, 57.0, 52.3, 38.1, 32.3, 31.8, 31.6. HRMS [M + H] calcd [C<sub>24</sub>H<sub>32</sub>NO<sub>5</sub>] 414.2280, found 414.2249. Purity 100% (as determined by RP-HPLC, method A, <i>t</i><sub>R</sub> = 24.95 min).</div></div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> General Procedure for the Synthesis of <b>7a</b>–<b>f</b></h3><div class="NLM_p">The mixture of <b>1</b> or <b>6</b> (1.0 equiv) and anhydrous potassium carbonate (3.0 equiv), alkyl or aryl halide (1.0 equiv) in DMF was stirred overnight at room temperature. The reaction mixture was diluted with EtOAc and subsequently washed with aqueous sodium bicarbonate, brine, and water. The organic layer was dried over anhydrous MgSO<sub>4</sub>. The solvent was filtered and evaporated under reduced pressure to afford a crude solid which was purified by silica gel column chromatography.</div><div id="sec4_1_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> Methyl 3-(2-(4-Adamantan-1-yl-phenoxy)acetamido)-4-(2-(pyrrolidin-1-yl)ethoxy)benzoate (<b>7a</b>)</h4><div class="NLM_p last">Obtained as a white solid (0.10 g, 77.8% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.06 (s, 1H), 9.02 (s, 1H), 7.82 (d, <i>J</i> = 8.0 Hz, 1H), 7.32 (d, <i>J</i> = 8.0 Hz, 2H), 6.95–6.91 (m, 3H), 4.62 (s, 2H), 4.22 (t, <i>J</i> = 4.0 Hz, 2H), 3.89 (s, 3H), 2.92 (t, <i>J</i> = 4.0 Hz, 2H), 2.64–2.62 (m, 4H), 2.09 (brs, 3H), 1.89–1.88 (m, 6H), 1.77–1.72 (m, 10H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 166.8, 166.5, 155.0, 151.1, 145.5, 126.8, 126.7, 126.2, 123.2, 121.1, 114.4, 110.6, 68.3, 68.0, 54.8, 54.7, 52.0, 43.4, 36.7, 35.7, 28.9, 23.6. HRMS [M + H] calcd [C<sub>32</sub>H<sub>41</sub>N<sub>2</sub>O<sub>5</sub>] 533.3015, found 533.2988. Purity 100% (as determined by RP-HPLC, method A, <i>t</i><sub>R</sub> = 13.39 min).</div></div><div id="sec4_1_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> Methyl 3-(2-(4-Adamantan-1-yl-phenoxy)acetamido)-4-(3-morpholinopropoxy)benzoate (<b>7b</b>)</h4><div class="NLM_p last">Obtained as a white solid (0.09 g, 69.7% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.05 (s, 1H), 9.04 (s, 1H), 7.82 (d, <i>J</i> = 8.0 Hz, 1H), 7.32 (d, <i>J</i> = 8.0 Hz, 2H), 6.94–6.92 (m, 3H), 4.62 (s, 2H), 4.16 (t, <i>J</i> = 4.0 Hz, 2H), 3.90 (s, 3H), 3.69–3.68 (m, 4H), 2.53 (t, <i>J</i> = 4.0 Hz, 2H), 2.42–2.40 (m, 4H), 2.09 (brs, 3H), 2.02 (t, <i>J</i> = 4.0 Hz, 2H), 1.89–1.88 (m, 6H), 1.77–1.72 (m, 6H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 166.8, 166.3, 154.9, 151.1, 145.7, 126.7, 126.5, 126.3, 123.0, 120.9, 114.4, 110.3, 68.0, 66.9, 55.2, 53.7, 52.0, 43.4, 36.7, 35.7, 28.9. HRMS [M + H] calcd [C<sub>33</sub>H<sub>43</sub>N<sub>2</sub>O<sub>6</sub>] 563.3121, found 563.3085. Purity 100% (as determined by RP-HPLC, method A, <i>t</i><sub>R</sub> = 13.38 min).</div></div><div id="sec4_1_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> Methyl 4-Methoxy-3-(2-(4-(2,4,4-trimethylpentan-2-yl)phenoxy)acetamido)benzoate (<b>7c</b>)</h4><div class="NLM_p last">Obtained as a white solid (0.08 g, 77.6% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.03 (s, 1H), 8.97 (s, 1H), 7.85–7.83 (m, 1H), 7.33 (d, <i>J</i> = 8.0 Hz, 2H), 6.93–6.90 (m, 3H), 4.63 (s, 2H), 3.93 (s, 3H), 3.89 (s, 3H), 1.71 (s, 2H), 1.35 (s, 6H), 0.71 (s, 9H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 166.7, 166.5, 154.8, 151.9, 144.1, 127.5, 126.8, 126.5, 123.1, 121.1, 114.1, 109.6, 67.9, 56.9, 56.1, 52.0, 38.1, 32.3, 31.8, 31.7. HRMS [M + H] calcd [C<sub>25</sub>H<sub>34</sub>NO<sub>5</sub>] 428.2437, found 428.2416. Purity 100% (as determined by RP-HPLC, method A, <i>t</i><sub>R</sub> = 27.91 min).</div></div><div id="sec4_1_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> Methyl 4-(2-Methoxyethoxy)-3-(2-(4-(2,4,4-trimethylpentan-2-yl)phenoxy)acetamido)benzoate (<b>7d</b>)</h4><div class="NLM_p last">Obtained as a white solid (0.10 g, 87.7% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.15 (s, 1H), 9.06 (s, 1H), 7.83–7.80 (m, 1H), 7.32 (d, <i>J</i> = 8.0 Hz, 2H), 6.94–6.90 (m, 3H), 4.62 (s, 2H), 4.23 (t, <i>J</i> = 4.0 Hz, 2H), 3.89 (s, 3H), 3.78 (t, <i>J</i> = 4.0 Hz, 2H), 3.44 (s, 3H), 1.71 (s, 2H), 1.34 (s, 6H), 0.70 (s, 9H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 166.7, 166.4, 154.8, 151.0, 144.0, 127.4, 126.9, 126.6, 123.4, 121.0, 114.0, 110.7, 70.7, 68.4, 67.0, 59.2, 57.0, 52.0, 38.1, 32.3, 31.8, 31.6. HRMS [M + H] calcd [C<sub>27</sub>H<sub>38</sub>NO<sub>6</sub>] 472.2699, found 472.2676. Purity 100% (as determined by RP-HPLC, method A, <i>t</i><sub>R</sub> = 27.57 min).</div></div><div id="sec4_1_3_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> Methyl 4-(2-Morpholinoethoxy)-3-(2-(4-(2,4,4-trimethylpentan-2-yl)phenoxy)acetamido)benzoate (<b>7e</b>)</h4><div class="NLM_p last">Obtained as a white solid (0.09 g, 70.8% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.06 (s, 1H), 9.04 (s, 1H), 7.84–7.81 (m, 1H), 7.32 (d, <i>J</i> = 8.0 Hz, 2H), 6.93–6.88 (m, 3H), 4.62 (s, 2H), 4.21 (t, <i>J</i> = 4.0 Hz, 2H), 3.90 (s, 3H), 3.69–3.66 (m, 4H), 2.83 (t, <i>J</i> = 4.0 Hz, 2H), 2.56–2.54 (m, 4H), 1.71 (s, 2H), 1.34 (s, 6H), 0.71 (s, 9H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 166.7, 166.4, 154.8, 151.0, 144.3, 127.5, 126.7, 123.3, 121.1, 114.1, 110.6, 68.1, 66.9, 66.8, 57.5, 56.9, 54.0, 52.1, 38.1, 32.3, 31.8, 31.6. HRMS [M + H] calcd [C<sub>30</sub>H<sub>43</sub>N<sub>2</sub>O<sub>6</sub>] 527.3121, found 527.3096. Purity 100% (as determined by RP-HPLC, method A, <i>t</i><sub>R</sub> = 12.90 min).</div></div><div id="sec4_1_3_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> Methyl 4-(Prop-2-ynyloxy)-3-(2-(4-(2,4,4-trimethylpentan-2-yl)phenoxy)acetamido)benzoate (<b>7f</b>)</h4><div class="NLM_p last">Obtained as a white solid (0.10 g, 91.7% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.06 (s, 1H), 9.02 (s, 1H), 7.85–7.83 (m, 1H), 7.33 (d, <i>J</i> = 8.0 Hz, 2H), 7.04 (d, <i>J</i> = 8.0 Hz, 1H), 6.92(d, <i>J</i> = 8.0 Hz, 2H), 4.81 (s, 2H), 4.63 (s, 2H), 3.90 (s, 3H), 2.60 (t, <i>J</i> = 4.0 Hz, 2H), 1.71 (s, 2H), 1.34 (s, 6H), 0.71 (s, 9H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 166.6, 166.4, 154.8, 149.8, 144.1, 127.4, 127.0, 126.5, 124.1, 121.4, 114.1, 111.1, 67.8, 57.0, 56.8, 52.1, 38.1, 32.3, 31.9, 31.8, 31.6. HRMS [M + H] calcd [C<sub>27</sub>H<sub>34</sub>NO<sub>5</sub>] 452.2437, found 452.2412. Purity 100% (as determined by RP-HPLC, method A, <i>t</i><sub>R</sub> = 27.33 min).</div></div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> General Procedure for the Synthesis of <b>8a</b>–<b>f</b></h3><div class="NLM_p">EDCI (1.2 equiv) and HOBt (1.2 equiv) were added to a solution of 2-(4-(2,4,4-trimethylpentan-2-yl)phenoxy)acetic acid <b>4l</b> (1.0 equiv), amine (1.0 equiv), and DIPEA (2.5 equiv) in DMF, and the reaction mixture was stirred at room temperature until completion as monitored by TLC. The reaction mixture was diluted with EtOAc brine. The organic layer was separated, dried over anhydrous MgSO<sub>4</sub>, filtered, and concentrated in vacuo. The resulting residue was purified by silica gel column chromatography.</div><div id="sec4_1_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> <i>N</i>-(4-(Trifluoromethyl)phenyl)-2-(4-(2,4,4-trimethylpentan-2-yl)phenoxy)acetamide (<b>8a</b>)</h4><div class="NLM_p last">Obtained as a white solid (0.11 g, 71.54% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 8.43 (s, 1H), 7.72 (d, <i>J</i> = 8.8 Hz, 2H), 7.61 (d, <i>J</i> = 8.8 Hz, 2H), 7.35 (d, <i>J</i> = 6.4 Hz, 2H), 6.91 (d, <i>J</i> = 6.8 Hz, 2H), 4.62 (s, 2H), 1.72 (s, 2H), 1.36 (s, 6H), 0.71 (s, 9H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 166.8, 154.5, 144.5, 139.9, 127.6, 126.8, 126.4, 126.3, 120.0, 114.1, 67.6, 56.9, 38.1, 32.3, 31.8, 31.6. HRMS [M + H] calcd [C<sub>23</sub>H<sub>29</sub>F<sub>3</sub>NO<sub>2</sub>] 408.2150, found 408.2122. Purity 100% (as determined by RP-HPLC, method A, <i>t</i><sub>R</sub> = 28.40 min).</div></div><div id="sec4_1_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> <i>N</i>-(4-(4-Methylpiperazin-1-yl)phenyl)-2-(4-(2,4,4-trimethylpentan-2-yl)phenoxy)acetamide (<b>8b</b>)</h4><div class="NLM_p last">Obtained as a white solid (0.12 g, 72.7% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 8.17 (s, 1H), 7.45 (d, <i>J</i> = 9.2 Hz, 2H), 7.33 (d, <i>J</i> = 8.8 Hz, 2H), 6.92–6.88 (m, 4H), 4.58 (s, 2H), 3.25–3.23 (m, 4H), 2.68–2.67 (m, 4H), 2.42 (s, 3H), 1.71 (s, 2H), 1.31 (s, 6H), 0.71 (s, 9H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 166.2, 154.7, 148.7, 144.1, 129.2, 127.5, 121.6, 116.6, 114.0, 67.7, 57.0, 55.1, 49.4, 46.1, 38.1, 32.3, 31.8, 31.6. HRMS [M + H] calcd [C<sub>27</sub>H<sub>40</sub>N<sub>3</sub>O<sub>2</sub>] 438.3121, found 438.3100. Purity 100% (as determined by RP-HPLC, method A, <i>t</i><sub>R</sub> = 12.56 min).</div></div><div id="sec4_1_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 1-(4-(4-(Trifluoromethyl)benzyl)piperazin-1-yl)-2-(4-(2,4,4-trimethylpentan-2-yl)phenoxy)ethanone (<b>8c</b>)</h4><div class="NLM_p last">Obtained as a white solid (0.15 g, 81.0% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.58 (d, <i>J</i> = 7.6 Hz, 2H), 7.43 (d, <i>J</i> = 7.6 Hz, 2H), 7.27 (d, <i>J</i> = 8.0 Hz, 2H), 6.85 (d, <i>J</i> = 8.8 Hz, 2H), 4.66 (s, 2H), 3.63–3.59 (m, 4H), 3.56 (s, 2H), 2.40–2.39 (m, 4H), 1.70 (s, 2H), 1.38 (s, 6H), 0.71 (s, 9H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 166.6, 155.4, 143.2, 142.0, 129.4, 129.1, 127.2, 125.3, 125.2, 113.8, 67.9, 62.2, 57.0, 53.2, 52.7, 45.4, 42.1, 38.0, 32.3, 31.8, 31.6. HRMS [M + H] calcd [C<sub>28</sub>H<sub>38</sub>F<sub>3</sub>N<sub>2</sub>O<sub>2</sub>] 491.2885, found 491.2854. Purity 100% (as determined by RP-HPLC, method A, <i>t</i><sub>R</sub> = 14.31 min).</div></div><div id="sec4_1_4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 1-(4-(Prop-2-ynyl)piperazin-1-yl)-2-(4-(2,4,4-trimethylpentan-2-yl)phenoxy)ethanone (<b>8d</b>)</h4><div class="NLM_p last">Obtained as a white solid (0.11 g, 78.5% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.30 (d, <i>J</i> = 8.0 Hz, 2H), 6.85 (d, <i>J</i> = 8.0 Hz, 2H), 4.67 (s, 2H), 3.68–3.63 (m, 4H), 3.29 (t, <i>J</i> = 4.0 Hz, 2H), 2.56–2.51 (m, 4H), 2.25 (t, <i>J</i> = 4.0 Hz, 1H), 1.69 (s, 2H), 1.33 (s, 6H), 0.70 (s, 9H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 166.6, 155.4, 143.3, 127.2, 113.8, 78.1, 73.6, 67.9, 57.0, 51.9, 51.6, 46.8, 45.2, 41.9, 38.0, 32.3, 31.8, 31.6. HRMS [M + H] calcd [C<sub>23</sub>H<sub>35</sub>N<sub>2</sub>O<sub>2</sub>] 371.2699, found 371.2680. Purity 100% (as determined by RP-HPLC, method A, <i>t</i><sub>R</sub> = 11.38 min).</div></div><div id="sec4_1_4_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> Prop-2-ynyl 4-Hydroxy-3-(2-(4-(2,4,4-trimethylpentan-2-yl)phenoxy)acetamido)benzoate (<b>8e</b>)</h4><div class="NLM_p last">Obtained as a white solid (0.10 g, 60.6% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ = 9.84 (s, 1H), 8.63 (s, 1H), 7.88 (d, <i>J</i> = 8.0 Hz, 1H), 7.76 (d, <i>J</i> = 4.0 Hz, 1H), 7.36 (d, <i>J</i> = 8.0 Hz, 2H), 7.07 (d, <i>J</i> = 8.0 Hz, 1H), 6.92 (d, <i>J</i> = 8.0 Hz, 2H), 4.91 (d, <i>J</i> = 4.0 Hz, 2H), 4.69 (s, 2H), 2.51 (t, <i>J</i> = 4.0 Hz, 1H), 1.72 (s, 2H), 1.36 (s, 6H), 0.72 (s, 9H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 169.0, 164.9, 154.2, 153.7, 144.8, 129.6, 127.7, 124.6, 124.5, 121.6, 120.2, 114.1, 77.7, 75.1, 67.1, 56.9, 52.4, 38.1, 32.3, 31.8, 31.6. HRMS [M + H] calcd [C<sub>26</sub>H<sub>32</sub>NO<sub>5</sub>] 438.2280, found 438.2247. Purity 100% (as determined by RP-HPLC, method A, <i>t</i><sub>R</sub> = 24.56 min).</div></div><div id="sec4_1_4_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> <i>N</i>-(3-Hydroxy-adamantan-1-yl)-2-(4-(2,4,4-trimethylpentan-2-yl)phenoxy)acetamide (<b>8f</b>)</h4><div class="NLM_p last">Obtained as a white solid (0.12 g, 76.9% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.02 (s, 1H), 7.31 (d, <i>J</i> = 4.0 Hz, 2H), 6.81 (d, <i>J</i> = 12.0 Hz, 2H), 6.31 (s, 1H), 4.36 (s, 2H), 2.28 (s, 2H), 2.02 (s, 2H), 1.99 (s, 4H), 1.70 (s, 6H), 1.58 (s, 2H), 1.34 (s, 6H), 0.70 (s, 9H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 167.4, 154.7, 143.7, 127.4, 113.9, 69.0, 67.6, 57.0, 54.2, 48.9, 44.0, 40.2, 38.0, 34.8, 32.3, 31.7, 31.6, 30.6. HRMS [M + H] calcd [C<sub>26</sub>H<sub>40</sub>NO<sub>3</sub>] 414.3008, found 414.2985. Purity 100% (as determined by RP-HPLC, method A, <i>t</i><sub>R</sub> = 23.33 min).</div></div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> General Procedure for the Synthesis of <b>9a</b> and <b>9b</b></h3><div class="NLM_p">The mixture of <b>3a</b> or <b>3l</b> (1.0 equiv) and methyl propiolate (2.0 equiv) in toluene was added to Ph<sub>3</sub>P (1.0 equiv) at −10 °C. The mixture was then allowed to heat up to 115 °C and stirred for 2 h. The solvent was removed under reduced pressure, and the residue was purified by purified by silica gel column chromatography.</div><div id="sec4_1_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> (<i>E</i>)-3-(4-Adamantan-1-yl-phenoxy)-acrylic Acid Methyl Ester (<b>9a</b>)</h4><div class="NLM_p last">Obtained as a white solid (2.48 g, 90.6% yield). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.81 (d, <i>J</i> = 12.3 Hz, 1H), 7.35 (d, <i>J</i> = 9.3 Hz, 2H), 7.01 (d, <i>J</i> = 8.7 Hz, 2H), 5.53 (d, <i>J</i> = 12.3 Hz, 1H), 3.73 (s, 3H), 2.10 (brs, 3H), 1.89–1.88 (m, 6H), 1.77–1.71 (m, 6H). MS (EI) <i>m</i>/<i>z</i> 312 (M+).</div></div><div id="sec4_1_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> (<i>E</i>)-3-[4-(2,4,4-Trimethylpentan-2-yl)phenoxy]acrylic Acid Methyl Ester (<b>9b</b>)</h4><div class="NLM_p last">Purified by silica gel column chromatography, white solid (2.00 g, 71.4% yield). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.8 (d, <i>J</i> = 12.3 Hz, 1H), 7.36 (d, <i>J</i> = 8.7 Hz, 2H), 6.97 (d, <i>J</i> = 8.4 Hz, 2H), 5.53 (d, <i>J</i> = 12.0 Hz, 1H), 3.73 (s, 3H), 1.73 (s, 2H), 1.36 (s, 6H), 0.71 (s, 9H). MS (EI) <i>m</i>/<i>z</i> 290 (M+).</div></div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> General Procedure for the Synthesis of <b>11a</b>–<b>d</b></h3><div class="NLM_p">The mixture of <b>3a</b> or <b>3l</b> (1.0 equiv), anhydrous potassium carbonate (2.0 equiv), and methyl 4-bromobutanoate or methyl α-bromoisobutyrate (2.0 equiv) in DMF was stirred overnight at room temperature. The reaction mixture was diluted with EtOAc and subsequentially washed with aqueous sodium bicarbonate, brine, and water. The organic layer was dried over anhydrous MgSO<sub>4</sub>. The solvent was filtered and evaporated under reduced pressure to afford a crude solid which was purified by silica gel column chromatography to give ester compound. A suspension of ester compound (1.0 equiv) in THF/H<sub>2</sub>O (1:1) was added to lithium hydroxide monohydrate (3.0 equiv) and stirred overnight at room temperature. The reaction mixture was neutralized with 10% HCl, diluted with EtOAc, and subsequentially washed with aqueous sodium bicarbonate, brine, and water. The organic layer was dried over anhydrous MgSO<sub>4</sub>. The solvent was filtered and evaporated under reduced pressure to afford a crude solid which was purified by silica gel column chromatography.</div><div id="sec4_1_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 4-(4-Adamantan-1-yl-phenoxy)-butanoic Acid (<b>11a</b>)</h4><div class="NLM_p last">Obtained as a white solid (0.48 g, 88.2% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.27 (d, <i>J</i> = 7.6 Hz, 2H), 6.84 (d, <i>J</i> = 8.4 Hz, 2H), 4.00 (t, <i>J</i> = 5.6 Hz, 2H), 2.58 (t, <i>J</i> = 7.2 Hz, 2H), 2.08–2.12 (m, 2H), 2.07 (brs, 3H), 1.88–1.87 (m, 6H), 1.77–1.76 (m, 6H). MS (EI) [M + H] <i>m</i>/<i>z</i> 315.</div></div><div id="sec4_1_6_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> 2-(4-Adamantan-1-yl-phenoxy)-2-methylpropanoic Acid (<b>11b</b>)</h4><div class="NLM_p last">Obtained as a white solid (0.92 g, 96.13% yield). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.94 (brs, 1H), 7.23 (d, <i>J</i> = 8.0 Hz, 2H), 6.74 (d, <i>J</i> = 7.2 Hz, 2H), 2.03 (brs, 3H), 1.81–1.80 (m, 6H), 1.75–1.71 (m, 6H), 1.47 (s, 6H). MS (EI) <i>m</i>/<i>z</i> 314 (M<sup>+</sup>).</div></div><div id="sec4_1_6_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> 4-(4-(2,4,4-Trimethylpentan-2-yl)phenoxy)butanoic Acid (<b>11c</b>)</h4><div class="NLM_p last">Obtained as a white solid (0.47 g, 86.9% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.04 (s, 1H), 7.25 (d, <i>J</i> = 8.0 Hz, 2H), 6.82 (d, <i>J</i> = 8.0 Hz, 2H), 3.90 (t, <i>J</i> = 4.0 Hz, 2H), 2.35 (t, <i>J</i> = 4.0 Hz, 2H), 1.98 (t, <i>J</i> = 4.0 Hz, 2H), 1.71 (s, 2H), 1.36 (s, 6H), 0.71 (s, 9H). MS (EI) <i>m</i>/<i>z</i> 292 (M<sup>+</sup>).</div></div><div id="sec4_1_6_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> 2-Methyl-2-(4-(2,4,4-trimethylpentan-2-yl)phenoxy)propanoic Acid (<b>11d</b>)</h4><div class="NLM_p last">Obtained as a white solid (0.50 g, 96.1% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.46 (brs, 1H), 7.25 (d, <i>J</i> = 8.0 Hz, 2H), 6.74 (d, <i>J</i> = 7.2 Hz, 2H), 1.66 (s, 2H), 1.45 (s, 6H), 1.29 (s, 6H), 0.66 (s, 9H). MS (EI) <i>m</i>/<i>z</i> 292 (M<sup>+</sup>).</div></div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> General Procedure for the Synthesis of <b>12a</b> and <b>12b</b></h3><div class="NLM_p">A suspension of ester <b>9a</b> or <b>9b</b> (1.0 equiv) in THF/H<sub>2</sub>O (1:1) was added to lithium hydroxide monohydrate (3.0 equiv) and stirred overnight at room temperature. The reaction mixture was neutralized with 10% HCl, diluted with EtOAc, and subsequentially washed with aqueous sodium bicarbonate, brine, and water. The organic layer was dried over anhydrous MgSO<sub>4</sub>. The solvent was filtered and evaporated under reduced pressure to afford a crude solid which was purified by silica gel column chromatography.</div><div id="sec4_1_7_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> (<i>E</i>)-3-(4-Adamantan-1-yl-phenoxy)-acrylic Acid (<b>12a</b>)</h4><div class="NLM_p last">Obtained as a white solid (0.91 g, 95.8% yield). <sup>1</sup>H NMR (300 MHz, DMSD-<i>d</i><sub>6</sub>) δ 12.07 (s, 1H), 7.55 (d, <i>J</i> = 7.2 Hz, 1H), 7.40 (d, <i>J</i> = 5.4 Hz, 2H), 7.11 (d, <i>J</i> = 5.1 Hz, 2H), 5.44 (d, <i>J</i> = 7.2 Hz, 1H), 2.06 (brs, 3H), 1.85–1.83 (m, 6H), 1.75–1.72 (m, 6H). MS (EI) <i>m</i>/<i>z</i> 298 (M+).</div></div><div id="sec4_1_7_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> (<i>E</i>)-3-[4-(2,4,4-Trimethylpentan-2-yl)phenoxy]acrylic Acid (<b>12b</b>)</h4><div class="NLM_p last">Obtained as a white solid (0.90 g, 94.7% yield). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.89 (d, <i>J</i> = 11.7 Hz, 1H), 7.37 (d, <i>J</i> = 9.0 Hz, 2H), 6.98 (d, <i>J</i> = 8.7 Hz, 2H), 5.50 (d, <i>J</i> = 12.3 Hz, 1H), 1.73 (s, 2H), 1.36 (s, 6H), 0.71 (s, 9H). MS (EI) <i>m</i>/<i>z</i> 276 (M+).</div></div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> General Procedure for the Synthesis of <b>13a</b> and <b>13b</b></h3><div class="NLM_p">A solution of acrylic acid methyl ester <b>9a</b> or <b>9b</b> (1.0 equiv) in methanol was treated with 10% Pd/C (10% w/w). The reaction was subjected to hydrogenation under 1 atm hydrogen gas pressure at room temperature, and the reaction mixture was stirred overnight. After completion of the reaction, the mixture was filtered through a Celite pad and concentrated. The resulting residue was purified by silica gel column chromatography. A suspension of methyl ester <b>10a</b> or <b>10b</b> (1.0 equiv) in THF/H<sub>2</sub>O (1:1) was added to lithium hydroxide monohydrate (4.0 equiv) and stirred overnight at room temperature. The reaction mixture was neutralized with 10% HCl, diluted with EtOAc, and subsequently washed with aqueous sodium bicarbonate, brine, and water. The organic layer was dried over anhydrous MgSO<sub>4</sub>. The solvent was filtered and evaporated under reduced pressure to afford a crude solid which was purified by silica gel column chromatography.</div><div id="sec4_1_8_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> 3-(4-Adamantan-1-yl-phenoxy)-propanoic Acid (<b>13a</b>)</h4><div class="NLM_p last">Obtained as a white solid (0.45 g, 94.3% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.48 (d, <i>J</i> = 7.6 Hz, 2H), 6.91 (d, <i>J</i> = 8.4 Hz, 2H), 4.21 (t, <i>J</i> = 5.6 Hz, 2H), 2.65 (t, <i>J</i> = 7.2 Hz, 2H), 2.07 (brs, 3H), 1.88–1.86 (m, 6H), 1.77–1.71 (m, 6H). MS (EI) <i>m</i>/<i>z</i> 300 (M+).</div></div><div id="sec4_1_8_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> 3-(4-(2,4,4-Trimethylpentan-2-yl)phenoxy)propanoic Acid (<b>13b</b>)</h4><div class="NLM_p last">Obtained as a white solid (0.44 g, 92.4% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.35 (s, 1H), 7.12 (d, <i>J</i> = 8.0 Hz, 2H), 6.65 (d, <i>J</i> = 8.0 Hz, 2H), 4.11 (t, <i>J</i> = 4.0 Hz, 2H), 2.65 (t, <i>J</i> = 4.0 Hz, 2H), 1.68 (s, 2H), 1.36 (s, 6H), 0.71 (s, 9H). MS (EI) <i>m</i>/<i>z</i> 278 (M+).</div></div></div><div id="sec4_1_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> General Procedure for the Synthesis of <b>14a</b>–<b>f</b>, <b>15a</b>,<b>b</b>, and <b>16a</b>–<b>c</b></h3><div class="NLM_p">EDCI (1.2 equiv) and HOBt (1.2 equiv) were added to a solution of acid <b>11a</b>–<b>d</b> or <b>12a</b>,<b>b</b> or <b>13a</b>,<b>b</b> (1.0 equiv), amine (1.0 equiv), and DIPEA (2.5 equiv) in DMF, and the reaction mixture was stirred at room temperature until completion as monitored by TLC. The reaction mixture was diluted with EtOAc brine. The organic layer was separated, dried over anhydrous MgSO<sub>4</sub>, filtered, and concentrated in vacuo. The resulting residue was purified by silica gel column chromatography.</div><div id="sec4_1_9_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> Methyl 3-[4-(4-Adamantan-1-yl-phenoxy)butanamido]benzoate (<b>14a</b>)<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a></h4><div class="NLM_p last">See ref <a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">15</a>.</div></div><div id="sec4_1_9_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> Methyl 3-(4-(4-(2,4,4-Trimethylpentan-2-yl)phenoxy)butanamido)benzoate (<b>14b</b>)</h4><div class="NLM_p last">Obtained as a white solid (0.12 g, 82.7% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.05 (s, 1H), 7.83 (d, <i>J</i> = 8.4 Hz, 1H), 7.77 (d, <i>J</i> = 7.6 Hz, 1H), 7.49 (s, 1H), 7.38 (t, <i>J</i> = 8.0 Hz, 1H), 7.26 (d, <i>J</i> = 8.4 Hz, 2H), 6.82 (d, <i>J</i> = 8.8 Hz, 2H), 4.04 (t, <i>J</i> = 6.6 Hz, 4H), 3.91 (s, 3H), 2.61 (t, <i>J</i> = 7.2 Hz, 2H), 2.26–2.19 (m, 2H), 1.70 (s, 2H), 1.34 (s, 6H), 0.71 (s, 9H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 171.5, 166.9, 156.3, 142.4, 138.4, 130.6, 129.0, 127.0, 125.1, 124.5, 120.8, 113.6, 66.8, 56.9, 52.2, 37.9, 34.0, 32.7, 31.7, 31.6, 25.1. HRMS (EI) <i>m</i>/<i>z</i> calcd for C<sub>26</sub>H<sub>36</sub>NO<sub>4</sub> [M + H] 426.2644, found 426.2610. Purity 100% (as determined by RP-HPLC, method A, <i>t</i><sub>R</sub> = 26.93 min).</div></div><div id="sec4_1_9_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> Methyl 4-Hydroxy-3-(4-(4-(2,4,4-trimethylpentan-2-yl)phenoxy)butanamido)benzoate (<b>14c</b>)</h4><div class="NLM_p last">Obtained as a white solid (0.10 g, 66.2% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.10 (s, 1H), 7.80 (dd, <i>J</i> = 2.0 Hz, 6.4 Hz, 1H), 7.72 (d, <i>J</i> = 1.6 Hz, 1H), 7.26 (d, <i>J</i> = 8.4 Hz, 2H), 7.01 (d, <i>J</i> = 8.4 Hz, 1H), 6.80 (d, <i>J</i> = 8.8 Hz, 2H), 4.06 (t, <i>J</i> = 5.6 Hz, 2H), 3.86 (s, 3H), 2.72 (t, <i>J</i> = 7.2 Hz, 6.8 Hz, 2H), 2.24–2.21 (m, 2H), 1.69 (s, 2H), 1.33 (s, 6H), 0.70 (s, 9H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 173.8, 166.8, 156.1, 153.4, 142.8, 128.7, 127.1, 125.8, 124.3, 121.9, 119.6, 113.6 66.7, 56.9, 52.2, 38.0, 33.6, 32.3, 31.8, 31.6, 25.2. MS (EI) <i>m</i>/<i>z</i> 448 (M + H). HRMS (EI) <i>m</i>/<i>z</i> calcd for C<sub>26</sub>H<sub>36</sub>NO<sub>5</sub> [M + H] 442.2593, found 442.2570. Purity 100% (as determined by RP-HPLC, method A, <i>t</i><sub>R</sub> = 25.63 min).</div></div><div id="sec4_1_9_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> Methyl 3-(2-(4-Adamantan-1-yl-phenoxy)-2-methylpropanamido)benzoate (<b>14d</b>)</h4><div class="NLM_p last">Obtained as a white solid (0.12 g, 84.5% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.74 (s, 1H) 8.14 (t, <i>J</i> = 2.0 Hz, 1H), 7.95–7.92 (m, 1H), 7.82–7.79 (m, 1H), 7.43 (t, <i>J</i> = 8.0 Hz, 1H), 7.27 (d, <i>J</i> = 9.2 Hz, 2H), 6.93 (d, <i>J</i> = 8.4 Hz, 2H), 3.91 (s, 3H), 2.09 (brs, 3H), 1.88–1.86 (m, 6H), 1.76–1.74 (m, 6H), 1.57 (s, 6H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 173.5, 166.7, 151.3, 147.2, 137.8, 131.0, 129.2, 125.8, 125.4, 124.1, 121.5, 120.6, 81.8, 52.2, 43.3, 36.7, 35.8, 28.9, 25.0. HRMS (EI) <i>m</i>/<i>z</i> calcd for C<sub>28</sub>H<sub>34</sub>NO<sub>4</sub> [M + H] 448.2488, found 448.2463. Purity 100% (as determined by RP-HPLC, method A, <i>t</i><sub>R</sub> = 29.60 min).</div></div><div id="sec4_1_9_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> Methyl 3-(2-Methyl-2-(4-(2,4,4-trimethylpentan-2-yl)phenoxy)propanamido)benzoate (<b>14e</b>)</h4><div class="NLM_p last">Obtained as a white solid (0.11 g, 75.8% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.79 (s, 1H), 8.14 (t, <i>J</i> = 2.0 Hz, 1H), 7.96–7.93 (m, 1H), 7.82–7.80 (m, 1H), 7.43 (t, <i>J</i> = 8.0 Hz, 1H), 7.28 (d, <i>J</i> = 8.4 Hz, 2H), 6.90 (d, <i>J</i> = 9.2 Hz, 2H), 3.91 (s, 3H), 1.71 (s, 2H), 1.55 (s, 6H), 1.35 (s, 6H), 0.70 (s, 9H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 173.4, 166.6, 151.1, 145.8, 137.8, 130.9, 129.1, 127.1, 125.4, 124.1, 121.4, 120.7, 81.8, 57.1, 52.1, 38.1, 32.3, 31.7, 31.6, 24.9. HRMS (EI) <i>m</i>/<i>z</i> calcd for C<sub>26</sub>H<sub>36</sub>NO<sub>4</sub> [M + H] 426.2644, found 426.2623. Purity 100% (as determined by RP-HPLC, method A, <i>t</i><sub>R</sub> = 28.88 min).</div></div><div id="sec4_1_9_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> Methyl 4-Hydroxy-3-(2-methyl-2-(4-(2,4,4-trimethylpentan-2-yl)phenoxy)propanamido)benzoate (<b>14f</b>)</h4><div class="NLM_p last">Obtained as a white solid (0.25 g, 83.2% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 10.1 (s, 1H), 9.09 (s, 1H), 7.82 (dd, <i>J</i> = 8.6 Hz, 1H), 7.77 (d, <i>J</i> = 2.0 Hz, 1H), 7.32 (d, <i>J</i> = 8.6 Hz, 2H), 7.05 (d, <i>J</i> = 8.6 Hz, 1H), 6.93 (d, <i>J</i> = 8.6 Hz, 2H), 3.87 (s, 3H), 1.72 (s, 2H), 1.57 (s, 6H), 1.37 (s, 6H), 0.71 (s, 9H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 175.7, 166.3, 153.2, 150.5, 146.5, 128.9, 127.2, 124.9, 124.2, 122.2, 122.0, 119.7, 81.7, 57.1, 52.0, 38.2, 32.3, 31.7, 31.5, 24.9. HRMS [M + H] calcd [C<sub>26</sub>H<sub>36</sub>NO<sub>5</sub>] 442.2515, found 442.2576. Purity 100% (as determined by RP-HPLC, method A, <i>t</i><sub>R</sub> = 16.29 min).</div></div><div id="sec4_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> (<i>E</i>)-3-[3-(4-Adamantan-1-ylphenoxy)acryloylamino]benzoic Acid Methyl Ester (<b>15a</b>)<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></h4><div class="NLM_p last">See ref <a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">25</a>.</div></div><div id="sec4_1_10_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> (<i>E</i>)-3-{3-[4-(2,4,4-Trimethylpentan-2-yl)phenoxy]acrylamido}benzoic Acid Methyl Ester (<b>15b</b>)<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></h4><div class="NLM_p last">See ref <a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">25</a>.</div></div><div id="sec4_1_10_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> Methyl 3-[3-(4-Adamantan-1-y-phenoxy)propanamido]benzoate (<b>16a</b>)<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></h4><div class="NLM_p last">See ref <a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">25</a>.</div></div><div id="sec4_1_10_1_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> Methyl 4-Hydroxy-3-(3-(4-(2,4,4-trimethylpentan-2-yl)phenoxy)propanamido)benzoate (<b>16b</b>)</h4><div class="NLM_p last">Obtained as a white solid (0.01 g, 75.0% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 9.74 (s, 1H), 8.36 (s, 1H), 7.81 (dd, <i>J</i><sub>1</sub> = 2.0 Hz, <i>J</i><sub>2</sub> = 2.0 Hz, 1H), 7.67 (d, <i>J</i> = 2.0 Hz, 1H), 7.32 (d, <i>J</i> = 8.8 Hz, 1H), 7.03 (d, <i>J</i> = 8.4 Hz, 1H), 6.89 (d, <i>J</i> = 8.4 Hz, 2H), 4.35 (t, <i>J</i> = 5.4 Hz, 2H), 3.88 (s, 3H), 2.94 (t, <i>J</i> = 5.6 Hz, 2H), 1.71 (s, 2H), 1.34 (s, 6H), 0.71 (s, 9H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 171.7, 166.4, 155.3, 153.2, 143.7, 128.9, 127.3, 125.5, 124.2, 122.1, 119.7, 113.9, 63.8, 56.9, 52.1, 38.0, 36.8, 32.3, 31.7, 31.6. HRMS (EI) <i>m</i>/<i>z</i> calcd for C<sub>25</sub>H<sub>34</sub>NO<sub>5</sub> [M + H] 428.2359, found 428.2431. Purity 99.99% (as determined by RP-HPLC, method A, <i>t</i><sub>R</sub> = 24.09 min).</div></div><div id="sec4_1_10_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> Methyl 3-(3-(4-(2,4,4-Trimethylpentan-2-yl)phenoxy)propanamido)benzoate (<b>16c</b>)</h4><div class="NLM_p last">Obtained as a white solid (0.13 g, 88.4% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.18 (s, 1H), 8.07 (t, <i>J</i> = 1.6 Hz, 1H), 7.88–7.86 (m, 1H), 7.77 (d, <i>J</i> = 8.0 Hz, 1H), 7.38 (t, <i>J</i> = 8.0 Hz, 1H), 7.29 (d, <i>J</i> = 8.8 Hz, 2H), 6.86 (d, <i>J</i> = 9.2 Hz, 2H), 4.32 (t, <i>J</i> = 4.0 Hz, 2H), 3.89 (s, 3H), 2.85 (t, <i>J</i> = 4.0 Hz, 2H), 1.70 (s, 2H), 1.34 (s, 6H), 0.71 (s, 9H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 169.2, 166.7, 155.6, 143.4, 138.0, 130.9, 129.2, 127.3, 125.4, 124.4, 120.8, 113.8, 64.1, 56.9, 52.2, 38.0, 37.8, 32.3, 31.8, 31.6, 29.7. HRMS (EI) <i>m</i>/<i>z</i> calcd for C<sub>25</sub>H<sub>34</sub>NO<sub>4</sub> [M + H] 412.2488, found 412.2463. Purity 100% (as determined by RP-HPLC, method A, <i>t</i><sub>R</sub> = 26.00 min).</div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> Cell Culture</h3><div class="NLM_p last">Human colorectal carcinoma HCT116 cells were cultured in a 5% CO<sub>2</sub> atmosphere at 37 °C in Dulbecco’s Modified Eagle’s Medium (Gibco, Carlsbad, CA, USA) supplemented with 5% fetal bovine serum (Gibco), 100 U/mL penicillin, and 100 μg/mL streptomycin (Gibco). A hypoxic condition was achieved by replacing the cells with 1% O<sub>2</sub>, 94% N<sub>2</sub>, and 5% CO<sub>2</sub> in a multigas incubator (Sanyo, Osaka, Japan).</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> MDH Activity Assay</h3><div class="NLM_p last">The enzyme activity of MDH1 and MDH2 was determined by oxaloacetate-dependent NADH oxidation assay. The reaction was performed in 100 mM potassium phosphate buffer (pH 7.4) with 0.25 nM human recombinant MDH1 (BioVision) or MDH2 (ref. JEM 2014), 200 μM oxaloacetic acid, and 200 μM NADH. In the case of the kinetic assay, the reaction was performed with 0.25 nM rhMDH2, 600 μM oxaloacetic acid, and various concentrations of NADH (60, 75, 100, 150, and 300 μM). After 30 min, the NADH concentration in the mixture was determined by measuring absorbance at 340 nm. The <i>V</i><sub>max</sub> and <i>K</i><sub>m</sub> were determined from double-reciprocal Lineweaver–Burk plots using Sigmaplot 13.0 (Systat Software), and the velocity was plotted against the NADH concentration.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> HRE-Luciferase Reporter Assay</h3><div class="NLM_p last">HCT116 cells stably expressing a hypoxia response element (HRE)-dependent firefly luciferase reporter construct (HRE-Luc) and a CMV-Renilla luciferase reporter construct were established with Cignal Lenti Reporter assay system (SABiosciences, Frederick, MD, USA) according to the manufacturer’s instructions. Cells were incubated with drugs for 12 h under normoxic or hypoxic conditions. After removing the supernatant, luciferase activity was measured with a Dual-Luciferase assay system (Promega, Madison, WI, USA) according to the manufacturer’s instructions with a Victor X Light luminescence reader (PerkinElmer, Boston, MA, USA).</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> Immunoblot Analysis</h3><div class="NLM_p last">Cells were lysed with a RIPA buffer (20 mM HEPES, pH 7.4, 1% Triton X-100, 10% glycerol, 1 mM EDTA, 5 mM sodium fluoride, 10 μg/mL phenylmethylsulfonylfluoride (PMSF), and 1 mM sodium vanadate) for 15 min at 4 °C and centrifuged at 13000 rpm for 15 min. Lysates were then boiled for 5 min in 5× sample buffer (50 mM Tris, pH 7.4, 4% sodium dodecyl sulfate (SDS), 10% glycerol, 4% 2-thioethanol, and 50 μg/mL Bromophenol blue) at a ratio of 4:1. Protein samples were subjected to SDS-polyacrylamide gel electrophoresis (PAGE), transferred to PVDF membranes (Millipore, Billerica, MA), and immunoblotted with the following antibodies: HIF-1α (BD Transduction Laboratories, San Diego, CA, USA), P-ACC (Cell Signaling, Danvers, MA, USA), ACC (Cell Signaling), P-AMPK (Cell Signaling), AMPK (Cell Signaling), P-mTOR (Cell Signaling), mTOR (Cell Signaling), and β-actin (Abcam, Cambridge, UK). Protein expression was visualized on Kodak Biomax X-ray film (Kodak, Rochester, NY, USA).</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> RT-PCR</h3><div class="NLM_p last">Total RNA was isolated with Trizol reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer’s instructions. First, 1 μg of total RNA was reverse transcribed using TOPscript RT DryMIX kit (Enzynomics, Seoul, Korea). The PCR primers used were 5′-GCAGCCAGATCTCGGCGAAG-3′ (forward) and 5′-CTGTGTCCAGTTAGTTCAAA-3′ (reverse) for HIF-1α, 5′-GGTGGACATCTTCCAGGAGT-3′ (forward) and 5′-GGCTTGTCACATCTGCAAGT-3′ (reverse) for VEGF, 5′-ATGATTGGCTCCTTCTCTGT-3′ (forward) and 5′-TCAGCATCTCAAAGGACTTG-3′ (reverse) for GLUT1, 5′-GGCCAGGTGGACTTCTA-3′ (forward) and 5′-TCATTGTGTCGGTTTCTGAT-3′ (reverse) for PDK1, and 5′-CATCGTGGCTAAACAGGTAC-3′ (forward) and 5′-GCACGACCTTGAGGGCAGC-3′ (reverse) for RPL13A. Then the amplified products were subjected to electrophoresis on 2% agarose gels and visualized by ethidium bromide staining.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> Measurement of Oxygen Consumption</h3><div class="NLM_p last">The oxygen consumption rate (OCR) in cells was measured using the XF24 extracellular flux analyzer (Seahorse Biosciences, North Billerica, MA). After determining basal OCR of HCT116 cells, oligomycin (1 μM), carbonylcyanide <i>p</i>-trifluoromethoxyphenylhydrazone (0.5 μM), and rotenone (1 μM)/antimycin A (1 μM) were added sequentially, and OCR was determined following each addition. The oxygen consumption of each respiratory chain was measured using an Oxygraph (Hansatech Instruments, Norfolk, UK). After permeabilization of HCT116 cells (1 × 10<sup>7</sup> cells) with digitonin (30 μM), substrates and inhibitors for each complex were added. The substrates and inhibitors used were: pyruvate (5 mM), malate (5 mM), rotenone (1 μM), succinate (5 mM), antimycin A (1 μM), ascorbate (5 mM), tetramethyl-<i>p</i>-phenylenediamine (TMPD) (2 mM), and KCN (1 mM).</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> Detection of Oxygen Tension</h3><div class="NLM_p last">The intracellular oxygen tension was detected using a hypoxia-detecting probe mono azo rhodamine (MAR, Goryo Chemical, Japan). HCT116 cells were incubated for 6 h with drug and 500 nM MAR under hypoxia and then analyzed with an IncuCyte live cell imaging system (Essen BioScience, Ann Arbor, MI, USA).</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> Xenograft Model</h3><div class="NLM_p last">The in vivo antitumor activity of compounds <b>5i</b>, <b>7c</b>, <b>15a</b>, and <b>16c</b> was determined in a HCT116 xenograft mouse model. All animal experimental protocols were approved by the bioethics committee of the Korea Research Institute of Bioscience and Biotechnology (KRIBB). Five-week-old female nude mice were subcutaneously inoculated with 5 × 10<sup>6</sup> HCT116 cells in the right flank. When the tumor volume reached 80–100 mm<sup>3</sup>, drugs were administered intraperitoneally once a day for 14 days. The drug was formulated in a mixture of 10% DMSO, 10% Cremophor EL, and 80% distilled water. Tumor volume was measured every other day with calipers and calculated using following equation: <i>V</i> (mm<sup>3</sup>) = (length × width × height) × 0.5.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> Statistical Analysis</h3><div class="NLM_p last">The statistical significance of the results was analyzed using the Student’s <i>t</i> test for unpaired observations and Dunnett’s test for multiple comparisons.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i85"><a href="/doi/suppl/10.1021/acs.jmedchem.7b01231">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78787" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78787" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b01231" class="ext-link">10.1021/acs.jmedchem.7b01231</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Protein–protein Blast of MDH1 and MDH2, structural and sequence alignment of the active site regions from MDH1 and MDH2, molecular docking study of compounds, effects of compounds on intracellular oxygen tension, effects on mitochondria complex II, III, and IV activity, body weight change in HCT116 xenograft model, in vivo antitumor effect of compound <b>5i</b> and <b>15a</b> in HCT116 xenograft model, and in vitro water solubility of <b>14b</b> and <b>16c</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01231/suppl_file/jm7b01231_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01231/suppl_file/jm7b01231_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01231/suppl_file/jm7b01231_si_001.pdf">jm7b01231_si_001.pdf (902.44 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01231/suppl_file/jm7b01231_si_002.csv">jm7b01231_si_002.csv (3.8 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.7b01231" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50157" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50157" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Misun Won</span> - <span class="hlFld-Affiliation affiliation">Personalized Genomic Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon 34141, Korea</span>; 
    <span class="hlFld-Affiliation affiliation">Functional Genomics, University of Science and Technology, Daejeon 34113, Korea</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#412c2832342f012a332823236f33246f2a33"><span class="__cf_email__" data-cfemail="5835312b2d3618332a313a3a762a3d76332a">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kyeong Lee</span> - <span class="hlFld-Affiliation affiliation">College of Pharmacy, Dongguk University, Goyang 10326, Korea</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5455-9956" title="Orcid link">http://orcid.org/0000-0002-5455-9956</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#59323820353c3c193d36373e3e2c32773c3d2c"><span class="__cf_email__" data-cfemail="c2a9a3bbaea7a782a6adaca5a5b7a9eca7a6b7">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ravi Naik</span> - <span class="hlFld-Affiliation affiliation">College of Pharmacy, Dongguk University, Goyang 10326, Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hyun Seung Ban</span> - <span class="hlFld-Affiliation affiliation">Metabolic Regulation Research Center, Korea
Research Institute of Bioscience and Biotechnology, Daejeon 34141, Korea</span>; 
    <span class="hlFld-Affiliation affiliation">Biomolecular Science, University of Science and Technology, Daejeon 34113, Korea</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2698-6037" title="Orcid link">http://orcid.org/0000-0002-2698-6037</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kyusic Jang</span> - <span class="hlFld-Affiliation affiliation">College of Pharmacy, Dongguk University, Goyang 10326, Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Inhyub Kim</span> - <span class="hlFld-Affiliation affiliation">Personalized Genomic Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon 34141, Korea</span>; 
    <span class="hlFld-Affiliation affiliation">Functional Genomics, University of Science and Technology, Daejeon 34113, Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xuezhen Xu</span> - <span class="hlFld-Affiliation affiliation">College of Pharmacy, Dongguk University, Goyang 10326, Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dipesh Harmalkar</span> - <span class="hlFld-Affiliation affiliation">College of Pharmacy, Dongguk University, Goyang 10326, Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Seong-Ah Shin</span> - <span class="hlFld-Affiliation affiliation">Personalized Genomic Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon 34141, Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Minkyoung Kim</span> - <span class="hlFld-Affiliation affiliation">College of Pharmacy, Dongguk University, Goyang 10326, Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bo-Kyung Kim</span> - <span class="hlFld-Affiliation affiliation">Personalized Genomic Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon 34141, Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jaehyung Park</span> - <span class="hlFld-Affiliation affiliation">College of Pharmacy, Dongguk University, Goyang 10326, Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bonsu Ku</span> - <span class="hlFld-Affiliation affiliation">Disease Target Structure Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon 34141, Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sujin Oh</span> - <span class="hlFld-Affiliation affiliation">New Drug Development Center, Asan Medical Center, Seoul 05505, Korea</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>This manuscript was written with contributions from all the coauthors. All coauthors have approved the final version of the manuscript. R.N and H.S.B. contributed equally.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d188e4386-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i87">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47830" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47830" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This study was supported by National Research Foundation (NRF) grants (2012M3A9C1053532 and 2015M3A6A4065734), Health Technology R&D (HI13C2162), and the KRIBB Initiative of the Korea Research Council of Fundamental Science and Technology.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i88" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i88"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i89" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i89"> Abbreviations Used</h2><tr><td class="NLM_term">AOA</td><td class="NLM_def"><p class="first last">amino-oxyacetic acid</p></td></tr><tr><td class="NLM_term">ERBB2</td><td class="NLM_def"><p class="first last">Erb-B2 receptor tyrosine kinase 2</p></td></tr><tr><td class="NLM_term">ETC</td><td class="NLM_def"><p class="first last">electron transport chain</p></td></tr><tr><td class="NLM_term">GLUT1</td><td class="NLM_def"><p class="first last">glucose transporter 1</p></td></tr><tr><td class="NLM_term">GOT</td><td class="NLM_def"><p class="first last">glutamate oxaloacetate transaminase</p></td></tr><tr><td class="NLM_term">HIF-1</td><td class="NLM_def"><p class="first last">hypoxia-inducible factor-1</p></td></tr><tr><td class="NLM_term">HRE</td><td class="NLM_def"><p class="first last">hypoxia-response element</p></td></tr><tr><td class="NLM_term">MDH</td><td class="NLM_def"><p class="first last">malate dehydrogenase</p></td></tr><tr><td class="NLM_term">mTOR</td><td class="NLM_def"><p class="first last">mechanistic target of rapamycin</p></td></tr><tr><td class="NLM_term">OCR</td><td class="NLM_def"><p class="first last">oxygen consumption rate</p></td></tr><tr><td class="NLM_term">PDAC</td><td class="NLM_def"><p class="first last">pancreatic ductal adenocarcinoma</p></td></tr><tr><td class="NLM_term">PDK1</td><td class="NLM_def"><p class="first last">pyruvate dehydrogenase kinase 1</p></td></tr><tr><td class="NLM_term">TCA</td><td class="NLM_def"><p class="first last">tricarboxylic acid</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i90">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38273" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38273" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 34 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Cairns, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, I. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, T. W.</span><span> </span><span class="NLM_article-title">Regulation of Cancer Cell Metabolism</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">85</span><span class="NLM_x">–</span> <span class="NLM_lpage">95</span><span class="refDoi"> DOI: 10.1038/nrc2981</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=10.1038%2Fnrc2981" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=21258394" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=1%3ACAS%3A528%3ADC%252BC3MXps1ahuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=85-95&author=R.+A.+Cairnsauthor=I.+S.+Harrisauthor=T.+W.+Mak&title=Regulation+of+Cancer+Cell+Metabolism&doi=10.1038%2Fnrc2981"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of cancer cell metabolism</span></div><div class="casAuthors">Cairns, Rob A.; Harris, Isaac S.; Mak, Tak W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">85-95</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Interest in the topic of tumor metab. has waxed and waned over the past century of cancer research.  The early observations of Warburg and his contemporaries established that there are fundamental differences in the central metabolic pathways operating in malignant tissue.  However, the initial hypotheses that were based on these observations proved inadequate to explain tumorigenesis, and the oncogene revolution pushed tumor metab. to the margins of cancer research.  In recent years, interest was renewed as it has become clear that many of the signaling pathways that are affected by genetic mutations and the tumor microenvironment have a profound effect on core metab., making this topic once again one of the most intense areas of research in cancer biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqideEJZiMGjrVg90H21EOLACvtfcHk0lhjIzevEQMWYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXps1ahuw%253D%253D&md5=ffbbec8c8159e88b026f44b249ee1ede</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrc2981&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2981%26sid%3Dliteratum%253Aachs%26aulast%3DCairns%26aufirst%3DR.%2BA.%26aulast%3DHarris%26aufirst%3DI.%2BS.%26aulast%3DMak%26aufirst%3DT.%2BW.%26atitle%3DRegulation%2520of%2520Cancer%2520Cell%2520Metabolism%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2011%26volume%3D11%26spage%3D85%26epage%3D95%26doi%3D10.1038%2Fnrc2981" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Williamson, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakob, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Refino, C.</span><span> </span><span class="NLM_article-title">Control of the Removal of Reducing Equivalents from the Cytosol in Perfused Rat Liver</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1971</span><span class="NLM_x">, </span> <span class="NLM_volume">246</span><span class="NLM_x">, </span> <span class="NLM_fpage">7632</span><span class="NLM_x">–</span> <span class="NLM_lpage">7641</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=246&publication_year=1971&pages=7632-7641&author=J.+R.+Williamsonauthor=A.+Jakobauthor=C.+Refino&title=Control+of+the+Removal+of+Reducing+Equivalents+from+the+Cytosol+in+Perfused+Rat+Liver"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilliamson%26aufirst%3DJ.%2BR.%26aulast%3DJakob%26aufirst%3DA.%26aulast%3DRefino%26aufirst%3DC.%26atitle%3DControl%2520of%2520the%2520Removal%2520of%2520Reducing%2520Equivalents%2520from%2520the%2520Cytosol%2520in%2520Perfused%2520Rat%2520Liver%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1971%26volume%3D246%26spage%3D7632%26epage%3D7641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">López-Alarcón, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eboli, M. L.</span><span> </span><span class="NLM_article-title">Oxidation of Reduced Cytosolic Nicotinamide Adenine Dinucleotide by the Malate-Aspartate Shuttle in the K-562 Human Leukemia Cell Line</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">5589</span><span class="NLM_x">–</span> <span class="NLM_lpage">5591</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1986&pages=5589-5591&author=L.+L%C3%B3pez-Alarc%C3%B3nauthor=M.+L.+Eboli&title=Oxidation+of+Reduced+Cytosolic+Nicotinamide+Adenine+Dinucleotide+by+the+Malate-Aspartate+Shuttle+in+the+K-562+Human+Leukemia+Cell+Line"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DL%25C3%25B3pez-Alarc%25C3%25B3n%26aufirst%3DL.%26aulast%3DEboli%26aufirst%3DM.%2BL.%26atitle%3DOxidation%2520of%2520Reduced%2520Cytosolic%2520Nicotinamide%2520Adenine%2520Dinucleotide%2520by%2520the%2520Malate-Aspartate%2520Shuttle%2520in%2520the%2520K-562%2520Human%2520Leukemia%2520Cell%2520Line%26jtitle%3DCancer%2520Res.%26date%3D1986%26volume%3D46%26spage%3D5589%26epage%3D5591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Barron, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parrillo, J. E.</span><span> </span><span class="NLM_article-title">Malate-Aspartate Shuttle, Cytoplasmic NADH Redox Potential, and Energetics in Vascular Smooth Muscle</span> <span class="citation_source-journal">J. Mol. Cell. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">1571</span><span class="NLM_x">–</span> <span class="NLM_lpage">1579</span><span class="refDoi"> DOI: 10.1006/jmcc.1998.0722</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=10.1006%2Fjmcc.1998.0722" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=9737943" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=1%3ACAS%3A528%3ADyaK1cXmtlCqtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1998&pages=1571-1579&author=J.+T.+Barronauthor=L.+Guauthor=J.+E.+Parrillo&title=Malate-Aspartate+Shuttle%2C+Cytoplasmic+NADH+Redox+Potential%2C+and+Energetics+in+Vascular+Smooth+Muscle&doi=10.1006%2Fjmcc.1998.0722"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Malate-aspartate shuttle, cytoplasmic NADH redox potential, and energetics in vascular smooth muscle</span></div><div class="casAuthors">Barron, John T.; Gu, Liping; Parrillo, Joseph E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular and Cellular Cardiology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1571-1579</span>CODEN:
                <span class="NLM_cas:coden">JMCDAY</span>;
        ISSN:<span class="NLM_cas:issn">0022-2828</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">The effect of inhibition of the malate-aspartate shuttle on the cytoplasmic NADH/NAD ratio and NADH redox state and its corresponding effects on mitochondrial energetics in vascular smooth muscle were examd.  Incubation of porcine carotid arteries with 0.4 mmol amino-oxyacetic acid an inhibitor of glutamate-oxaloacetate transaminase and, hence the malate-aspartate shuttle, inhibited O2 consumption by 21%, decreased the content of phosphocreatine and inhibited activity of the tricarboxylic acid cycle.  The rate of glycolysis and lactate prodn. was increased but glucose oxidn. was inhibited.  These effects of amino-oxyacetic acid were accompanied by evidence of inhibition of the malate-aspartate shuttle and elevation in the cytoplasmic redox potential and NADH/NAD ratio as indicated by elevation of the concn. ratios of the lactate/pyruvate and glycerol-3-phosphate/dihydroxyacetone phosphate metabolite redox couples.  Addn. of the fatty acid octanoate normalized the adverse energetic effects of malate-aspartate shuttle inhibition.  It is concluded that the malate-aspartate shuttle is a primary mode of clearance of NADH reducing equiv. from the cytoplasm in vascular smooth muscle.  Glucose oxidn. and lactate prodn. are influenced by the activity of the shuttle.  The results support the hypothesis that an increased cytoplasmic NADH redox potential impairs mitochondrial energy metab.  (c) 1998 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAU9kC-zm30rVg90H21EOLACvtfcHk0ljvqMZo1VD2Eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmtlCqtbc%253D&md5=aee17d93acfd5ead7eee039777253743</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1006%2Fjmcc.1998.0722&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmcc.1998.0722%26sid%3Dliteratum%253Aachs%26aulast%3DBarron%26aufirst%3DJ.%2BT.%26aulast%3DGu%26aufirst%3DL.%26aulast%3DParrillo%26aufirst%3DJ.%2BE.%26atitle%3DMalate-Aspartate%2520Shuttle%252C%2520Cytoplasmic%2520NADH%2520Redox%2520Potential%252C%2520and%2520Energetics%2520in%2520Vascular%2520Smooth%2520Muscle%26jtitle%3DJ.%2520Mol.%2520Cell.%2520Cardiol.%26date%3D1998%26volume%3D30%26spage%3D1571%26epage%3D1579%26doi%3D10.1006%2Fjmcc.1998.0722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Thornburg, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clem, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arumugam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmons, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eaton, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Telang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chesney, J.</span><span> </span><span class="NLM_article-title">Targeting Aspartate Aminotransferase in Breast Cancer</span> <span class="citation_source-journal">Breast Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">R84</span><span class="refDoi"> DOI: 10.1186/bcr2154</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=10.1186%2Fbcr2154" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=18922152" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=1%3ACAS%3A280%3ADC%252BD1M%252FlsVGlsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&pages=R84&author=J.+M.+Thornburgauthor=K.+K.+Nelsonauthor=B.+F.+Clemauthor=A.+N.+Laneauthor=S.+Arumugamauthor=A.+Simmonsauthor=J.+W.+Eatonauthor=S.+Telangauthor=J.+Chesney&title=Targeting+Aspartate+Aminotransferase+in+Breast+Cancer&doi=10.1186%2Fbcr2154"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting aspartate aminotransferase in breast cancer</span></div><div class="casAuthors">Thornburg Joshua Marshall; Nelson Kristin K; Clem Brian F; Lane Andrew N; Arumugam Sengodagounder; Simmons Allan; Eaton John W; Telang Sucheta; Chesney Jason</div><div class="citationInfo"><span class="NLM_cas:title">Breast cancer research : BCR</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">R84</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">INTRODUCTION:  Glycolysis is increased in breast adenocarcinoma cells relative to adjacent normal cells in order to produce the ATP and anabolic precursors required for survival, growth and invasion.  Glycolysis also serves as a key source of the reduced form of cytoplasmic nicotinamide adenine dinucleotide (NADH) necessary for the shuttling of electrons into mitochondria for electron transport.  Lactate dehydrogenase (LDH) regulates glycolytic flux by converting pyruvate to lactate and has been found to be highly expressed in breast tumours.  Aspartate aminotransferase (AAT) functions in tandem with malate dehydrogenase to transfer electrons from NADH across the inner mitochondrial membrane.  Oxamate is an inhibitor of both LDH and AAT, and we hypothesised that oxamate may disrupt the metabolism and growth of breast adenocarcinoma cells.  METHODS:  We examined the effects of oxamate and the AAT inhibitor amino oxyacetate (AOA) on 13C-glucose utilisation, oxygen consumption, NADH and ATP in MDA-MB-231 cells.  We then determined the effects of oxamate and AOA on normal human mammary epithelial cells and MDA-MB-231 breast adenocarcinoma cell proliferation, and on the growth of MDA-MB-231 cells as tumours in athymic BALB/c female mice.  We ectopically expressed AAT in MDA-MB-231 cells and examined the consequences on the cytostatic effects of oxamate.  Finally, we examined the effect of AAT-specific siRNA transfection on MDA-MB-231 cell proliferation.  RESULTS:  We found that oxamate did not attenuate cellular lactate production as predicted by its LDH inhibitory activity, but did have an anti-metabolic effect that was similar to AAT inhibition with AOA.  Specifically, we found that oxamate and AOA decreased the flux of 13C-glucose-derived carbons into glutamate and uridine, both products of the mitochondrial tricarboxylic acid cycle, as well as oxygen consumption, a measure of electron transport chain activity.  Oxamate and AOA also selectively suppressed the proliferation of MDA-MB-231 cells relative to normal human mammary epithelial cells and decreased the growth of MDA-MB-231 breast tumours in athymic mice.  Importantly, we found that ectopic expression of AAT in MDA-MB-231 cells conferred resistance to the anti-proliferative effects of oxamate and that siRNA silencing of AAT decreased MDA-MB-231 cell proliferation.  CONCLUSIONS:  We conclude that AAT may be a valid molecular target for the development of anti-neoplastic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRBenhyt5omvCA3UY9EwTNrfW6udTcc2eYtvTwP37MZV7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M%252FlsVGlsA%253D%253D&md5=d1bf6a2f48a7f93c1211f4d158ddab56</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1186%2Fbcr2154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fbcr2154%26sid%3Dliteratum%253Aachs%26aulast%3DThornburg%26aufirst%3DJ.%2BM.%26aulast%3DNelson%26aufirst%3DK.%2BK.%26aulast%3DClem%26aufirst%3DB.%2BF.%26aulast%3DLane%26aufirst%3DA.%2BN.%26aulast%3DArumugam%26aufirst%3DS.%26aulast%3DSimmons%26aufirst%3DA.%26aulast%3DEaton%26aufirst%3DJ.%2BW.%26aulast%3DTelang%26aufirst%3DS.%26aulast%3DChesney%26aufirst%3DJ.%26atitle%3DTargeting%2520Aspartate%2520Aminotransferase%2520in%2520Breast%2520Cancer%26jtitle%3DBreast%2520Cancer%2520Res.%26date%3D2008%26volume%3D10%26spage%3DR84%26doi%3D10.1186%2Fbcr2154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ling, Z. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guan, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, D.</span><span> </span><span class="NLM_article-title">SIRT3-dependent GOT2 Acetylation Status Affects the Malate–Aspartate NADH Shuttle Activity and Pancreatic Tumor Growth</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1110</span><span class="NLM_x">–</span> <span class="NLM_lpage">1125</span><span class="refDoi"> DOI: 10.15252/embj.201591041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=10.15252%2Fembj.201591041" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2015&pages=1110-1125&author=H.+Yangauthor=L.+Zhouauthor=Q.+Shiauthor=Y.+Zhaoauthor=H.+Linauthor=M.+Zhangauthor=S.+Zhaoauthor=Y.+Yangauthor=Z.+Q.+Lingauthor=K.+L.+Guanauthor=Y.+Xiongauthor=D.+Ye&title=SIRT3-dependent+GOT2+Acetylation+Status+Affects+the+Malate%E2%80%93Aspartate+NADH+Shuttle+Activity+and+Pancreatic+Tumor+Growth&doi=10.15252%2Fembj.201591041"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.15252%2Fembj.201591041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.15252%252Fembj.201591041%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DH.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DShi%26aufirst%3DQ.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DLin%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DLing%26aufirst%3DZ.%2BQ.%26aulast%3DGuan%26aufirst%3DK.%2BL.%26aulast%3DXiong%26aufirst%3DY.%26aulast%3DYe%26aufirst%3DD.%26atitle%3DSIRT3-dependent%2520GOT2%2520Acetylation%2520Status%2520Affects%2520the%2520Malate%25E2%2580%2593Aspartate%2520NADH%2520Shuttle%2520Activity%2520and%2520Pancreatic%2520Tumor%2520Growth%26jtitle%3DEMBO%2520J.%26date%3D2015%26volume%3D34%26spage%3D1110%26epage%3D1125%26doi%3D10.15252%2Fembj.201591041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Son, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyssiotis, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ying, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hua, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ligorio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perera, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrone, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullarky, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shyh-Chang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleming, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardeesy, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asara, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haigis, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DePinho, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantley, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimmelman, A. C.</span><span> </span><span class="NLM_article-title">Glutamine Supports Pancreatic Cancer Growth through a KRAS-Regulated Metabolic Pathway</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">496</span><span class="NLM_x">, </span> <span class="NLM_fpage">101</span><span class="NLM_x">–</span> <span class="NLM_lpage">105</span><span class="refDoi"> DOI: 10.1038/nature12040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=10.1038%2Fnature12040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=23535601" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=1%3ACAS%3A528%3ADC%252BC3sXkvFyjsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=496&publication_year=2013&pages=101-105&author=J.+Sonauthor=C.+A.+Lyssiotisauthor=H.+Yingauthor=X.+Wangauthor=S.+Huaauthor=M.+Ligorioauthor=R.+M.+Pereraauthor=C.+R.+Ferroneauthor=E.+Mullarkyauthor=N.+Shyh-Changauthor=Y.+Kangauthor=J.+B.+Flemingauthor=N.+Bardeesyauthor=J.+M.+Asaraauthor=M.+C.+Haigisauthor=R.+A.+DePinhoauthor=L.+C.+Cantleyauthor=A.+C.+Kimmelman&title=Glutamine+Supports+Pancreatic+Cancer+Growth+through+a+KRAS-Regulated+Metabolic+Pathway&doi=10.1038%2Fnature12040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway</span></div><div class="casAuthors">Son, Jaekyoung; Lyssiotis, Costas A.; Ying, Haoqiang; Wang, Xiaoxu; Hua, Sujun; Ligorio, Matteo; Perera, Rushika M.; Ferrone, Cristina R.; Mullarky, Edouard; Ng, Shyh-Chang; Kang, Ya'an; Fleming, Jason B.; Bardeesy, Nabeel; Asara, John M.; Haigis, Marcia C.; DePinho, Ronald A.; Cantley, Lewis C.; Kimmelman, Alec C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">496</span>
        (<span class="NLM_cas:issue">7443</span>),
    <span class="NLM_cas:pages">101-105</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Cancer cells have metabolic dependencies that distinguish them from their normal counterparts.  Among these dependencies is an increased use of the amino acid glutamine to fuel anabolic processes.  Indeed, the spectrum of glutamine-dependent tumors and the mechanisms whereby glutamine supports cancer metab. remain areas of active investigation.  Here we report the identification of a non-canonical pathway of glutamine use in human pancreatic ductal adenocarcinoma (PDAC) cells that is required for tumor growth.  Whereas most cells use glutamate dehydrogenase (GLUD1) to convert glutamine-derived glutamate into α-ketoglutarate in the mitochondria to fuel the tricarboxylic acid cycle, PDAC relies on a distinct pathway in which glutamine-derived aspartate is transported into the cytoplasm where it can be converted into oxaloacetate by aspartate transaminase (GOT1).  Subsequently, this oxaloacetate is converted into malate and then pyruvate, ostensibly increasing the NADPH/NADP+ ratio which can potentially maintain the cellular redox state.  Importantly, PDAC cells are strongly dependent on this series of reactions, as glutamine deprivation or genetic inhibition of any enzyme in this pathway leads to an increase in reactive oxygen species and a redn. in reduced glutathione.  Moreover, knockdown of any component enzyme in this series of reactions also results in a pronounced suppression of PDAC growth in vitro and in vivo.  Furthermore, we establish that the reprogramming of glutamine metab. is mediated by oncogenic KRAS, the signature genetic alteration in PDAC, through the transcriptional upregulation and repression of key metabolic enzymes in this pathway.  The essentiality of this pathway in PDAC and the fact that it is dispensable in normal cells may provide novel therapeutic approaches to treat these refractory tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzWAEWZvCWcbVg90H21EOLACvtfcHk0lhAftCT5YHxmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXkvFyjsrc%253D&md5=162af18c1102745226aa2096179f1cc6</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnature12040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature12040%26sid%3Dliteratum%253Aachs%26aulast%3DSon%26aufirst%3DJ.%26aulast%3DLyssiotis%26aufirst%3DC.%2BA.%26aulast%3DYing%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DHua%26aufirst%3DS.%26aulast%3DLigorio%26aufirst%3DM.%26aulast%3DPerera%26aufirst%3DR.%2BM.%26aulast%3DFerrone%26aufirst%3DC.%2BR.%26aulast%3DMullarky%26aufirst%3DE.%26aulast%3DShyh-Chang%26aufirst%3DN.%26aulast%3DKang%26aufirst%3DY.%26aulast%3DFleming%26aufirst%3DJ.%2BB.%26aulast%3DBardeesy%26aufirst%3DN.%26aulast%3DAsara%26aufirst%3DJ.%2BM.%26aulast%3DHaigis%26aufirst%3DM.%2BC.%26aulast%3DDePinho%26aufirst%3DR.%2BA.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26aulast%3DKimmelman%26aufirst%3DA.%2BC.%26atitle%3DGlutamine%2520Supports%2520Pancreatic%2520Cancer%2520Growth%2520through%2520a%2520KRAS-Regulated%2520Metabolic%2520Pathway%26jtitle%3DNature%26date%3D2013%26volume%3D496%26spage%3D101%26epage%3D105%26doi%3D10.1038%2Fnature12040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Lee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ban, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naik, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Son, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Won, M.</span><span> </span><span class="NLM_article-title">Identification of Malate Dehydrogenase 2 as a Target Protein of the HIF-1 Inhibitor LW6 using Chemical Probes</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">10286</span><span class="NLM_x">–</span> <span class="NLM_lpage">10289</span><span class="refDoi"> DOI: 10.1002/anie.201304987</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=10.1002%2Fanie.201304987" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=10286-10289&author=K.+Leeauthor=H.+S.+Banauthor=R.+Naikauthor=Y.+S.+Hongauthor=S.+Sonauthor=B.+K.+Kimauthor=Y.+Xiaauthor=K.+B.+Songauthor=H.+S.+Leeauthor=M.+Won&title=Identification+of+Malate+Dehydrogenase+2+as+a+Target+Protein+of+the+HIF-1+Inhibitor+LW6+using+Chemical+Probes&doi=10.1002%2Fanie.201304987"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1002%2Fanie.201304987&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201304987%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DK.%26aulast%3DBan%26aufirst%3DH.%2BS.%26aulast%3DNaik%26aufirst%3DR.%26aulast%3DHong%26aufirst%3DY.%2BS.%26aulast%3DSon%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DB.%2BK.%26aulast%3DXia%26aufirst%3DY.%26aulast%3DSong%26aufirst%3DK.%2BB.%26aulast%3DLee%26aufirst%3DH.%2BS.%26aulast%3DWon%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520Malate%2520Dehydrogenase%25202%2520as%2520a%2520Target%2520Protein%2520of%2520the%2520HIF-1%2520Inhibitor%2520LW6%2520using%2520Chemical%2520Probes%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2013%26volume%3D52%26spage%3D10286%26epage%3D10289%26doi%3D10.1002%2Fanie.201304987" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Kim, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattarai, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwon, H. J.</span><span> </span><span class="NLM_article-title">HIF-1α suppressing small molecule, LW6, Inhibits Cancer Cell Growth by Binding to Calcineurin B Homologous Protein 1</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">458</span><span class="NLM_x">, </span> <span class="NLM_fpage">14</span><span class="NLM_x">–</span> <span class="NLM_lpage">20</span><span class="refDoi"> DOI: 10.1016/j.bbrc.2015.01.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=10.1016%2Fj.bbrc.2015.01.031" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=458&publication_year=2015&pages=14-20&author=B.+S.+Kimauthor=K.+Leeauthor=H.+J.+Jungauthor=D.+Bhattaraiauthor=H.+J.+Kwon&title=HIF-1%CE%B1+suppressing+small+molecule%2C+LW6%2C+Inhibits+Cancer+Cell+Growth+by+Binding+to+Calcineurin+B+Homologous+Protein+1&doi=10.1016%2Fj.bbrc.2015.01.031"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2015.01.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2015.01.031%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DB.%2BS.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DJung%26aufirst%3DH.%2BJ.%26aulast%3DBhattarai%26aufirst%3DD.%26aulast%3DKwon%26aufirst%3DH.%2BJ.%26atitle%3DHIF-1%25CE%25B1%2520suppressing%2520small%2520molecule%252C%2520LW6%252C%2520Inhibits%2520Cancer%2520Cell%2520Growth%2520by%2520Binding%2520to%2520Calcineurin%2520B%2520Homologous%2520Protein%25201%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2015%26volume%3D458%26spage%3D14%26epage%3D20%26doi%3D10.1016%2Fj.bbrc.2015.01.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Kourtidis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carkner, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eifert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brosnan, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conklin, D. S.</span><span> </span><span class="NLM_article-title">An RNA Interference Screen Identifies Metabolic Regulators NR1D1 and PBP as Novel Survival Factors for Breast Cancer Cells with the ERBB2 Signature</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">1783</span><span class="NLM_x">–</span> <span class="NLM_lpage">1792</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-09-1550</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=10.1158%2F0008-5472.CAN-09-1550" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=1783-1792&author=A.+Kourtidisauthor=R.+Jainauthor=R.+D.+Carknerauthor=C.+Eifertauthor=M.+J.+Brosnanauthor=D.+S.+Conklin&title=An+RNA+Interference+Screen+Identifies+Metabolic+Regulators+NR1D1+and+PBP+as+Novel+Survival+Factors+for+Breast+Cancer+Cells+with+the+ERBB2+Signature&doi=10.1158%2F0008-5472.CAN-09-1550"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-09-1550&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-09-1550%26sid%3Dliteratum%253Aachs%26aulast%3DKourtidis%26aufirst%3DA.%26aulast%3DJain%26aufirst%3DR.%26aulast%3DCarkner%26aufirst%3DR.%2BD.%26aulast%3DEifert%26aufirst%3DC.%26aulast%3DBrosnan%26aufirst%3DM.%2BJ.%26aulast%3DConklin%26aufirst%3DD.%2BS.%26atitle%3DAn%2520RNA%2520Interference%2520Screen%2520Identifies%2520Metabolic%2520Regulators%2520NR1D1%2520and%2520PBP%2520as%2520Novel%2520Survival%2520Factors%2520for%2520Breast%2520Cancer%2520Cells%2520with%2520the%2520ERBB2%2520Signature%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26spage%3D1783%26epage%3D1792%26doi%3D10.1158%2F0008-5472.CAN-09-1550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Lee, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youn, H. D.</span><span> </span><span class="NLM_article-title">A Nucleocytoplasmic Malate Dehydrogenase Regulates p53 Transcriptional Activity in Response to Metabolic Stress</span> <span class="citation_source-journal">Cell Death Differ.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">738</span><span class="NLM_x">–</span> <span class="NLM_lpage">748</span><span class="refDoi"> DOI: 10.1038/cdd.2009.5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=10.1038%2Fcdd.2009.5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=19229245" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=1%3ACAS%3A528%3ADC%252BD1MXks1ygs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=738-748&author=S.+M.+Leeauthor=J.+H.+Kimauthor=E.+J.+Choauthor=H.+D.+Youn&title=A+Nucleocytoplasmic+Malate+Dehydrogenase+Regulates+p53+Transcriptional+Activity+in+Response+to+Metabolic+Stress&doi=10.1038%2Fcdd.2009.5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">A nucleocytoplasmic malate dehydrogenase regulates p53 transcriptional activity in response to metabolic stress</span></div><div class="casAuthors">Lee, S. M.; Kim, J. H.; Cho, E. J.; Youn, H. D.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death and Differentiation</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">738-748</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Metabolic enzymes have been shown to function as transcriptional regulators.  P53, a tumor-suppressive transcription factor, was recently found to regulate energy metab.  These combined facts raise the possibility that metabolic enzymes may directly regulate p53 function.  Here, we discover that nucleocytoplasmic malate dehydrogenase-1 (MDH1) phys. assocs. with p53.  Upon glucose deprivation, MDH1 stabilizes and transactivates p53 by binding to p53-responsive elements in the promoter of downstream genes.  Knockdown of MDH1 significantly reduces binding of acetylated-p53 and transcription-active histone codes to the promoter upon glucose depletion.  MDH1 regulates p53-dependent cell-cycle arrest and apoptosis in response to glucose deprivation, suggesting that MDH1 functions as a transcriptional regulator for a p53-dependent metabolic checkpoint.  Our findings provide insight into how metab. is directly linked to gene expression for controlling cellular events in response to metabolic stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsnQbb5OnE4LVg90H21EOLACvtfcHk0lgzkUZoSsf00g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXks1ygs7w%253D&md5=cfa110fb5a8b57b3030f096c02551efe</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fcdd.2009.5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcdd.2009.5%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DS.%2BM.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DCho%26aufirst%3DE.%2BJ.%26aulast%3DYoun%26aufirst%3DH.%2BD.%26atitle%3DA%2520Nucleocytoplasmic%2520Malate%2520Dehydrogenase%2520Regulates%2520p53%2520Transcriptional%2520Activity%2520in%2520Response%2520to%2520Metabolic%2520Stress%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2009%26volume%3D16%26spage%3D738%26epage%3D748%26doi%3D10.1038%2Fcdd.2009.5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beer, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, D. Z.</span><span> </span><span class="NLM_article-title">Malate Dehydrogenase 2 Confers Docetaxel Resistance via Regulations of JNK Signaling and Oxidative Metabolism</span> <span class="citation_source-journal">Prostate</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">1028</span><span class="NLM_x">–</span> <span class="NLM_lpage">1037</span><span class="refDoi"> DOI: 10.1002/pros.22650</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=10.1002%2Fpros.22650" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2013&pages=1028-1037&author=Q.+Liuauthor=C.+T.+Harveyauthor=H.+Gengauthor=C.+Xueauthor=V.+Chenauthor=T.+M.+Beerauthor=D.+Z.+Qian&title=Malate+Dehydrogenase+2+Confers+Docetaxel+Resistance+via+Regulations+of+JNK+Signaling+and+Oxidative+Metabolism&doi=10.1002%2Fpros.22650"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1002%2Fpros.22650&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpros.22650%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DHarvey%26aufirst%3DC.%2BT.%26aulast%3DGeng%26aufirst%3DH.%26aulast%3DXue%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DV.%26aulast%3DBeer%26aufirst%3DT.%2BM.%26aulast%3DQian%26aufirst%3DD.%2BZ.%26atitle%3DMalate%2520Dehydrogenase%25202%2520Confers%2520Docetaxel%2520Resistance%2520via%2520Regulations%2520of%2520JNK%2520Signaling%2520and%2520Oxidative%2520Metabolism%26jtitle%3DProstate%26date%3D2013%26volume%3D73%26spage%3D1028%26epage%3D1037%26doi%3D10.1002%2Fpros.22650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Naik, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Won, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ban, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattarai, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span> </span><span class="NLM_article-title">Synthesis and Structure-Activity Relationship Study of Chemical Probes as Hypoxia-inducable Factor-1 alpha/Malate Dehydrogenase 2 Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">9522</span><span class="NLM_x">–</span> <span class="NLM_lpage">9538</span><span class="refDoi"> DOI: 10.1021/jm501241g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501241g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=9522-9538&author=R.+Naikauthor=M.+Wonauthor=H.+S.+Banauthor=D.+Bhattaraiauthor=X.+Xuauthor=Y.+Eoauthor=Y.+S.+Hongauthor=S.+Singhauthor=Y.+Choiauthor=H.+C.+Ahnauthor=K.+Lee&title=Synthesis+and+Structure-Activity+Relationship+Study+of+Chemical+Probes+as+Hypoxia-inducable+Factor-1+alpha%2FMalate+Dehydrogenase+2+Inhibitors&doi=10.1021%2Fjm501241g"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm501241g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501241g%26sid%3Dliteratum%253Aachs%26aulast%3DNaik%26aufirst%3DR.%26aulast%3DWon%26aufirst%3DM.%26aulast%3DBan%26aufirst%3DH.%2BS.%26aulast%3DBhattarai%26aufirst%3DD.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DEo%26aufirst%3DY.%26aulast%3DHong%26aufirst%3DY.%2BS.%26aulast%3DSingh%26aufirst%3DS.%26aulast%3DChoi%26aufirst%3DY.%26aulast%3DAhn%26aufirst%3DH.%2BC.%26aulast%3DLee%26aufirst%3DK.%26atitle%3DSynthesis%2520and%2520Structure-Activity%2520Relationship%2520Study%2520of%2520Chemical%2520Probes%2520as%2520Hypoxia-inducable%2520Factor-1%2520alpha%252FMalate%2520Dehydrogenase%25202%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D9522%26epage%3D9538%26doi%3D10.1021%2Fjm501241g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Xia, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span> </span><span class="NLM_article-title">Recent Advances in Hypoxia-Inducible Factor (HIF)-1 Inhibitors</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">24</span><span class="NLM_x">–</span> <span class="NLM_lpage">40</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2012.01.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=10.1016%2Fj.ejmech.2012.01.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=22305612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=1%3ACAS%3A528%3ADC%252BC38XisFOrs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2012&pages=24-40&author=Y.+Xiaauthor=H.+K.+Choiauthor=K.+Lee&title=Recent+Advances+in+Hypoxia-Inducible+Factor+%28HIF%29-1+Inhibitors&doi=10.1016%2Fj.ejmech.2012.01.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors</span></div><div class="casAuthors">Xia, Yan; Choi, Hyun-Kyung; Lee, Kyeong</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">24-40</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A review.  Tumor hypoxia has been recognized as a common feature of solid tumors and a neg. prognostic factor for response to treatment and survival of cancer patients.  The discovery of hypoxia-inducible factor-1 (HIF-1), a mol. determinant of responses to hypoxia in mammalian cells, has renewed enthusiasm for discovery and development of targeted therapies exploiting the hypoxic tumor microenvironment.  HIF-1 activity in tumors depends on availability of the HIF-1α subunit, the levels of which increase under hypoxic conditions and through activation of oncogenes and/or inactivation of tumor suppressor genes.  Increased HIF-1 has been correlated with increased angiogenesis, aggressive tumor growth, and poor patient prognosis, leading to current interest in HIF-1 as promising anticancer drug target.  In spite of an ever increasing no. of putative small mol. inhibitors of HIF-1, only a few are progressing through preclin. and early clin. development.  In this review, we will discuss recent advances in discovery and development of small mol. inhibitors that target the HIF-1 pathway as potential anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrV9MyS5Xicm7Vg90H21EOLACvtfcHk0ljiwc1uSCjupg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XisFOrs7w%253D&md5=04225108ab97c18845f7760ac4027185</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2012.01.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2012.01.033%26sid%3Dliteratum%253Aachs%26aulast%3DXia%26aufirst%3DY.%26aulast%3DChoi%26aufirst%3DH.%2BK.%26aulast%3DLee%26aufirst%3DK.%26atitle%3DRecent%2520Advances%2520in%2520Hypoxia-Inducible%2520Factor%2520%2528HIF%2529-1%2520Inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D49%26spage%3D24%26epage%3D40%26doi%3D10.1016%2Fj.ejmech.2012.01.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Harris, A. L.</span><span> </span><span class="NLM_article-title">Hypoxia - A Key Regulatory Factor in Tumor Growth</span> <span class="citation_source-journal">Nature Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">38</span><span class="NLM_x">–</span> <span class="NLM_lpage">47</span><span class="refDoi"> DOI: 10.1038/nrc704</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=10.1038%2Fnrc704" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=11902584" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=1%3ACAS%3A528%3ADC%252BD38XhvF2jtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=38-47&author=A.+L.+Harris&title=Hypoxia+-+A+Key+Regulatory+Factor+in+Tumor+Growth&doi=10.1038%2Fnrc704"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Hypoxia - a key regulatory factor in tumor growth</span></div><div class="casAuthors">Harris, Adrian L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">38-47</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Cells undergo a variety of biol. responses when placed in hypoxic conditions, including activation of signaling pathways that regulate proliferation, angiogenesis and death.  Cancer cells have adapted these pathways, allowing tumors to survive and even grow under hypoxic conditions, and tumor hypoxia is assocd. with poor prognosis and resistance to radiation therapy.  Many elements of the hypoxia-response pathway are therefore good candidates for therapeutic targeting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoO3m4smDSP37Vg90H21EOLACvtfcHk0ljiwc1uSCjupg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhvF2jtL4%253D&md5=e3f65ce80422e4743d49905e1796fe5c</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnrc704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc704%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DA.%2BL.%26atitle%3DHypoxia%2520-%2520A%2520Key%2520Regulatory%2520Factor%2520in%2520Tumor%2520Growth%26jtitle%3DNature%2520Rev.%2520Cancer%26date%3D2002%26volume%3D2%26spage%3D38%26epage%3D47%26doi%3D10.1038%2Fnrc704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Semenza, G. L.</span><span> </span><span class="NLM_article-title">HIF-1: Upstream and Downstream of Cancer Metabolism</span> <span class="citation_source-journal">Curr. Opin. Genet. Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">51</span><span class="NLM_x">–</span> <span class="NLM_lpage">56</span><span class="refDoi"> DOI: 10.1016/j.gde.2009.10.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=10.1016%2Fj.gde.2009.10.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=19942427" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhslWktr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=51-56&author=G.+L.+Semenza&title=HIF-1%3A+Upstream+and+Downstream+of+Cancer+Metabolism&doi=10.1016%2Fj.gde.2009.10.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">HIF-1: upstream and downstream of cancer metabolism</span></div><div class="casAuthors">Semenza, Gregg L.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Genetics & Development</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">51-56</span>CODEN:
                <span class="NLM_cas:coden">COGDET</span>;
        ISSN:<span class="NLM_cas:issn">0959-437X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Hypoxia-inducible factor 1 (HIF-1) plays a key role in the reprogramming of cancer metab. by activating transcription of genes encoding glucose transporters and glycolytic enzymes, which take up glucose and convert it to lactate; pyruvate dehydrogenase kinase 1, which shunts pyruvate away from the mitochondria; and BNIP3, which triggers selective mitochondrial autophagy.  The shift from oxidative to glycolytic metab. allows maintenance of redox homeostasis and cell survival under conditions of prolonged hypoxia.  Many metabolic abnormalities in cancer cells increase HIF-1 activity.  As a result, a feed-forward mechanism can be activated that drives HIF-1 activation and may promote tumor progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxecD_Xx5HALVg90H21EOLACvtfcHk0lhkPzgJj5MbVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhslWktr0%253D&md5=e4ef52f0c940a7c48cf26f09758d0303</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.gde.2009.10.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.gde.2009.10.009%26sid%3Dliteratum%253Aachs%26aulast%3DSemenza%26aufirst%3DG.%2BL.%26atitle%3DHIF-1%253A%2520Upstream%2520and%2520Downstream%2520of%2520Cancer%2520Metabolism%26jtitle%3DCurr.%2520Opin.%2520Genet.%2520Dev.%26date%3D2010%26volume%3D20%26spage%3D51%26epage%3D56%26doi%3D10.1016%2Fj.gde.2009.10.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Won, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Im, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boovanahalli, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwon, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span> </span><span class="NLM_article-title">A Novel Benzimidazole Analogue Inhibits the Hypoxia-Inducible Factor (HIF)-1 Pathway</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">385</span><span class="NLM_x">, </span> <span class="NLM_fpage">16</span><span class="NLM_x">–</span> <span class="NLM_lpage">21</span><span class="refDoi"> DOI: 10.1016/j.bbrc.2009.05.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=10.1016%2Fj.bbrc.2009.05.022" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=385&publication_year=2009&pages=16-21&author=M.+S.+Wonauthor=N.+Imauthor=S.+Parkauthor=S.+K.+Boovanahalliauthor=Y.+Jinauthor=X.+Jinauthor=K.+S.+Chungauthor=M.+Kangauthor=K.+Leeauthor=S.+K.+Parkauthor=H.+M.+Kimauthor=B.+M.+Kwonauthor=J.+J.+Leeauthor=K.+Lee&title=A+Novel+Benzimidazole+Analogue+Inhibits+the+Hypoxia-Inducible+Factor+%28HIF%29-1+Pathway&doi=10.1016%2Fj.bbrc.2009.05.022"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2009.05.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2009.05.022%26sid%3Dliteratum%253Aachs%26aulast%3DWon%26aufirst%3DM.%2BS.%26aulast%3DIm%26aufirst%3DN.%26aulast%3DPark%26aufirst%3DS.%26aulast%3DBoovanahalli%26aufirst%3DS.%2BK.%26aulast%3DJin%26aufirst%3DY.%26aulast%3DJin%26aufirst%3DX.%26aulast%3DChung%26aufirst%3DK.%2BS.%26aulast%3DKang%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DPark%26aufirst%3DS.%2BK.%26aulast%3DKim%26aufirst%3DH.%2BM.%26aulast%3DKwon%26aufirst%3DB.%2BM.%26aulast%3DLee%26aufirst%3DJ.%2BJ.%26aulast%3DLee%26aufirst%3DK.%26atitle%3DA%2520Novel%2520Benzimidazole%2520Analogue%2520Inhibits%2520the%2520Hypoxia-Inducible%2520Factor%2520%2528HIF%2529-1%2520Pathway%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2009%26volume%3D385%26spage%3D16%26epage%3D21%26doi%3D10.1016%2Fj.bbrc.2009.05.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Rapisarda, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uranchimeg, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scudiero, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selby, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sausville, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoemaker, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melillo, G.</span><span> </span><span class="NLM_article-title">Identification of Small Molecule Inhibitors of Hypoxia-Inducible Factor 1 Transcriptional Activation Pathway</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">4316</span><span class="NLM_x">–</span> <span class="NLM_lpage">4324</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2002&pages=4316-4324&author=A.+Rapisardaauthor=B.+Uranchimegauthor=D.+A.+Scudieroauthor=M.+Selbyauthor=E.+A.+Sausvilleauthor=R.+H.+Shoemakerauthor=G.+Melillo&title=Identification+of+Small+Molecule+Inhibitors+of+Hypoxia-Inducible+Factor+1+Transcriptional+Activation+Pathway"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRapisarda%26aufirst%3DA.%26aulast%3DUranchimeg%26aufirst%3DB.%26aulast%3DScudiero%26aufirst%3DD.%2BA.%26aulast%3DSelby%26aufirst%3DM.%26aulast%3DSausville%26aufirst%3DE.%2BA.%26aulast%3DShoemaker%26aufirst%3DR.%2BH.%26aulast%3DMelillo%26aufirst%3DG.%26atitle%3DIdentification%2520of%2520Small%2520Molecule%2520Inhibitors%2520of%2520Hypoxia-Inducible%2520Factor%25201%2520Transcriptional%2520Activation%2520Pathway%26jtitle%3DCancer%2520Res.%26date%3D2002%26volume%3D62%26spage%3D4316%26epage%3D4324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Giaccia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siim, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, R. S.</span><span> </span><span class="NLM_article-title">HIF-1 as a Target for Drug Development</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">803</span><span class="NLM_x">–</span> <span class="NLM_lpage">811</span><span class="refDoi"> DOI: 10.1038/nrd1199</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=10.1038%2Fnrd1199" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=14526383" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnslarsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=803-811&author=A.+Giacciaauthor=B.+G.+Siimauthor=R.+S.+Johnson&title=HIF-1+as+a+Target+for+Drug+Development&doi=10.1038%2Fnrd1199"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">HIF-1 as a target for drug development</span></div><div class="casAuthors">Giaccia, Amato; Siim, Bronwyn G.; Johnson, Randall S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">803-811</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Sensing and responding to fluxes in oxygen tension is perhaps the single most important variable in physiol., and animal tissues have developed a no. of essential mechanisms to cope with the stress of low physiol. oxygen levels, or hypoxia.  Among these coping mechanisms is the response mediated by the hypoxia-inducible transcription factor, or HIF-1.  HIF-1 is an essential component in changing the transcriptional repertoire of tissues as oxygen levels drop, and could prove to be a very important target for drug development, as treatments evolve for diseases, such as cancer, heart disease and stroke, in which hypoxia is a central aspect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGZK-i6A6JQrVg90H21EOLACvtfcHk0lgqHsuPblez4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnslarsbw%253D&md5=f7cb7b615106f4716a2293dbfe873ea1</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fnrd1199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1199%26sid%3Dliteratum%253Aachs%26aulast%3DGiaccia%26aufirst%3DA.%26aulast%3DSiim%26aufirst%3DB.%2BG.%26aulast%3DJohnson%26aufirst%3DR.%2BS.%26atitle%3DHIF-1%2520as%2520a%2520Target%2520for%2520Drug%2520Development%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2003%26volume%3D2%26spage%3D803%26epage%3D811%26doi%3D10.1038%2Fnrd1199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Shimizu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruyama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasui, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minegishi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ban, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, H.</span><span> </span><span class="NLM_article-title">Boron-Containing Phenoxyacetanilide Derivatives as Hypoxia-Inducible Factor (HIF)-1alpha Inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1453</span><span class="NLM_x">–</span> <span class="NLM_lpage">1456</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2009.12.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=10.1016%2Fj.bmcl.2009.12.037" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1453-1456&author=K.+Shimizuauthor=M.+Maruyamaauthor=Y.+Yasuiauthor=H.+Minegishiauthor=H.+S.+Banauthor=H.+Nakamura&title=Boron-Containing+Phenoxyacetanilide+Derivatives+as+Hypoxia-Inducible+Factor+%28HIF%29-1alpha+Inhibitors&doi=10.1016%2Fj.bmcl.2009.12.037"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.12.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.12.037%26sid%3Dliteratum%253Aachs%26aulast%3DShimizu%26aufirst%3DK.%26aulast%3DMaruyama%26aufirst%3DM.%26aulast%3DYasui%26aufirst%3DY.%26aulast%3DMinegishi%26aufirst%3DH.%26aulast%3DBan%26aufirst%3DH.%2BS.%26aulast%3DNakamura%26aufirst%3DH.%26atitle%3DBoron-Containing%2520Phenoxyacetanilide%2520Derivatives%2520as%2520Hypoxia-Inducible%2520Factor%2520%2528HIF%2529-1alpha%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D1453%26epage%3D1456%26doi%3D10.1016%2Fj.bmcl.2009.12.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Lee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boovanahalli, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. J.</span><span> </span><span class="NLM_article-title">Aryloxyacetylamino)benzoic Acid Analogues: a New Class of Hypoxia-Inducible Factor-1 Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1675</span><span class="NLM_x">–</span> <span class="NLM_lpage">1684</span><span class="refDoi"> DOI: 10.1021/jm0610292</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0610292" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=1675-1684&author=K.+Leeauthor=J.+H.+Leeauthor=S.+K.+Boovanahalliauthor=Y.+Jinauthor=M.+Leeauthor=X.+Jinauthor=J.+H.+Kimauthor=Y.+S.+Hongauthor=J.+J.+Lee&title=Aryloxyacetylamino%29benzoic+Acid+Analogues%3A+a+New+Class+of+Hypoxia-Inducible+Factor-1+Inhibitors&doi=10.1021%2Fjm0610292"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm0610292&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0610292%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DBoovanahalli%26aufirst%3DS.%2BK.%26aulast%3DJin%26aufirst%3DY.%26aulast%3DLee%26aufirst%3DM.%26aulast%3DJin%26aufirst%3DX.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DHong%26aufirst%3DY.%2BS.%26aulast%3DLee%26aufirst%3DJ.%2BJ.%26atitle%3DAryloxyacetylamino%2529benzoic%2520Acid%2520Analogues%253A%2520a%2520New%2520Class%2520of%2520Hypoxia-Inducible%2520Factor-1%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D1675%26epage%3D1684%26doi%3D10.1021%2Fjm0610292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Boovanahalli, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dat, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. J.</span><span> </span><span class="NLM_article-title">Synthesis of (Aryloxyacetylamino)-Isonicotinic/Nicotinic Acid Analogues as Potent Hypoxia-inducible Factor (HIF)-1alpha Inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">6305</span><span class="NLM_x">–</span> <span class="NLM_lpage">6310</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2007.09.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=10.1016%2Fj.bmcl.2007.09.005" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=6305-6310&author=S.+K.+Boovanahalliauthor=X.+Jinauthor=Y.+Jinauthor=J.+H.+Kimauthor=N.+T.+Datauthor=Y.+S.+Hongauthor=J.+H.+Leeauthor=S.+H.+Jungauthor=K.+Leeauthor=J.+J.+Lee&title=Synthesis+of+%28Aryloxyacetylamino%29-Isonicotinic%2FNicotinic+Acid+Analogues+as+Potent+Hypoxia-inducible+Factor+%28HIF%29-1alpha+Inhibitors&doi=10.1016%2Fj.bmcl.2007.09.005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.09.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.09.005%26sid%3Dliteratum%253Aachs%26aulast%3DBoovanahalli%26aufirst%3DS.%2BK.%26aulast%3DJin%26aufirst%3DX.%26aulast%3DJin%26aufirst%3DY.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DDat%26aufirst%3DN.%2BT.%26aulast%3DHong%26aufirst%3DY.%2BS.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DJung%26aufirst%3DS.%2BH.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DJ.%2BJ.%26atitle%3DSynthesis%2520of%2520%2528Aryloxyacetylamino%2529-Isonicotinic%252FNicotinic%2520Acid%2520Analogues%2520as%2520Potent%2520Hypoxia-inducible%2520Factor%2520%2528HIF%2529-1alpha%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D6305%26epage%3D6310%26doi%3D10.1016%2Fj.bmcl.2007.09.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Kaur, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dat, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gajulapati, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span> </span><span class="NLM_article-title">The First Total Synthesis of Moracin O and Moracin P, and Establishment of the Absolute Configuration of Moracin O</span> <span class="citation_source-journal">Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1879</span><span class="NLM_x">–</span> <span class="NLM_lpage">1881</span><span class="refDoi"> DOI: 10.1039/b823340c</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=10.1039%2Fb823340c" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=1879-1881&author=N.+Kaurauthor=Y.+Xiaauthor=Y.+Jinauthor=N.+T.+Datauthor=K.+Gajulapatiauthor=Y.+Choiauthor=Y.+S.+Hongauthor=J.+J.+Leeauthor=K.+Lee&title=The+First+Total+Synthesis+of+Moracin+O+and+Moracin+P%2C+and+Establishment+of+the+Absolute+Configuration+of+Moracin+O&doi=10.1039%2Fb823340c"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1039%2Fb823340c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb823340c%26sid%3Dliteratum%253Aachs%26aulast%3DKaur%26aufirst%3DN.%26aulast%3DXia%26aufirst%3DY.%26aulast%3DJin%26aufirst%3DY.%26aulast%3DDat%26aufirst%3DN.%2BT.%26aulast%3DGajulapati%26aufirst%3DK.%26aulast%3DChoi%26aufirst%3DY.%26aulast%3DHong%26aufirst%3DY.%2BS.%26aulast%3DLee%26aufirst%3DJ.%2BJ.%26aulast%3DLee%26aufirst%3DK.%26atitle%3DThe%2520First%2520Total%2520Synthesis%2520of%2520Moracin%2520O%2520and%2520Moracin%2520P%252C%2520and%2520Establishment%2520of%2520the%2520Absolute%2520Configuration%2520of%2520Moracin%2520O%26jtitle%3DChem.%2520Commun.%26date%3D2009%26volume%3D14%26spage%3D1879%26epage%3D1881%26doi%3D10.1039%2Fb823340c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Xia, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaur, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span> </span><span class="NLM_article-title">HIF-1a Inhibitors: Synthesis and Biological Evaluation of Novel Moracin O and P Analogues</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">2386</span><span class="NLM_x">–</span> <span class="NLM_lpage">2396</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2011.03.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=10.1016%2Fj.ejmech.2011.03.022" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=2386-2396&author=Y.+Xiaauthor=Y.+Jinauthor=N.+Kaurauthor=Y.+Choiauthor=K.+Lee&title=HIF-1a+Inhibitors%3A+Synthesis+and+Biological+Evaluation+of+Novel+Moracin+O+and+P+Analogues&doi=10.1016%2Fj.ejmech.2011.03.022"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2011.03.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2011.03.022%26sid%3Dliteratum%253Aachs%26aulast%3DXia%26aufirst%3DY.%26aulast%3DJin%26aufirst%3DY.%26aulast%3DKaur%26aufirst%3DN.%26aulast%3DChoi%26aufirst%3DY.%26aulast%3DLee%26aufirst%3DK.%26atitle%3DHIF-1a%2520Inhibitors%253A%2520Synthesis%2520and%2520Biological%2520Evaluation%2520of%2520Novel%2520Moracin%2520O%2520and%2520P%2520Analogues%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2011%26volume%3D46%26spage%3D2386%26epage%3D2396%26doi%3D10.1016%2Fj.ejmech.2011.03.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Naik, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Won, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span> </span><span class="NLM_article-title">Synthesis and Structure–Activity Relationship of (<i>E</i>)-Phenoxyacrylic Amide Derivatives as Hypoxia-Inducible Factor (HIF) 1α Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">10564</span><span class="NLM_x">–</span> <span class="NLM_lpage">10571</span><span class="refDoi"> DOI: 10.1021/jm301419d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301419d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=10564-10571&author=R.+Naikauthor=M.+Wonauthor=B.+K.+Kimauthor=Y.+Xiaauthor=H.+K.+Choiauthor=G.+Jinauthor=Y.+Jungauthor=H.+M.+Kimauthor=K.+Lee&title=Synthesis+and+Structure%E2%80%93Activity+Relationship+of+%28E%29-Phenoxyacrylic+Amide+Derivatives+as+Hypoxia-Inducible+Factor+%28HIF%29+1%CE%B1+Inhibitors&doi=10.1021%2Fjm301419d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm301419d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301419d%26sid%3Dliteratum%253Aachs%26aulast%3DNaik%26aufirst%3DR.%26aulast%3DWon%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DB.%2BK.%26aulast%3DXia%26aufirst%3DY.%26aulast%3DChoi%26aufirst%3DH.%2BK.%26aulast%3DJin%26aufirst%3DG.%26aulast%3DJung%26aufirst%3DY.%26aulast%3DKim%26aufirst%3DH.%2BM.%26aulast%3DLee%26aufirst%3DK.%26atitle%3DSynthesis%2520and%2520Structure%25E2%2580%2593Activity%2520Relationship%2520of%2520%2528E%2529-Phenoxyacrylic%2520Amide%2520Derivatives%2520as%2520Hypoxia-Inducible%2520Factor%2520%2528HIF%2529%25201%25CE%25B1%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D10564%26epage%3D10571%26doi%3D10.1021%2Fjm301419d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Lee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Won, M.</span><span> </span><span class="NLM_article-title">LW6, a Novel HIF-1 Inhibitor, Promotes Proteasomal Degradation of HIF-1alpha via Upregulation of VHL in a Colon Cancer Cell Line</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">982</span><span class="NLM_x">–</span> <span class="NLM_lpage">989</span><span class="refDoi"> DOI: 10.1016/j.bcp.2010.06.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=10.1016%2Fj.bcp.2010.06.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=20599784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVeku7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2010&pages=982-989&author=K.+Leeauthor=J.+E.+Kangauthor=S.+K.+Parkauthor=Y.+Jinauthor=K.+S.+Chungauthor=H.+M.+Kimauthor=K.+Leeauthor=M.+R.+Kangauthor=M.+K.+Leeauthor=K.+B.+Songauthor=E.+G.+Yangauthor=J.+J.+Leeauthor=M.+Won&title=LW6%2C+a+Novel+HIF-1+Inhibitor%2C+Promotes+Proteasomal+Degradation+of+HIF-1alpha+via+Upregulation+of+VHL+in+a+Colon+Cancer+Cell+Line&doi=10.1016%2Fj.bcp.2010.06.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">LW6, a novel HIF-1 inhibitor, promotes proteasomal degradation of HIF-1α via upregulation of VHL in a colon cancer cell line</span></div><div class="casAuthors">Lee, Kyeong; Kang, Jung-Eun; Park, Song-Kyu; Jin, Ying-Lan; Chung, Kyung-Sook; Kim, Hwan-Mook; Lee, Ki-Ho; Kang, Moo-Rim; Lee, Myung-Kyu; Song, Kyung-Bin; Yang, Eun-Gyeong; Lee, Jung-Jun; Won, Mi-Sun</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">982-989</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Hypoxia-inducible factor HIF-1 is responsible for radiation resistance and poor prognosis in cancer therapy.  As part of our drug discovery program, a novel HIF inhibitor, LW6, was identified as a small compd. that inhibits the accumulation of HIF-1α.  We found that LW6 decreased HIF-1α protein expression without affecting HIF-1β expression.  MG132, a proteasome inhibitor, protected HIF-1α from LW6-induced proteasomal degrdn., indicating that LW6 affects the stability of the HIF-1α protein.  We found that LW6 promoted the degrdn. of wild type HIF-1α, but not of a DM-HIF-1α with modifications of P402A and P564A, at hydroxylation sites in the oxygen-dependent degrdn. domain (ODDD).  LW6 did not affect the activity of prolyl hydroxylase (PHD), but induced the expression of von Hippel-Lindau (VHL), which interacts with prolyl-hydroxylated HIF-1α for proteasomal degrdn.  In the presence of LW6, knockdown of VHL did not abolish HIF-1α protein accumulation, indicating that LW6 degraded HIF-1α via regulation of VHL expression.  In mice carrying xenografts of human colon cancer HCT116 cells, LW6 demonstrated strong antitumor efficacy in vivo and caused a decrease in HIF-1α expression in frozen-tissue immunohistochem. staining.  These data suggest that LW6 may be valuable in the development of a HIF-1α inhibitor for cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3Ksyrt_nbn7Vg90H21EOLACvtfcHk0lgCSW5Y27Bxnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVeku7fK&md5=4d6b427c3fc3e7d106fc9f7200802e9d</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2010.06.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2010.06.018%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DK.%26aulast%3DKang%26aufirst%3DJ.%2BE.%26aulast%3DPark%26aufirst%3DS.%2BK.%26aulast%3DJin%26aufirst%3DY.%26aulast%3DChung%26aufirst%3DK.%2BS.%26aulast%3DKim%26aufirst%3DH.%2BM.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DKang%26aufirst%3DM.%2BR.%26aulast%3DLee%26aufirst%3DM.%2BK.%26aulast%3DSong%26aufirst%3DK.%2BB.%26aulast%3DYang%26aufirst%3DE.%2BG.%26aulast%3DLee%26aufirst%3DJ.%2BJ.%26aulast%3DWon%26aufirst%3DM.%26atitle%3DLW6%252C%2520a%2520Novel%2520HIF-1%2520Inhibitor%252C%2520Promotes%2520Proteasomal%2520Degradation%2520of%2520HIF-1alpha%2520via%2520Upregulation%2520of%2520VHL%2520in%2520a%2520Colon%2520Cancer%2520Cell%2520Line%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2010%26volume%3D80%26spage%3D982%26epage%3D989%26doi%3D10.1016%2Fj.bcp.2010.06.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Semenza, G. L.</span><span> </span><span class="NLM_article-title">Targeting HIF-1 for Cancer Therapy</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">721</span><span class="NLM_x">–</span> <span class="NLM_lpage">732</span><span class="refDoi"> DOI: 10.1038/nrc1187</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=10.1038%2Fnrc1187" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=13130303" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=1%3ACAS%3A528%3ADC%252BD3sXotFCiu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=721-732&author=G.+L.+Semenza&title=Targeting+HIF-1+for+Cancer+Therapy&doi=10.1038%2Fnrc1187"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting HIF-1 for cancer therapy</span></div><div class="casAuthors">Semenza, Gregg L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">721-732</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Hypoxia-inducible factor 1 (HIF-1) activates the transcription of genes that are involved in crucial aspects of cancer biol., including angiogenesis, cell survival, glucose metab. and invasion.  Intratumoral hypoxia and genetic alterations can lead to HIF-1α overexpression, which has been assocd. with increased patient mortality in several cancer types.  In preclin. studies, inhibition of HIF-1 activity has marked effects on tumor growth.  Efforts are underway to identify inhibitors of HIF-1 and to test their efficacy as anticancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9RRo9WvLxN7Vg90H21EOLACvtfcHk0lgCSW5Y27Bxnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXotFCiu70%253D&md5=099f0fe5908dc1aae0c177a8aa530047</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Fnrc1187&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1187%26sid%3Dliteratum%253Aachs%26aulast%3DSemenza%26aufirst%3DG.%2BL.%26atitle%3DTargeting%2520HIF-1%2520for%2520Cancer%2520Therapy%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2003%26volume%3D3%26spage%3D721%26epage%3D732%26doi%3D10.1038%2Fnrc1187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Lee, K.; Won, M.; Kim, H. M.; Park, S. K.; Lee, K. H.; Lee, C. W.; Kim, B. K.; Ban, H. S.; Chung, K. S.; Naik, R.</span><span> </span><span class="NLM_article-title">Preparation of Adamantly Heterocyclic Compounds as HIF-1α Inhibitors for Treatment of Cancer</span>, Diabeticretinopathy, and Rheumatoid Arthritis Patent WO2013048164A1,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=K.+Lee&author=M.+Won&author=H.+M.+Kim&author=S.+K.+Park&author=K.+H.+Lee&author=C.+W.+Lee&author=B.+K.+Kim&author=H.+S.+Ban&author=K.+S.+Chung&author=R.+Naik&title=Preparation+of+Adamantly+Heterocyclic+Compounds+as+HIF-1%CE%B1+Inhibitors+for+Treatment+of+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DK.%26atitle%3DPreparation%2520of%2520Adamantly%2520Heterocyclic%2520Compounds%2520as%2520HIF-1%25CE%25B1%2520Inhibitors%2520for%2520Treatment%2520of%2520Cancer%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Ban, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naik, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Won, M.</span><span> </span><span class="NLM_article-title">Identification of Targets of the HIF-1 Inhibitor IDF-11774 Using Alkyne-Conjugated Photoaffinity Probes</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">1911</span><span class="NLM_x">–</span> <span class="NLM_lpage">1920</span><span class="refDoi"> DOI: 10.1021/acs.bioconjchem.6b00305</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.bioconjchem.6b00305" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFaisL7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2016&pages=1911-1920&author=H.+S.+Banauthor=R.+Naikauthor=H.+M.+Kimauthor=B.+K.+Kimauthor=H.+Leeauthor=I.+Kimauthor=H.+Ahnauthor=Y.+Jangauthor=K.+Jangauthor=Y.+Eoauthor=K.+B.+Songauthor=K.+Leeauthor=M.+Won&title=Identification+of+Targets+of+the+HIF-1+Inhibitor+IDF-11774+Using+Alkyne-Conjugated+Photoaffinity+Probes&doi=10.1021%2Facs.bioconjchem.6b00305"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Targets of the HIF-1 Inhibitor IDF-11774 Using Alkyne-Conjugated Photoaffinity Probes</span></div><div class="casAuthors">Ban, Hyun Seung; Naik, Ravi; Kim, Hwan Mook; Kim, Bo-Kyung; Lee, Hongsub; Kim, Inhyub; Ahn, Heechul; Jang, Yerin; Jang, Kyusik; Eo, Yumi; Song, Kyung Bin; Lee, Kyeong; Won, Misun</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1911-1920</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We developed a hypoxia-inducible factor-1 (HIF-1) inhibitor, IDF-11774, as a clin. candidate for cancer therapy.  To understand the mechanism of action of IDF-11774, we attempted to isolate target proteins of IDF-11774 using bioconjugated probes.  Multifunctional chem. probes contg. sites for click conjugation and photoaffinity labeling were designed and synthesized.  After fluorescence and photoaffinity labeling of proteins, two-dimensional electrophoresis (2DE) was performed to isolate specific mol. targets of IDF-11774.  Heat shock protein (HSP) 70 was identified as a target protein of IDF-11774.  We revealed that IDF-11774 inhibited HSP70 chaperone activity by binding to its allosteric pocket, rather than the ATP-binding site in its nucleotide-binding domain (NBD).  Moreover, IDF-11774 reduced the oxygen consumption rate (OCR) and ATP prodn., thereby increasing intracellular oxygen tension.  This result suggests that the inhibition of HSP70 chaperone activity by IDF-11774 suppresses HIF-1α refolding and stimulates HIF-1α degrdn.  Taken together, these findings indicate that IDF-11774-derived chem. probes successfully identified IDF-11774's target mol., HSP70, and elucidated the mode of action of IDF-11774 in inhibiting HSP70 chaperone activity and stimulating HIF-1α degrdn. in cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVWcAtICkwsrVg90H21EOLACvtfcHk0lhRvb1vnU5GAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFaisL7F&md5=f7620ba08d26831d0662f282570ab6ff</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Facs.bioconjchem.6b00305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.bioconjchem.6b00305%26sid%3Dliteratum%253Aachs%26aulast%3DBan%26aufirst%3DH.%2BS.%26aulast%3DNaik%26aufirst%3DR.%26aulast%3DKim%26aufirst%3DH.%2BM.%26aulast%3DKim%26aufirst%3DB.%2BK.%26aulast%3DLee%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DI.%26aulast%3DAhn%26aufirst%3DH.%26aulast%3DJang%26aufirst%3DY.%26aulast%3DJang%26aufirst%3DK.%26aulast%3DEo%26aufirst%3DY.%26aulast%3DSong%26aufirst%3DK.%2BB.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DWon%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520Targets%2520of%2520the%2520HIF-1%2520Inhibitor%2520IDF-11774%2520Using%2520Alkyne-Conjugated%2520Photoaffinity%2520Probes%26jtitle%3DBioconjugate%2520Chem.%26date%3D2016%26volume%3D27%26spage%3D1911%26epage%3D1920%26doi%3D10.1021%2Facs.bioconjchem.6b00305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Tehrani, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emami, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asadi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saeedi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirzahekmati, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebrahimi, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahdavi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nadri, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moradi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moghadam, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farzipour, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vosooghi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foroumadi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shafiee, A.</span><span> </span><span class="NLM_article-title">Imidazo[2,1-b]thiazole Derivatives as New Inhibitors of 15-Lipoxygenase</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">759</span><span class="NLM_x">–</span> <span class="NLM_lpage">764</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2014.10.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=10.1016%2Fj.ejmech.2014.10.011" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2014&pages=759-764&author=M.+B.+Tehraniauthor=S.+Emamiauthor=M.+Asadiauthor=M.+Saeediauthor=M.+Mirzahekmatiauthor=S.+M.+Ebrahimiauthor=M.+Mahdaviauthor=H.+Nadriauthor=A.+Moradiauthor=F.+H.+Moghadamauthor=S.+Farzipourauthor=M.+Vosooghiauthor=A.+Foroumadiauthor=A.+Shafiee&title=Imidazo%5B2%2C1-b%5Dthiazole+Derivatives+as+New+Inhibitors+of+15-Lipoxygenase&doi=10.1016%2Fj.ejmech.2014.10.011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.10.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.10.011%26sid%3Dliteratum%253Aachs%26aulast%3DTehrani%26aufirst%3DM.%2BB.%26aulast%3DEmami%26aufirst%3DS.%26aulast%3DAsadi%26aufirst%3DM.%26aulast%3DSaeedi%26aufirst%3DM.%26aulast%3DMirzahekmati%26aufirst%3DM.%26aulast%3DEbrahimi%26aufirst%3DS.%2BM.%26aulast%3DMahdavi%26aufirst%3DM.%26aulast%3DNadri%26aufirst%3DH.%26aulast%3DMoradi%26aufirst%3DA.%26aulast%3DMoghadam%26aufirst%3DF.%2BH.%26aulast%3DFarzipour%26aufirst%3DS.%26aulast%3DVosooghi%26aufirst%3DM.%26aulast%3DForoumadi%26aufirst%3DA.%26aulast%3DShafiee%26aufirst%3DA.%26atitle%3DImidazo%255B2%252C1-b%255Dthiazole%2520Derivatives%2520as%2520New%2520Inhibitors%2520of%252015-Lipoxygenase%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D87%26spage%3D759%26epage%3D764%26doi%3D10.1016%2Fj.ejmech.2014.10.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Yoon, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, Y. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sung, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeon, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, W. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, T. W.</span><span> </span><span class="NLM_article-title">A Novel Synthetic Analog of Militarin, MA-1 Induces Mitochondrial Dependent Apoptosis by ROS Generation in Human Lung Cancer Cells</span> <span class="citation_source-journal">Toxicol. Appl. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">273</span><span class="NLM_x">, </span> <span class="NLM_fpage">659</span><span class="NLM_x">–</span> <span class="NLM_lpage">671</span><span class="refDoi"> DOI: 10.1016/j.taap.2013.10.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=10.1016%2Fj.taap.2013.10.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=24161344" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslyqurfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=2013&pages=659-671&author=D.+H.+Yoonauthor=M.+H.+Limauthor=Y.+R.+Leeauthor=G.+H.+Sungauthor=T.+H.+Leeauthor=B.+H.+Jeonauthor=J.+Y.+Choauthor=W.+O.+Songauthor=H.+Parkauthor=S.+Choiauthor=T.+W.+Kim&title=A+Novel+Synthetic+Analog+of+Militarin%2C+MA-1+Induces+Mitochondrial+Dependent+Apoptosis+by+ROS+Generation+in+Human+Lung+Cancer+Cells&doi=10.1016%2Fj.taap.2013.10.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">A novel synthetic analog of militarin, MA-1 induces mitochondrial dependent apoptosis by ROS generation in human lung cancer cells</span></div><div class="casAuthors">Yoon, Deok Hyo; Lim, Mi-Hee; Lee, Yu Ran; Sung, Gi-Ho; Lee, Tae-Ho; Jeon, Byeong Hwa; Cho, Jae Youl; Song, Won O.; Park, Haeil; Choi, Sunga; Kim, Tae Woong</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology and Applied Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">273</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">659-671</span>CODEN:
                <span class="NLM_cas:coden">TXAPA9</span>;
        ISSN:<span class="NLM_cas:issn">0041-008X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A synthetic Militarin analog-1[(2R,3R,4R,5R)-1,6-bis(4-(2,4,4-trimethylpentan-2-yl)phenoxy) hexane-2,3,4,5-tetraol] is a novel deriv. of constituents from Cordyceps militaris, which has been used to treat a variety of chronic diseases including inflammation, diabetes, hyperglycemia and cancers.  Here, we report for the first time the synthesis of Militarin analog-1 (MA-1) and the apoptotic mechanism of MA-1 against human lung cancer cell lines.  Treatment with MA-1 significantly inhibited the viability of 3 human lung cancer cell lines.  The inhibition of viability and growth in MA-1-treated A549 cells with an IC50 of 5 μM were mediated through apoptosis induction, as demonstrated by an increase in DNA fragmentation, sub-G0/G1-DNA fraction, nuclear condensation, and phosphatidylserine exposure.  The apoptotic cell death caused mitochondrial membrane permeabilization through regulation of expression of the Bcl-2 family proteins, leading to cytochrome c release in a time-dependent manner.  Subsequently, the final stage of apoptosis, activation of caspase-9/-3 and cleavage of poly (ADP ribose) polymerase, was induced.  Furthermore, A549 lung cancer cells were more responsive to MA-1 than a bronchial epithelial cell line (BEAS-2B), involving the rapid generation of reactive oxygen species (ROS), c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein kinase (MAPK) activation.  The pharmacol. inhibition of ROS generation and JNK/p38 MAPK exhibited attenuated DNA fragmentation in MA-1-induced apoptosis.  Oral administration of MA-1 also retarded growth of A549 orthotopic xenografts.  In conclusion, the present study indicates that the new synthetic deriv. MA-1 triggers mitochondrial apoptosis through ROS generation and regulation of MAPKs and may be a potent therapeutic agent against human lung cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaxeXs5b5L67Vg90H21EOLACvtfcHk0lj3L9XepAwuXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslyqurfK&md5=cce11c4af995c0be97c4f8397d1fbfe2</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.taap.2013.10.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.taap.2013.10.015%26sid%3Dliteratum%253Aachs%26aulast%3DYoon%26aufirst%3DD.%2BH.%26aulast%3DLim%26aufirst%3DM.%2BH.%26aulast%3DLee%26aufirst%3DY.%2BR.%26aulast%3DSung%26aufirst%3DG.%2BH.%26aulast%3DLee%26aufirst%3DT.%2BH.%26aulast%3DJeon%26aufirst%3DB.%2BH.%26aulast%3DCho%26aufirst%3DJ.%2BY.%26aulast%3DSong%26aufirst%3DW.%2BO.%26aulast%3DPark%26aufirst%3DH.%26aulast%3DChoi%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DT.%2BW.%26atitle%3DA%2520Novel%2520Synthetic%2520Analog%2520of%2520Militarin%252C%2520MA-1%2520Induces%2520Mitochondrial%2520Dependent%2520Apoptosis%2520by%2520ROS%2520Generation%2520in%2520Human%2520Lung%2520Cancer%2520Cells%26jtitle%3DToxicol.%2520Appl.%2520Pharmacol.%26date%3D2013%26volume%3D273%26spage%3D659%26epage%3D671%26doi%3D10.1016%2Fj.taap.2013.10.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Varrone, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Consiglio, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Covelli, I.</span><span> </span><span class="NLM_article-title">The Nature of Inhibition of Mitochondrial Malate Dehydrogenase by Thyroxine, Iodine Cyanide and Molecular Iodine</span> <span class="citation_source-journal">Eur. J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1970</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">305</span><span class="NLM_x">–</span> <span class="NLM_lpage">312</span><span class="refDoi"> DOI: 10.1111/j.1432-1033.1970.tb00932.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=10.1111%2Fj.1432-1033.1970.tb00932.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=4314809" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=1%3ACAS%3A528%3ADyaE3cXht1yqsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1970&pages=305-312&author=S.+Varroneauthor=E.+Consiglioauthor=I.+Covelli&title=The+Nature+of+Inhibition+of+Mitochondrial+Malate+Dehydrogenase+by+Thyroxine%2C+Iodine+Cyanide+and+Molecular+Iodine&doi=10.1111%2Fj.1432-1033.1970.tb00932.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Nature of inhibition of mitochondrial malate dehydrogenase by thyroxine, iodine cyanide, and molecular iodine</span></div><div class="casAuthors">Varrone, Stelio; Consiglio, Eduardo; Covelli, Italo</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">1970</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">305-12</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    </div><div class="casAbstract">The mechanism of inhibition of the enzyme activity of mitochondrial malate dehydrogenase by thyroxine, ICN and mol. I was further investigated.  The results obtained excluded formation of a protein/inhibitor stable complex, iodination of the enzyme, or disaggregation of the protein mol. into inactive subunits as explanations for the enzyme inactivation induced by the I-contg. compds.  It was demonstrated that in all cases the enzyme inhibition was dependent on the oxidn. of certain SH groups necessary for the activity.  Direct oxidn. of the thiol groups of the protein by mol. I and ICN can be easily assumed, whereas the chem. mechanism of the thyroxine-induced enzyme inactivation was harder to explain.  However, since neither hormone deiodination nor metal chelation occurred, while thyroxine by itself was also able to oxidize the thiol group of reduced glutathione, a direct effect of thyroxine on the sulfhydryl groups of the enzyme was postulated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq96A5Z8neeUbVg90H21EOLACvtfcHk0lj3L9XepAwuXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3cXht1yqsLg%253D&md5=87a556ff5423982b9ae1d4668fc4fa09</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1111%2Fj.1432-1033.1970.tb00932.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1432-1033.1970.tb00932.x%26sid%3Dliteratum%253Aachs%26aulast%3DVarrone%26aufirst%3DS.%26aulast%3DConsiglio%26aufirst%3DE.%26aulast%3DCovelli%26aufirst%3DI.%26atitle%3DThe%2520Nature%2520of%2520Inhibition%2520of%2520Mitochondrial%2520Malate%2520Dehydrogenase%2520by%2520Thyroxine%252C%2520Iodine%2520Cyanide%2520and%2520Molecular%2520Iodine%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D1970%26volume%3D13%26spage%3D305%26epage%3D312%26doi%3D10.1111%2Fj.1432-1033.1970.tb00932.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">McGovern, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoichet, B. K.</span><span> </span><span class="NLM_article-title">Kinase Inhibitors: Not Just for Kinases Anymore</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">1478</span><span class="NLM_x">–</span> <span class="NLM_lpage">483</span><span class="refDoi"> DOI: 10.1021/jm020427b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm020427b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhvFeksLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=1478-483&author=S.+L.+McGovernauthor=B.+K.+Shoichet&title=Kinase+Inhibitors%3A+Not+Just+for+Kinases+Anymore&doi=10.1021%2Fjm020427b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Kinase Inhibitors: Not Just for Kinases Anymore</span></div><div class="casAuthors">McGovern, Susan L.; Shoichet, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1478-1483</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Kinase inhibitors are widely employed as biol. reagents and as leads for drug design.  Their use is often complicated by their lack of specificity.  Although binding conserved ATP sites accounts for some of their nonspecificity, some compds. inhibit proteins not known to bind ATP.  It has been found that promiscuous hits from high-throughput screening may act as aggregates.  To explore whether this mechanism might explain the action of widely used nonspecific kinase inhibitors, 15 such compds. were studied.  Eight of these, rottlerin, quercetin, K-252c, bisindolylmaleimide I, bisindolylmaleimide IX, U0126, indirubin, and indigo, inhibited three diverse non-kinase enzymes.  Inhibition was time-dependent and sensitive to enzyme concn.; by light scattering, the compds. formed particles of 100-1000 nm diam.  These observations suggest that these eight kinase inhibitors, at least at micromolar concns., are promiscuous and act as aggregates.  Results obtained from the use of these compds. at micromolar or higher concns. against individual enzymes should be interpreted cautiously.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-JSJ7FPf7e7Vg90H21EOLACvtfcHk0lj8UodhpRLJxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhvFeksLs%253D&md5=1d7e4e99a27be5ab279744aff92de26d</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm020427b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020427b%26sid%3Dliteratum%253Aachs%26aulast%3DMcGovern%26aufirst%3DS.%2BL.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26atitle%3DKinase%2520Inhibitors%253A%2520Not%2520Just%2520for%2520Kinases%2520Anymore%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D1478%26epage%3D483%26doi%3D10.1021%2Fjm020427b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Rupert, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Segar, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schutte, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scholz, T. D.</span><span> </span><span class="NLM_article-title">Metabolic Adaptation of the Hypertrophied Heart: Role of the Malate/Aspartate and α -Glycerophosphate Shuttles</span> <span class="citation_source-journal">J. Mol. Cell. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">2287</span><span class="NLM_x">–</span> <span class="NLM_lpage">2297</span><span class="refDoi"> DOI: 10.1006/jmcc.2000.1257</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=10.1006%2Fjmcc.2000.1257" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=11113004" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=1%3ACAS%3A528%3ADC%252BD3cXos1Kiu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2000&pages=2287-2297&author=B.+E.+Rupertauthor=J.+L.+Segarauthor=B.+C.+Schutteauthor=T.+D.+Scholz&title=Metabolic+Adaptation+of+the+Hypertrophied+Heart%3A+Role+of+the+Malate%2FAspartate+and+%CE%B1+-Glycerophosphate+Shuttles&doi=10.1006%2Fjmcc.2000.1257"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolic adaptation of the hypertrophied heart: role of the malate/aspartate and α-glycerophosphate shuttles</span></div><div class="casAuthors">Rupert, Brian E.; Segar, Jeffrey L.; Schutte, Brian C.; Scholz, Thomas D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular and Cellular Cardiology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2287-2297</span>CODEN:
                <span class="NLM_cas:coden">JMCDAY</span>;
        ISSN:<span class="NLM_cas:issn">0022-2828</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Activation of the malate/aspartate and α-glycerophosphate shuttles (the NADH shuttles) has been identified in glycolytically active newborn myocardium.  The goal of this study was to det. if the NADH shuttles and their regulatory genes are activated in hypertrophied myocardium as substrate utilization shifts away from fatty acids and toward glucose and lactate.  Capacity of the shuttles was detd. in cardiac mitochondria isolated one week, one month, and three months following aortic banding or sham operation.  Myocardial steady-state mRNA and protein levels of regulatory enzymes were also measured.  Despite a significant increase in left ventricular mass and activation of the atrial natriuretic peptide gene, no change in malate/aspartate nor α-glycerophosphate shuttle capacity was found at any of the three time points studied.  Reactivation of the genes encoding the regulatory inner mitochondrial membrane proteins was not found in the hypertrophied myocardium, though these genes were down-regulated one week following aortic-banding.  Apparently, sufficient malate/aspartate and α-glycerophosphate shuttle capacity exists in cardiac mitochondria to accommodate increased shuttle flux as hypertrophied myocardium becomes more glycolytically active.  (c) 2000 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFFtaAzu4wyrVg90H21EOLACvtfcHk0lj8UodhpRLJxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXos1Kiu7w%253D&md5=134973d669ec0bb77f3c30ac53945aea</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1006%2Fjmcc.2000.1257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmcc.2000.1257%26sid%3Dliteratum%253Aachs%26aulast%3DRupert%26aufirst%3DB.%2BE.%26aulast%3DSegar%26aufirst%3DJ.%2BL.%26aulast%3DSchutte%26aufirst%3DB.%2BC.%26aulast%3DScholz%26aufirst%3DT.%2BD.%26atitle%3DMetabolic%2520Adaptation%2520of%2520the%2520Hypertrophied%2520Heart%253A%2520Role%2520of%2520the%2520Malate%252FAspartate%2520and%2520%25CE%25B1%2520-Glycerophosphate%2520Shuttles%26jtitle%3DJ.%2520Mol.%2520Cell.%2520Cardiol.%26date%3D2000%26volume%3D32%26spage%3D2287%26epage%3D2297%26doi%3D10.1006%2Fjmcc.2000.1257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 11 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kshitis Chandra  Baral</span>, <span class="hlFld-ContribAuthor ">Jae-Geun  Song</span>, <span class="hlFld-ContribAuthor ">Sang Hoon  Lee</span>, <span class="hlFld-ContribAuthor ">Rajiv  Bajracharya</span>, <span class="hlFld-ContribAuthor ">Godesi  Sreenivasulu</span>, <span class="hlFld-ContribAuthor ">Minkyoung  Kim</span>, <span class="hlFld-ContribAuthor ">Kyeong  Lee</span>, <span class="hlFld-ContribAuthor ">Hyo-Kyung  Han</span>. </span><span class="cited-content_cbyCitation_article-title">Enhanced Bioavailability of AC1497, a Novel Anticancer Drug Candidate, via a Self-Nanoemulsifying Drug Delivery System. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceutics</span><span> <strong>2021,</strong> <em>13 </em>
                                    (8)
                                     , 1142. <a href="https://doi.org/10.3390/pharmaceutics13081142" title="DOI URL">https://doi.org/10.3390/pharmaceutics13081142</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/pharmaceutics13081142&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fpharmaceutics13081142%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceutics%26atitle%3DEnhanced%252BBioavailability%252Bof%252BAC1497%25252C%252Ba%252BNovel%252BAnticancer%252BDrug%252BCandidate%25252C%252Bvia%252Ba%252BSelf-Nanoemulsifying%252BDrug%252BDelivery%252BSystem%26aulast%3DBaral%26aufirst%3DKshitis%2BChandra%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D8%26spage%3D1142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christian  Bailly</span>, <span class="hlFld-ContribAuthor ">Gérard  Vergoten</span>. </span><span class="cited-content_cbyCitation_article-title">A new horizon for the old antibacterial drug clofoctol. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2021,</strong> <em>26 </em>
                                    (5)
                                     , 1302-1310. <a href="https://doi.org/10.1016/j.drudis.2021.02.004" title="DOI URL">https://doi.org/10.1016/j.drudis.2021.02.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2021.02.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2021.02.004%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DA%252Bnew%252Bhorizon%252Bfor%252Bthe%252Bold%252Bantibacterial%252Bdrug%252Bclofoctol%26aulast%3DBailly%26aufirst%3DChristian%26date%3D2021%26volume%3D26%26issue%3D5%26spage%3D1302%26epage%3D1310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu‐Chen  Ma</span>, <span class="hlFld-ContribAuthor ">Peng‐Fei  Tian</span>, <span class="hlFld-ContribAuthor ">Zhi‐Peng  Chen</span>, <span class="hlFld-ContribAuthor ">Dong‐Sheng  Yue</span>, <span class="hlFld-ContribAuthor ">Cui‐Cui  Liu</span>, <span class="hlFld-ContribAuthor ">Chen‐Guang  Li</span>, <span class="hlFld-ContribAuthor ">Chen  Chen</span>, <span class="hlFld-ContribAuthor ">Hua  Zhang</span>, <span class="hlFld-ContribAuthor ">Hai‐Lin  Liu</span>, <span class="hlFld-ContribAuthor ">Zhen‐Fa  Zhang</span>, <span class="hlFld-ContribAuthor ">Liang  Chen</span>, <span class="hlFld-ContribAuthor ">Bin  Zhang</span>, <span class="hlFld-ContribAuthor ">Chang‐Li  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Urinary malate dehydrogenase 2 is a new biomarker for early detection of non‐small‐cell lung cancer. </span><span class="cited-content_cbyCitation_journal-name">Cancer Science</span><span> <strong>2021,</strong> <em>68 </em><a href="https://doi.org/10.1111/cas.14845" title="DOI URL">https://doi.org/10.1111/cas.14845</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cas.14845&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcas.14845%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Science%26atitle%3DUrinary%252Bmalate%252Bdehydrogenase%252B2%252Bis%252Ba%252Bnew%252Bbiomarker%252Bfor%252Bearly%252Bdetection%252Bof%252Bnon%2525E2%252580%252590small%2525E2%252580%252590cell%252Blung%252Bcancer%26aulast%3DMa%26aufirst%3DYu%25E2%2580%2590Chen%26date%3D2021%26date%3D2021%26volume%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Patrícia F.  Lainetti</span>, <span class="hlFld-ContribAuthor ">Antonio F.  Leis-Filho</span>, <span class="hlFld-ContribAuthor ">Priscila E.  Kobayashi</span>, <span class="hlFld-ContribAuthor ">Laíza S.  de Camargo</span>, <span class="hlFld-ContribAuthor ">Renee  Laufer-Amorim</span>, <span class="hlFld-ContribAuthor ">Carlos E.  Fonseca-Alves</span>, <span class="hlFld-ContribAuthor ">Fabiana F.  Souza</span>. </span><span class="cited-content_cbyCitation_article-title">Proteomics Approach of Rapamycin Anti-Tumoral Effect on Primary and Metastatic Canine Mammary Tumor Cells In Vitro. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (5)
                                     , 1213. <a href="https://doi.org/10.3390/molecules26051213" title="DOI URL">https://doi.org/10.3390/molecules26051213</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26051213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26051213%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DProteomics%252BApproach%252Bof%252BRapamycin%252BAnti-Tumoral%252BEffect%252Bon%252BPrimary%252Band%252BMetastatic%252BCanine%252BMammary%252BTumor%252BCells%252BIn%252BVitro%26aulast%3DLainetti%26aufirst%3DPatr%25C3%25ADcia%2BF.%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D5%26spage%3D1213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xingting  Bao</span>, <span class="hlFld-ContribAuthor ">Jinhua  Zhang</span>, <span class="hlFld-ContribAuthor ">Guomin  Huang</span>, <span class="hlFld-ContribAuthor ">Junfang  Yan</span>, <span class="hlFld-ContribAuthor ">Caipeng  Xu</span>, <span class="hlFld-ContribAuthor ">Zhihui  Dou</span>, <span class="hlFld-ContribAuthor ">Chao  Sun</span>, <span class="hlFld-ContribAuthor ">Hong  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">The crosstalk between HIFs and mitochondrial dysfunctions in cancer development. </span><span class="cited-content_cbyCitation_journal-name">Cell Death & Disease</span><span> <strong>2021,</strong> <em>12 </em>
                                    (2)
                                     <a href="https://doi.org/10.1038/s41419-021-03505-1" title="DOI URL">https://doi.org/10.1038/s41419-021-03505-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41419-021-03505-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41419-021-03505-1%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Death%2520%2526%2520Disease%26atitle%3DThe%252Bcrosstalk%252Bbetween%252BHIFs%252Band%252Bmitochondrial%252Bdysfunctions%252Bin%252Bcancer%252Bdevelopment%26aulast%3DBao%26aufirst%3DXingting%26date%3D2021%26date%3D2021%26volume%3D12%26issue%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Min Kyung  Park</span>, <span class="hlFld-ContribAuthor ">Jun  Ji</span>, <span class="hlFld-ContribAuthor ">Keeok  Haam</span>, <span class="hlFld-ContribAuthor ">Tae-Hee  Han</span>, <span class="hlFld-ContribAuthor ">Seona  Lim</span>, <span class="hlFld-ContribAuthor ">Mi-Jung  Kang</span>, <span class="hlFld-ContribAuthor ">Soon Sung  Lim</span>, <span class="hlFld-ContribAuthor ">Hyun Seung  Ban</span>. </span><span class="cited-content_cbyCitation_article-title">Licochalcone A inhibits hypoxia-inducible factor-1α accumulation by suppressing mitochondrial respiration in hypoxic cancer cells. </span><span class="cited-content_cbyCitation_journal-name">Biomedicine & Pharmacotherapy</span><span> <strong>2021,</strong> <em>133 </em>, 111082. <a href="https://doi.org/10.1016/j.biopha.2020.111082" title="DOI URL">https://doi.org/10.1016/j.biopha.2020.111082</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.biopha.2020.111082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.biopha.2020.111082%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomedicine%2520%2526%2520Pharmacotherapy%26atitle%3DLicochalcone%252BA%252Binhibits%252Bhypoxia-inducible%252Bfactor-1%2525CE%2525B1%252Baccumulation%252Bby%252Bsuppressing%252Bmitochondrial%252Brespiration%252Bin%252Bhypoxic%252Bcancer%252Bcells%26aulast%3DPark%26aufirst%3DMin%2BKyung%26date%3D2021%26volume%3D133%26spage%3D111082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Inhyub  Kim</span>, <span class="hlFld-ContribAuthor ">Minkyoung  Kim</span>, <span class="hlFld-ContribAuthor ">Min Kyung  Park</span>, <span class="hlFld-ContribAuthor ">Ravi  Naik</span>, <span class="hlFld-ContribAuthor ">Jae Hyung  Park</span>, <span class="hlFld-ContribAuthor ">Bo-Kyung  Kim</span>, <span class="hlFld-ContribAuthor ">Yongseok  Choi</span>, <span class="hlFld-ContribAuthor ">Kwan Young  Chang</span>, <span class="hlFld-ContribAuthor ">Misun  Won</span>, <span class="hlFld-ContribAuthor ">Hyun Seung  Ban</span>, <span class="hlFld-ContribAuthor ">Kyeong  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">The disubstituted adamantyl derivative LW1564 inhibits the growth of cancer cells by targeting mitochondrial respiration and reducing hypoxia-inducible factor (HIF)-1α accumulation. </span><span class="cited-content_cbyCitation_journal-name">Experimental & Molecular Medicine</span><span> <strong>2020,</strong> <em>52 </em>
                                    (11)
                                     , 1845-1856. <a href="https://doi.org/10.1038/s12276-020-00523-5" title="DOI URL">https://doi.org/10.1038/s12276-020-00523-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s12276-020-00523-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs12276-020-00523-5%26sid%3Dliteratum%253Aachs%26jtitle%3DExperimental%2520%2526%2520Molecular%2520Medicine%26atitle%3DThe%252Bdisubstituted%252Badamantyl%252Bderivative%252BLW1564%252Binhibits%252Bthe%252Bgrowth%252Bof%252Bcancer%252Bcells%252Bby%252Btargeting%252Bmitochondrial%252Brespiration%252Band%252Breducing%252Bhypoxia-inducible%252Bfactor%252B%252528HIF%252529-1%2525CE%2525B1%252Baccumulation%26aulast%3DKim%26aufirst%3DInhyub%26date%3D2020%26date%3D2020%26volume%3D52%26issue%3D11%26spage%3D1845%26epage%3D1856" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mariángeles Ávila  Maniero</span>, <span class="hlFld-ContribAuthor ">Rodolfo G.  Wuilloud</span>, <span class="hlFld-ContribAuthor ">Eduardo A.  Callegari</span>, <span class="hlFld-ContribAuthor ">Patricia N.  Smichowski</span>, <span class="hlFld-ContribAuthor ">Mariel A.  Fanelli</span>. </span><span class="cited-content_cbyCitation_article-title">Metalloproteomics analysis in human mammary cell lines treated with inorganic mercury. </span><span class="cited-content_cbyCitation_journal-name">Journal of Trace Elements in Medicine and Biology</span><span> <strong>2020,</strong> <em>58 </em>, 126441. <a href="https://doi.org/10.1016/j.jtemb.2019.126441" title="DOI URL">https://doi.org/10.1016/j.jtemb.2019.126441</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jtemb.2019.126441&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jtemb.2019.126441%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Trace%2520Elements%2520in%2520Medicine%2520and%2520Biology%26atitle%3DMetalloproteomics%252Banalysis%252Bin%252Bhuman%252Bmammary%252Bcell%252Blines%252Btreated%252Bwith%252Binorganic%252Bmercury%26aulast%3DManiero%26aufirst%3DMari%25C3%25A1ngeles%2B%25C3%2581vila%26date%3D2020%26volume%3D58%26spage%3D126441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lei  Xu</span>, <span class="hlFld-ContribAuthor ">Hua  Xia</span>, <span class="hlFld-ContribAuthor ">Dongsheng  Ni</span>, <span class="hlFld-ContribAuthor ">Yanxia  Hu</span>, <span class="hlFld-ContribAuthor ">Jianing  Liu</span>, <span class="hlFld-ContribAuthor ">Yao  Qin</span>, <span class="hlFld-ContribAuthor ">Qin  Zhou</span>, <span class="hlFld-ContribAuthor ">Qiying  Yi</span>, <span class="hlFld-ContribAuthor ">Yajun  Xie</span>. </span><span class="cited-content_cbyCitation_article-title">High-Dose Dexamethasone Manipulates the Tumor Microenvironment and Internal Metabolic Pathways in Anti-Tumor Progression. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (5)
                                     , 1846. <a href="https://doi.org/10.3390/ijms21051846" title="DOI URL">https://doi.org/10.3390/ijms21051846</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21051846&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21051846%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DHigh-Dose%252BDexamethasone%252BManipulates%252Bthe%252BTumor%252BMicroenvironment%252Band%252BInternal%252BMetabolic%252BPathways%252Bin%252BAnti-Tumor%252BProgression%26aulast%3DXu%26aufirst%3DLei%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D5%26spage%3D1846" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yoshiaki  Sunami</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Metabolism. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 183-202. <a href="https://doi.org/10.1007/978-3-030-49476-6_13" title="DOI URL">https://doi.org/10.1007/978-3-030-49476-6_13</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-49476-6_13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-49476-6_13%26sid%3Dliteratum%253Aachs%26atitle%3DTargeting%252BMetabolism%26aulast%3DSunami%26aufirst%3DYoshiaki%26date%3D2020%26date%3D2020%26spage%3D183%26epage%3D202%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DTranslational%252BPancreatic%252BCancer%252BResearch%26aulast%3DMichalski%26aufirst%3DChristoph%2BW.%26date%3D2020%26volume%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yoshiaki  Sunami</span>, <span class="hlFld-ContribAuthor ">Artur  Rebelo</span>, <span class="hlFld-ContribAuthor ">Jörg  Kleeff</span>. </span><span class="cited-content_cbyCitation_article-title">Lipid Metabolism and Lipid Droplets in Pancreatic Cancer and Stellate Cells. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2018,</strong> <em>10 </em>
                                    (1)
                                     , 3. <a href="https://doi.org/10.3390/cancers10010003" title="DOI URL">https://doi.org/10.3390/cancers10010003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers10010003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers10010003%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DLipid%252BMetabolism%252Band%252BLipid%252BDroplets%252Bin%252BPancreatic%252BCancer%252Band%252BStellate%252BCells%26aulast%3DSunami%26aufirst%3DYoshiaki%26date%3D2018%26date%3D2017%26volume%3D10%26issue%3D1%26spage%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/medium/jm-2017-01231h_0018.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/large/jm-2017-01231h_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01231&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/medium/jm-2017-01231h_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/large/jm-2017-01231h_0019.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Schematic overview of the malate–aspartate shuttle. The malate–aspartate shuttle is operated by malate dehydrogenases (MDHs) and glutamate oxaloacetate transaminases (GOTs). MDH1 in the cytoplasm reduces oxaloacetate to malate while oxidizing NADH to NAD<sup>+</sup>. Then, malate is transported to the interior of the mitochondrion and oxidized once again to oxaloacetate by mitochondrial MDH2, thereby generating NADH to produce ATP in the electron transport chain (ETC).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/large/jm-2017-01231h_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01231&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/medium/jm-2017-01231h_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/large/jm-2017-01231h_0020.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Malate dehydrogenase (MDH) inhibitor design.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/large/jm-2017-01231h_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01231&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/medium/jm-2017-01231h_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/large/jm-2017-01231h_0006.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Amide Derivatives <b>5a</b>–<b>l</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/large/jm-2017-01231h_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01231&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) EDC·HCl, <i>N</i>-(3-(dimethylamino)propyl)-<i>N</i>′-ethylcarbonate hydrochloride; HOBT, 1-hydroxybenzotriazole; DIPEA, <i>N</i>,<i>N</i>-diisopropylethylamine; DMF, dimethylformamide.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/medium/jm-2017-01231h_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/large/jm-2017-01231h_0007.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of 4-Adamantyl and Trimethylpentane Derivatives <b>7a</b>–<b>f</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/large/jm-2017-01231h_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01231&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) methyl 3-amino-4-hydroxybenzoate EDC·HCl, <i>N</i>-(3-(dimethylamino)propyl)-<i>N</i>′-ethylcarbonate hydrochloride; HOBT, 1-hydroxybenzotriazole; DIPEA, <i>N</i>,<i>N</i>-di-isopropylethylamine; DMF, dimethylformamide; (b) alkyl or aryl halide, potassium carbonate (K<sub>2</sub>CO<sub>3</sub>), DMF.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/medium/jm-2017-01231h_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/large/jm-2017-01231h_0008.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Trimethylpentane Derivatives <b>8a</b>–<b>f</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/large/jm-2017-01231h_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01231&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) amines, EDC·HCl, <i>N</i>-(3-(dimethylamino)propyl)-<i>N</i>′-ethylcarbonate hydrochloride; HOBT, 1-hydroxybenzotriazole; DIPEA, <i>N</i>,<i>N</i>-diisopropylethylamine; DMF, dimethylformamide.</p></p></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/medium/jm-2017-01231h_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/large/jm-2017-01231h_0009.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of 4-Adamantyl and Trimethylpentane Derivatives <b>14a</b>–<b>f</b>, <b>15a</b>–<b>b</b>, and <b>16a</b>–<b>c</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/large/jm-2017-01231h_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01231&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) K<sub>2</sub>CO<sub>3</sub>, methyl 4-bromobutanoate for <b>11a</b> and <b>11c</b> and methyl 2-bromo-2-methylpropanoate for <b>11b</b> and <b>11d</b>, DMF, (ii) LiOH, THF/H<sub>2</sub>O; (b) PPh<sub>3</sub>, methyl propiolate, toluene; (c) Pd/C, H<sub>2</sub>, MeOH; (d,e) LiOH, THF/H<sub>2</sub>O; (f,g,h) EDC·HCl, HOBT, DIPEA, DMF, methyl 3-amino-4-hydroxybenzoate for <b>14c</b>, <b>14f</b>, and <b>16b</b> and methyl 3-aminobenzoate for <b>14a</b>,<b>b</b>, <b>14d</b>,<b>e</b>, <b>15a</b>,<b>b</b>, and <b>16a</b>,<b>c</b>.</p></p></figure><figure data-id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/medium/jm-2017-01231h_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/large/jm-2017-01231h_0001.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Mode of malate dehydrogenase (MDH) inhibition by compound <b>16c</b>. Enzyme kinetics of (A) MDH1 and (B) MDH2 were performed at various concentrations of NADH. Concentrations of compound <b>16c</b>: 0 μM (●), 0.625 μM (○), 1.25 μM (▼closed triangle), and 2.5 μM (▽).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/large/jm-2017-01231h_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01231&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/medium/jm-2017-01231h_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/large/jm-2017-01231h_0002.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Inhibition of hypoxia-induced hypoxia-inducible factor-1 (HIF-1)-α activation by compound <b>16c</b>. (A) Effects of compound <b>16c</b> on hypoxia-induced HIF-1α accumulation. After treatment of HCT116 cells with compound <b>16c</b> under hypoxic conditions, proteins were detected using immunoblot analysis in HCT116 cells. (B) Effects of compound <b>16c</b> on mRNA expression levels of HIF-1α target genes were detected using reverse transcription–polymerase chain reaction (RT-PCR) analysis.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/large/jm-2017-01231h_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01231&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/medium/jm-2017-01231h_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/large/jm-2017-01231h_0003.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Inhibition of mitochondrial respiration by compound <b>16c</b>. (A) Oxygen consumption rate (OCR) was measured using XF24 extracellular flux analyzer by adding oligomycin (1 μM), carbonyl cyanide <i>p</i>-trifluoromethoxy-phenylhydrazone (FCCP, 0.5 μM), and rotenone (1 μM)/antimycin A (1 μM) to compound <b>16c</b>-treated HCT116 cells. (B) Adenosine monophosphate (AMP)-activated protein kinase (AMPK) activation was determined using immunoblot analysis with each specific antibody. (C) The intracellular adenosine triphosphate (ATP) content of compound <b>16c</b>-treated HCT116 cells was measured using a luciferase-based assay system. (D) Intracellular oxygen tension was determined using a hypoxia-sensitive probe mono azo rhodamine (MAR, 0.5 μM). Scale bar, 100 μm. Fluorescence intensity of the MAR probe is shown by vertical bars; *<i>P</i> < 0.05 and **<i>P</i> < 0.01, compared with hypoxic control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/large/jm-2017-01231h_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01231&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/medium/jm-2017-01231h_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/large/jm-2017-01231h_0004.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Inhibition of mitochondria complex I activity by compound <b>16c</b>. (A) The exogenous substrate-dependent mitochondrial respiration rate was measured in digitonin-permeabilized HCT116 cells by adding a substrate and inhibitor of each complex. Substrates and inhibitors used were as follows: pyruvate (5 mM), malate (5 mM), rotenone (1 μM), succinate (5 mM), antimycin A (1 μM), ascorbate (5 mM), and tetramethyl-<i>p</i>-phenylenediamine (TMPD, 2 mM). (B) Inhibitory activity of compound <b>16c</b> against mitochondria complex I was determined by adding compound <b>16c</b> (30 μM) after treatment with complex I substrates.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/large/jm-2017-01231h_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01231&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/medium/jm-2017-01231h_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/large/jm-2017-01231h_0005.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. In vivo antitumor effects of compound <b>16c</b> in a HCT116 cell xenograft model. (A) HCT116 cells (5 × 10<sup>6</sup>) were subcutaneously inoculated into the right flank of female nude mice. Drugs were administered intraperitoneally once a day for 14 days after the tumor reached a volume of 80–100 mm<sup>3</sup>. (B) Image and weight of tumors at the end of the experiment; *<i>P</i> < 0.05 and **<i>P</i> < 0.01, compared with vehicle control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01231/20171020/images/large/jm-2017-01231h_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01231&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i90">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22271" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22271" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 34 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Cairns, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, I. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, T. W.</span><span> </span><span class="NLM_article-title">Regulation of Cancer Cell Metabolism</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">85</span><span class="NLM_x">–</span> <span class="NLM_lpage">95</span><span class="refDoi"> DOI: 10.1038/nrc2981</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=10.1038%2Fnrc2981" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=21258394" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=1%3ACAS%3A528%3ADC%252BC3MXps1ahuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=85-95&author=R.+A.+Cairnsauthor=I.+S.+Harrisauthor=T.+W.+Mak&title=Regulation+of+Cancer+Cell+Metabolism&doi=10.1038%2Fnrc2981"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of cancer cell metabolism</span></div><div class="casAuthors">Cairns, Rob A.; Harris, Isaac S.; Mak, Tak W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">85-95</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Interest in the topic of tumor metab. has waxed and waned over the past century of cancer research.  The early observations of Warburg and his contemporaries established that there are fundamental differences in the central metabolic pathways operating in malignant tissue.  However, the initial hypotheses that were based on these observations proved inadequate to explain tumorigenesis, and the oncogene revolution pushed tumor metab. to the margins of cancer research.  In recent years, interest was renewed as it has become clear that many of the signaling pathways that are affected by genetic mutations and the tumor microenvironment have a profound effect on core metab., making this topic once again one of the most intense areas of research in cancer biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqideEJZiMGjrVg90H21EOLACvtfcHk0liyrjpVqy_oWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXps1ahuw%253D%253D&md5=ffbbec8c8159e88b026f44b249ee1ede</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrc2981&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2981%26sid%3Dliteratum%253Aachs%26aulast%3DCairns%26aufirst%3DR.%2BA.%26aulast%3DHarris%26aufirst%3DI.%2BS.%26aulast%3DMak%26aufirst%3DT.%2BW.%26atitle%3DRegulation%2520of%2520Cancer%2520Cell%2520Metabolism%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2011%26volume%3D11%26spage%3D85%26epage%3D95%26doi%3D10.1038%2Fnrc2981" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Williamson, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakob, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Refino, C.</span><span> </span><span class="NLM_article-title">Control of the Removal of Reducing Equivalents from the Cytosol in Perfused Rat Liver</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1971</span><span class="NLM_x">, </span> <span class="NLM_volume">246</span><span class="NLM_x">, </span> <span class="NLM_fpage">7632</span><span class="NLM_x">–</span> <span class="NLM_lpage">7641</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=246&publication_year=1971&pages=7632-7641&author=J.+R.+Williamsonauthor=A.+Jakobauthor=C.+Refino&title=Control+of+the+Removal+of+Reducing+Equivalents+from+the+Cytosol+in+Perfused+Rat+Liver"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilliamson%26aufirst%3DJ.%2BR.%26aulast%3DJakob%26aufirst%3DA.%26aulast%3DRefino%26aufirst%3DC.%26atitle%3DControl%2520of%2520the%2520Removal%2520of%2520Reducing%2520Equivalents%2520from%2520the%2520Cytosol%2520in%2520Perfused%2520Rat%2520Liver%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1971%26volume%3D246%26spage%3D7632%26epage%3D7641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">López-Alarcón, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eboli, M. L.</span><span> </span><span class="NLM_article-title">Oxidation of Reduced Cytosolic Nicotinamide Adenine Dinucleotide by the Malate-Aspartate Shuttle in the K-562 Human Leukemia Cell Line</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">5589</span><span class="NLM_x">–</span> <span class="NLM_lpage">5591</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1986&pages=5589-5591&author=L.+L%C3%B3pez-Alarc%C3%B3nauthor=M.+L.+Eboli&title=Oxidation+of+Reduced+Cytosolic+Nicotinamide+Adenine+Dinucleotide+by+the+Malate-Aspartate+Shuttle+in+the+K-562+Human+Leukemia+Cell+Line"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DL%25C3%25B3pez-Alarc%25C3%25B3n%26aufirst%3DL.%26aulast%3DEboli%26aufirst%3DM.%2BL.%26atitle%3DOxidation%2520of%2520Reduced%2520Cytosolic%2520Nicotinamide%2520Adenine%2520Dinucleotide%2520by%2520the%2520Malate-Aspartate%2520Shuttle%2520in%2520the%2520K-562%2520Human%2520Leukemia%2520Cell%2520Line%26jtitle%3DCancer%2520Res.%26date%3D1986%26volume%3D46%26spage%3D5589%26epage%3D5591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Barron, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parrillo, J. E.</span><span> </span><span class="NLM_article-title">Malate-Aspartate Shuttle, Cytoplasmic NADH Redox Potential, and Energetics in Vascular Smooth Muscle</span> <span class="citation_source-journal">J. Mol. Cell. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">1571</span><span class="NLM_x">–</span> <span class="NLM_lpage">1579</span><span class="refDoi"> DOI: 10.1006/jmcc.1998.0722</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=10.1006%2Fjmcc.1998.0722" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=9737943" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=1%3ACAS%3A528%3ADyaK1cXmtlCqtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1998&pages=1571-1579&author=J.+T.+Barronauthor=L.+Guauthor=J.+E.+Parrillo&title=Malate-Aspartate+Shuttle%2C+Cytoplasmic+NADH+Redox+Potential%2C+and+Energetics+in+Vascular+Smooth+Muscle&doi=10.1006%2Fjmcc.1998.0722"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Malate-aspartate shuttle, cytoplasmic NADH redox potential, and energetics in vascular smooth muscle</span></div><div class="casAuthors">Barron, John T.; Gu, Liping; Parrillo, Joseph E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular and Cellular Cardiology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1571-1579</span>CODEN:
                <span class="NLM_cas:coden">JMCDAY</span>;
        ISSN:<span class="NLM_cas:issn">0022-2828</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">The effect of inhibition of the malate-aspartate shuttle on the cytoplasmic NADH/NAD ratio and NADH redox state and its corresponding effects on mitochondrial energetics in vascular smooth muscle were examd.  Incubation of porcine carotid arteries with 0.4 mmol amino-oxyacetic acid an inhibitor of glutamate-oxaloacetate transaminase and, hence the malate-aspartate shuttle, inhibited O2 consumption by 21%, decreased the content of phosphocreatine and inhibited activity of the tricarboxylic acid cycle.  The rate of glycolysis and lactate prodn. was increased but glucose oxidn. was inhibited.  These effects of amino-oxyacetic acid were accompanied by evidence of inhibition of the malate-aspartate shuttle and elevation in the cytoplasmic redox potential and NADH/NAD ratio as indicated by elevation of the concn. ratios of the lactate/pyruvate and glycerol-3-phosphate/dihydroxyacetone phosphate metabolite redox couples.  Addn. of the fatty acid octanoate normalized the adverse energetic effects of malate-aspartate shuttle inhibition.  It is concluded that the malate-aspartate shuttle is a primary mode of clearance of NADH reducing equiv. from the cytoplasm in vascular smooth muscle.  Glucose oxidn. and lactate prodn. are influenced by the activity of the shuttle.  The results support the hypothesis that an increased cytoplasmic NADH redox potential impairs mitochondrial energy metab.  (c) 1998 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAU9kC-zm30rVg90H21EOLACvtfcHk0licZxCSgKuB4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmtlCqtbc%253D&md5=aee17d93acfd5ead7eee039777253743</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1006%2Fjmcc.1998.0722&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmcc.1998.0722%26sid%3Dliteratum%253Aachs%26aulast%3DBarron%26aufirst%3DJ.%2BT.%26aulast%3DGu%26aufirst%3DL.%26aulast%3DParrillo%26aufirst%3DJ.%2BE.%26atitle%3DMalate-Aspartate%2520Shuttle%252C%2520Cytoplasmic%2520NADH%2520Redox%2520Potential%252C%2520and%2520Energetics%2520in%2520Vascular%2520Smooth%2520Muscle%26jtitle%3DJ.%2520Mol.%2520Cell.%2520Cardiol.%26date%3D1998%26volume%3D30%26spage%3D1571%26epage%3D1579%26doi%3D10.1006%2Fjmcc.1998.0722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Thornburg, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clem, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arumugam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmons, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eaton, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Telang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chesney, J.</span><span> </span><span class="NLM_article-title">Targeting Aspartate Aminotransferase in Breast Cancer</span> <span class="citation_source-journal">Breast Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">R84</span><span class="refDoi"> DOI: 10.1186/bcr2154</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=10.1186%2Fbcr2154" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=18922152" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=1%3ACAS%3A280%3ADC%252BD1M%252FlsVGlsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&pages=R84&author=J.+M.+Thornburgauthor=K.+K.+Nelsonauthor=B.+F.+Clemauthor=A.+N.+Laneauthor=S.+Arumugamauthor=A.+Simmonsauthor=J.+W.+Eatonauthor=S.+Telangauthor=J.+Chesney&title=Targeting+Aspartate+Aminotransferase+in+Breast+Cancer&doi=10.1186%2Fbcr2154"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting aspartate aminotransferase in breast cancer</span></div><div class="casAuthors">Thornburg Joshua Marshall; Nelson Kristin K; Clem Brian F; Lane Andrew N; Arumugam Sengodagounder; Simmons Allan; Eaton John W; Telang Sucheta; Chesney Jason</div><div class="citationInfo"><span class="NLM_cas:title">Breast cancer research : BCR</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">R84</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">INTRODUCTION:  Glycolysis is increased in breast adenocarcinoma cells relative to adjacent normal cells in order to produce the ATP and anabolic precursors required for survival, growth and invasion.  Glycolysis also serves as a key source of the reduced form of cytoplasmic nicotinamide adenine dinucleotide (NADH) necessary for the shuttling of electrons into mitochondria for electron transport.  Lactate dehydrogenase (LDH) regulates glycolytic flux by converting pyruvate to lactate and has been found to be highly expressed in breast tumours.  Aspartate aminotransferase (AAT) functions in tandem with malate dehydrogenase to transfer electrons from NADH across the inner mitochondrial membrane.  Oxamate is an inhibitor of both LDH and AAT, and we hypothesised that oxamate may disrupt the metabolism and growth of breast adenocarcinoma cells.  METHODS:  We examined the effects of oxamate and the AAT inhibitor amino oxyacetate (AOA) on 13C-glucose utilisation, oxygen consumption, NADH and ATP in MDA-MB-231 cells.  We then determined the effects of oxamate and AOA on normal human mammary epithelial cells and MDA-MB-231 breast adenocarcinoma cell proliferation, and on the growth of MDA-MB-231 cells as tumours in athymic BALB/c female mice.  We ectopically expressed AAT in MDA-MB-231 cells and examined the consequences on the cytostatic effects of oxamate.  Finally, we examined the effect of AAT-specific siRNA transfection on MDA-MB-231 cell proliferation.  RESULTS:  We found that oxamate did not attenuate cellular lactate production as predicted by its LDH inhibitory activity, but did have an anti-metabolic effect that was similar to AAT inhibition with AOA.  Specifically, we found that oxamate and AOA decreased the flux of 13C-glucose-derived carbons into glutamate and uridine, both products of the mitochondrial tricarboxylic acid cycle, as well as oxygen consumption, a measure of electron transport chain activity.  Oxamate and AOA also selectively suppressed the proliferation of MDA-MB-231 cells relative to normal human mammary epithelial cells and decreased the growth of MDA-MB-231 breast tumours in athymic mice.  Importantly, we found that ectopic expression of AAT in MDA-MB-231 cells conferred resistance to the anti-proliferative effects of oxamate and that siRNA silencing of AAT decreased MDA-MB-231 cell proliferation.  CONCLUSIONS:  We conclude that AAT may be a valid molecular target for the development of anti-neoplastic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRBenhyt5omvCA3UY9EwTNrfW6udTcc2eYlZvsqOEPKf7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M%252FlsVGlsA%253D%253D&md5=d1bf6a2f48a7f93c1211f4d158ddab56</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1186%2Fbcr2154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fbcr2154%26sid%3Dliteratum%253Aachs%26aulast%3DThornburg%26aufirst%3DJ.%2BM.%26aulast%3DNelson%26aufirst%3DK.%2BK.%26aulast%3DClem%26aufirst%3DB.%2BF.%26aulast%3DLane%26aufirst%3DA.%2BN.%26aulast%3DArumugam%26aufirst%3DS.%26aulast%3DSimmons%26aufirst%3DA.%26aulast%3DEaton%26aufirst%3DJ.%2BW.%26aulast%3DTelang%26aufirst%3DS.%26aulast%3DChesney%26aufirst%3DJ.%26atitle%3DTargeting%2520Aspartate%2520Aminotransferase%2520in%2520Breast%2520Cancer%26jtitle%3DBreast%2520Cancer%2520Res.%26date%3D2008%26volume%3D10%26spage%3DR84%26doi%3D10.1186%2Fbcr2154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ling, Z. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guan, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, D.</span><span> </span><span class="NLM_article-title">SIRT3-dependent GOT2 Acetylation Status Affects the Malate–Aspartate NADH Shuttle Activity and Pancreatic Tumor Growth</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1110</span><span class="NLM_x">–</span> <span class="NLM_lpage">1125</span><span class="refDoi"> DOI: 10.15252/embj.201591041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=10.15252%2Fembj.201591041" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2015&pages=1110-1125&author=H.+Yangauthor=L.+Zhouauthor=Q.+Shiauthor=Y.+Zhaoauthor=H.+Linauthor=M.+Zhangauthor=S.+Zhaoauthor=Y.+Yangauthor=Z.+Q.+Lingauthor=K.+L.+Guanauthor=Y.+Xiongauthor=D.+Ye&title=SIRT3-dependent+GOT2+Acetylation+Status+Affects+the+Malate%E2%80%93Aspartate+NADH+Shuttle+Activity+and+Pancreatic+Tumor+Growth&doi=10.15252%2Fembj.201591041"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.15252%2Fembj.201591041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.15252%252Fembj.201591041%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DH.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DShi%26aufirst%3DQ.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DLin%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DLing%26aufirst%3DZ.%2BQ.%26aulast%3DGuan%26aufirst%3DK.%2BL.%26aulast%3DXiong%26aufirst%3DY.%26aulast%3DYe%26aufirst%3DD.%26atitle%3DSIRT3-dependent%2520GOT2%2520Acetylation%2520Status%2520Affects%2520the%2520Malate%25E2%2580%2593Aspartate%2520NADH%2520Shuttle%2520Activity%2520and%2520Pancreatic%2520Tumor%2520Growth%26jtitle%3DEMBO%2520J.%26date%3D2015%26volume%3D34%26spage%3D1110%26epage%3D1125%26doi%3D10.15252%2Fembj.201591041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Son, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyssiotis, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ying, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hua, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ligorio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perera, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrone, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullarky, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shyh-Chang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleming, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardeesy, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asara, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haigis, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DePinho, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantley, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimmelman, A. C.</span><span> </span><span class="NLM_article-title">Glutamine Supports Pancreatic Cancer Growth through a KRAS-Regulated Metabolic Pathway</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">496</span><span class="NLM_x">, </span> <span class="NLM_fpage">101</span><span class="NLM_x">–</span> <span class="NLM_lpage">105</span><span class="refDoi"> DOI: 10.1038/nature12040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=10.1038%2Fnature12040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=23535601" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=1%3ACAS%3A528%3ADC%252BC3sXkvFyjsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=496&publication_year=2013&pages=101-105&author=J.+Sonauthor=C.+A.+Lyssiotisauthor=H.+Yingauthor=X.+Wangauthor=S.+Huaauthor=M.+Ligorioauthor=R.+M.+Pereraauthor=C.+R.+Ferroneauthor=E.+Mullarkyauthor=N.+Shyh-Changauthor=Y.+Kangauthor=J.+B.+Flemingauthor=N.+Bardeesyauthor=J.+M.+Asaraauthor=M.+C.+Haigisauthor=R.+A.+DePinhoauthor=L.+C.+Cantleyauthor=A.+C.+Kimmelman&title=Glutamine+Supports+Pancreatic+Cancer+Growth+through+a+KRAS-Regulated+Metabolic+Pathway&doi=10.1038%2Fnature12040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway</span></div><div class="casAuthors">Son, Jaekyoung; Lyssiotis, Costas A.; Ying, Haoqiang; Wang, Xiaoxu; Hua, Sujun; Ligorio, Matteo; Perera, Rushika M.; Ferrone, Cristina R.; Mullarky, Edouard; Ng, Shyh-Chang; Kang, Ya'an; Fleming, Jason B.; Bardeesy, Nabeel; Asara, John M.; Haigis, Marcia C.; DePinho, Ronald A.; Cantley, Lewis C.; Kimmelman, Alec C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">496</span>
        (<span class="NLM_cas:issue">7443</span>),
    <span class="NLM_cas:pages">101-105</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Cancer cells have metabolic dependencies that distinguish them from their normal counterparts.  Among these dependencies is an increased use of the amino acid glutamine to fuel anabolic processes.  Indeed, the spectrum of glutamine-dependent tumors and the mechanisms whereby glutamine supports cancer metab. remain areas of active investigation.  Here we report the identification of a non-canonical pathway of glutamine use in human pancreatic ductal adenocarcinoma (PDAC) cells that is required for tumor growth.  Whereas most cells use glutamate dehydrogenase (GLUD1) to convert glutamine-derived glutamate into α-ketoglutarate in the mitochondria to fuel the tricarboxylic acid cycle, PDAC relies on a distinct pathway in which glutamine-derived aspartate is transported into the cytoplasm where it can be converted into oxaloacetate by aspartate transaminase (GOT1).  Subsequently, this oxaloacetate is converted into malate and then pyruvate, ostensibly increasing the NADPH/NADP+ ratio which can potentially maintain the cellular redox state.  Importantly, PDAC cells are strongly dependent on this series of reactions, as glutamine deprivation or genetic inhibition of any enzyme in this pathway leads to an increase in reactive oxygen species and a redn. in reduced glutathione.  Moreover, knockdown of any component enzyme in this series of reactions also results in a pronounced suppression of PDAC growth in vitro and in vivo.  Furthermore, we establish that the reprogramming of glutamine metab. is mediated by oncogenic KRAS, the signature genetic alteration in PDAC, through the transcriptional upregulation and repression of key metabolic enzymes in this pathway.  The essentiality of this pathway in PDAC and the fact that it is dispensable in normal cells may provide novel therapeutic approaches to treat these refractory tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzWAEWZvCWcbVg90H21EOLACvtfcHk0lgH6HwZeIhyEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXkvFyjsrc%253D&md5=162af18c1102745226aa2096179f1cc6</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnature12040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature12040%26sid%3Dliteratum%253Aachs%26aulast%3DSon%26aufirst%3DJ.%26aulast%3DLyssiotis%26aufirst%3DC.%2BA.%26aulast%3DYing%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DHua%26aufirst%3DS.%26aulast%3DLigorio%26aufirst%3DM.%26aulast%3DPerera%26aufirst%3DR.%2BM.%26aulast%3DFerrone%26aufirst%3DC.%2BR.%26aulast%3DMullarky%26aufirst%3DE.%26aulast%3DShyh-Chang%26aufirst%3DN.%26aulast%3DKang%26aufirst%3DY.%26aulast%3DFleming%26aufirst%3DJ.%2BB.%26aulast%3DBardeesy%26aufirst%3DN.%26aulast%3DAsara%26aufirst%3DJ.%2BM.%26aulast%3DHaigis%26aufirst%3DM.%2BC.%26aulast%3DDePinho%26aufirst%3DR.%2BA.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26aulast%3DKimmelman%26aufirst%3DA.%2BC.%26atitle%3DGlutamine%2520Supports%2520Pancreatic%2520Cancer%2520Growth%2520through%2520a%2520KRAS-Regulated%2520Metabolic%2520Pathway%26jtitle%3DNature%26date%3D2013%26volume%3D496%26spage%3D101%26epage%3D105%26doi%3D10.1038%2Fnature12040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Lee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ban, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naik, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Son, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Won, M.</span><span> </span><span class="NLM_article-title">Identification of Malate Dehydrogenase 2 as a Target Protein of the HIF-1 Inhibitor LW6 using Chemical Probes</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">10286</span><span class="NLM_x">–</span> <span class="NLM_lpage">10289</span><span class="refDoi"> DOI: 10.1002/anie.201304987</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=10.1002%2Fanie.201304987" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=10286-10289&author=K.+Leeauthor=H.+S.+Banauthor=R.+Naikauthor=Y.+S.+Hongauthor=S.+Sonauthor=B.+K.+Kimauthor=Y.+Xiaauthor=K.+B.+Songauthor=H.+S.+Leeauthor=M.+Won&title=Identification+of+Malate+Dehydrogenase+2+as+a+Target+Protein+of+the+HIF-1+Inhibitor+LW6+using+Chemical+Probes&doi=10.1002%2Fanie.201304987"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1002%2Fanie.201304987&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201304987%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DK.%26aulast%3DBan%26aufirst%3DH.%2BS.%26aulast%3DNaik%26aufirst%3DR.%26aulast%3DHong%26aufirst%3DY.%2BS.%26aulast%3DSon%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DB.%2BK.%26aulast%3DXia%26aufirst%3DY.%26aulast%3DSong%26aufirst%3DK.%2BB.%26aulast%3DLee%26aufirst%3DH.%2BS.%26aulast%3DWon%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520Malate%2520Dehydrogenase%25202%2520as%2520a%2520Target%2520Protein%2520of%2520the%2520HIF-1%2520Inhibitor%2520LW6%2520using%2520Chemical%2520Probes%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2013%26volume%3D52%26spage%3D10286%26epage%3D10289%26doi%3D10.1002%2Fanie.201304987" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Kim, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattarai, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwon, H. J.</span><span> </span><span class="NLM_article-title">HIF-1α suppressing small molecule, LW6, Inhibits Cancer Cell Growth by Binding to Calcineurin B Homologous Protein 1</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">458</span><span class="NLM_x">, </span> <span class="NLM_fpage">14</span><span class="NLM_x">–</span> <span class="NLM_lpage">20</span><span class="refDoi"> DOI: 10.1016/j.bbrc.2015.01.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=10.1016%2Fj.bbrc.2015.01.031" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=458&publication_year=2015&pages=14-20&author=B.+S.+Kimauthor=K.+Leeauthor=H.+J.+Jungauthor=D.+Bhattaraiauthor=H.+J.+Kwon&title=HIF-1%CE%B1+suppressing+small+molecule%2C+LW6%2C+Inhibits+Cancer+Cell+Growth+by+Binding+to+Calcineurin+B+Homologous+Protein+1&doi=10.1016%2Fj.bbrc.2015.01.031"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2015.01.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2015.01.031%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DB.%2BS.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DJung%26aufirst%3DH.%2BJ.%26aulast%3DBhattarai%26aufirst%3DD.%26aulast%3DKwon%26aufirst%3DH.%2BJ.%26atitle%3DHIF-1%25CE%25B1%2520suppressing%2520small%2520molecule%252C%2520LW6%252C%2520Inhibits%2520Cancer%2520Cell%2520Growth%2520by%2520Binding%2520to%2520Calcineurin%2520B%2520Homologous%2520Protein%25201%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2015%26volume%3D458%26spage%3D14%26epage%3D20%26doi%3D10.1016%2Fj.bbrc.2015.01.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Kourtidis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carkner, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eifert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brosnan, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conklin, D. S.</span><span> </span><span class="NLM_article-title">An RNA Interference Screen Identifies Metabolic Regulators NR1D1 and PBP as Novel Survival Factors for Breast Cancer Cells with the ERBB2 Signature</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">1783</span><span class="NLM_x">–</span> <span class="NLM_lpage">1792</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-09-1550</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=10.1158%2F0008-5472.CAN-09-1550" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=1783-1792&author=A.+Kourtidisauthor=R.+Jainauthor=R.+D.+Carknerauthor=C.+Eifertauthor=M.+J.+Brosnanauthor=D.+S.+Conklin&title=An+RNA+Interference+Screen+Identifies+Metabolic+Regulators+NR1D1+and+PBP+as+Novel+Survival+Factors+for+Breast+Cancer+Cells+with+the+ERBB2+Signature&doi=10.1158%2F0008-5472.CAN-09-1550"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-09-1550&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-09-1550%26sid%3Dliteratum%253Aachs%26aulast%3DKourtidis%26aufirst%3DA.%26aulast%3DJain%26aufirst%3DR.%26aulast%3DCarkner%26aufirst%3DR.%2BD.%26aulast%3DEifert%26aufirst%3DC.%26aulast%3DBrosnan%26aufirst%3DM.%2BJ.%26aulast%3DConklin%26aufirst%3DD.%2BS.%26atitle%3DAn%2520RNA%2520Interference%2520Screen%2520Identifies%2520Metabolic%2520Regulators%2520NR1D1%2520and%2520PBP%2520as%2520Novel%2520Survival%2520Factors%2520for%2520Breast%2520Cancer%2520Cells%2520with%2520the%2520ERBB2%2520Signature%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26spage%3D1783%26epage%3D1792%26doi%3D10.1158%2F0008-5472.CAN-09-1550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Lee, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youn, H. D.</span><span> </span><span class="NLM_article-title">A Nucleocytoplasmic Malate Dehydrogenase Regulates p53 Transcriptional Activity in Response to Metabolic Stress</span> <span class="citation_source-journal">Cell Death Differ.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">738</span><span class="NLM_x">–</span> <span class="NLM_lpage">748</span><span class="refDoi"> DOI: 10.1038/cdd.2009.5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=10.1038%2Fcdd.2009.5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=19229245" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=1%3ACAS%3A528%3ADC%252BD1MXks1ygs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=738-748&author=S.+M.+Leeauthor=J.+H.+Kimauthor=E.+J.+Choauthor=H.+D.+Youn&title=A+Nucleocytoplasmic+Malate+Dehydrogenase+Regulates+p53+Transcriptional+Activity+in+Response+to+Metabolic+Stress&doi=10.1038%2Fcdd.2009.5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">A nucleocytoplasmic malate dehydrogenase regulates p53 transcriptional activity in response to metabolic stress</span></div><div class="casAuthors">Lee, S. M.; Kim, J. H.; Cho, E. J.; Youn, H. D.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death and Differentiation</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">738-748</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Metabolic enzymes have been shown to function as transcriptional regulators.  P53, a tumor-suppressive transcription factor, was recently found to regulate energy metab.  These combined facts raise the possibility that metabolic enzymes may directly regulate p53 function.  Here, we discover that nucleocytoplasmic malate dehydrogenase-1 (MDH1) phys. assocs. with p53.  Upon glucose deprivation, MDH1 stabilizes and transactivates p53 by binding to p53-responsive elements in the promoter of downstream genes.  Knockdown of MDH1 significantly reduces binding of acetylated-p53 and transcription-active histone codes to the promoter upon glucose depletion.  MDH1 regulates p53-dependent cell-cycle arrest and apoptosis in response to glucose deprivation, suggesting that MDH1 functions as a transcriptional regulator for a p53-dependent metabolic checkpoint.  Our findings provide insight into how metab. is directly linked to gene expression for controlling cellular events in response to metabolic stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsnQbb5OnE4LVg90H21EOLACvtfcHk0lj8MUuXjR-rwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXks1ygs7w%253D&md5=cfa110fb5a8b57b3030f096c02551efe</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fcdd.2009.5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcdd.2009.5%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DS.%2BM.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DCho%26aufirst%3DE.%2BJ.%26aulast%3DYoun%26aufirst%3DH.%2BD.%26atitle%3DA%2520Nucleocytoplasmic%2520Malate%2520Dehydrogenase%2520Regulates%2520p53%2520Transcriptional%2520Activity%2520in%2520Response%2520to%2520Metabolic%2520Stress%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2009%26volume%3D16%26spage%3D738%26epage%3D748%26doi%3D10.1038%2Fcdd.2009.5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beer, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, D. Z.</span><span> </span><span class="NLM_article-title">Malate Dehydrogenase 2 Confers Docetaxel Resistance via Regulations of JNK Signaling and Oxidative Metabolism</span> <span class="citation_source-journal">Prostate</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">1028</span><span class="NLM_x">–</span> <span class="NLM_lpage">1037</span><span class="refDoi"> DOI: 10.1002/pros.22650</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=10.1002%2Fpros.22650" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2013&pages=1028-1037&author=Q.+Liuauthor=C.+T.+Harveyauthor=H.+Gengauthor=C.+Xueauthor=V.+Chenauthor=T.+M.+Beerauthor=D.+Z.+Qian&title=Malate+Dehydrogenase+2+Confers+Docetaxel+Resistance+via+Regulations+of+JNK+Signaling+and+Oxidative+Metabolism&doi=10.1002%2Fpros.22650"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1002%2Fpros.22650&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpros.22650%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DHarvey%26aufirst%3DC.%2BT.%26aulast%3DGeng%26aufirst%3DH.%26aulast%3DXue%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DV.%26aulast%3DBeer%26aufirst%3DT.%2BM.%26aulast%3DQian%26aufirst%3DD.%2BZ.%26atitle%3DMalate%2520Dehydrogenase%25202%2520Confers%2520Docetaxel%2520Resistance%2520via%2520Regulations%2520of%2520JNK%2520Signaling%2520and%2520Oxidative%2520Metabolism%26jtitle%3DProstate%26date%3D2013%26volume%3D73%26spage%3D1028%26epage%3D1037%26doi%3D10.1002%2Fpros.22650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Naik, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Won, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ban, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattarai, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span> </span><span class="NLM_article-title">Synthesis and Structure-Activity Relationship Study of Chemical Probes as Hypoxia-inducable Factor-1 alpha/Malate Dehydrogenase 2 Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">9522</span><span class="NLM_x">–</span> <span class="NLM_lpage">9538</span><span class="refDoi"> DOI: 10.1021/jm501241g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501241g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=9522-9538&author=R.+Naikauthor=M.+Wonauthor=H.+S.+Banauthor=D.+Bhattaraiauthor=X.+Xuauthor=Y.+Eoauthor=Y.+S.+Hongauthor=S.+Singhauthor=Y.+Choiauthor=H.+C.+Ahnauthor=K.+Lee&title=Synthesis+and+Structure-Activity+Relationship+Study+of+Chemical+Probes+as+Hypoxia-inducable+Factor-1+alpha%2FMalate+Dehydrogenase+2+Inhibitors&doi=10.1021%2Fjm501241g"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm501241g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501241g%26sid%3Dliteratum%253Aachs%26aulast%3DNaik%26aufirst%3DR.%26aulast%3DWon%26aufirst%3DM.%26aulast%3DBan%26aufirst%3DH.%2BS.%26aulast%3DBhattarai%26aufirst%3DD.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DEo%26aufirst%3DY.%26aulast%3DHong%26aufirst%3DY.%2BS.%26aulast%3DSingh%26aufirst%3DS.%26aulast%3DChoi%26aufirst%3DY.%26aulast%3DAhn%26aufirst%3DH.%2BC.%26aulast%3DLee%26aufirst%3DK.%26atitle%3DSynthesis%2520and%2520Structure-Activity%2520Relationship%2520Study%2520of%2520Chemical%2520Probes%2520as%2520Hypoxia-inducable%2520Factor-1%2520alpha%252FMalate%2520Dehydrogenase%25202%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D9522%26epage%3D9538%26doi%3D10.1021%2Fjm501241g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Xia, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span> </span><span class="NLM_article-title">Recent Advances in Hypoxia-Inducible Factor (HIF)-1 Inhibitors</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">24</span><span class="NLM_x">–</span> <span class="NLM_lpage">40</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2012.01.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=10.1016%2Fj.ejmech.2012.01.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=22305612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=1%3ACAS%3A528%3ADC%252BC38XisFOrs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2012&pages=24-40&author=Y.+Xiaauthor=H.+K.+Choiauthor=K.+Lee&title=Recent+Advances+in+Hypoxia-Inducible+Factor+%28HIF%29-1+Inhibitors&doi=10.1016%2Fj.ejmech.2012.01.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors</span></div><div class="casAuthors">Xia, Yan; Choi, Hyun-Kyung; Lee, Kyeong</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">24-40</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A review.  Tumor hypoxia has been recognized as a common feature of solid tumors and a neg. prognostic factor for response to treatment and survival of cancer patients.  The discovery of hypoxia-inducible factor-1 (HIF-1), a mol. determinant of responses to hypoxia in mammalian cells, has renewed enthusiasm for discovery and development of targeted therapies exploiting the hypoxic tumor microenvironment.  HIF-1 activity in tumors depends on availability of the HIF-1α subunit, the levels of which increase under hypoxic conditions and through activation of oncogenes and/or inactivation of tumor suppressor genes.  Increased HIF-1 has been correlated with increased angiogenesis, aggressive tumor growth, and poor patient prognosis, leading to current interest in HIF-1 as promising anticancer drug target.  In spite of an ever increasing no. of putative small mol. inhibitors of HIF-1, only a few are progressing through preclin. and early clin. development.  In this review, we will discuss recent advances in discovery and development of small mol. inhibitors that target the HIF-1 pathway as potential anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrV9MyS5Xicm7Vg90H21EOLACvtfcHk0livpyIvCO-g3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XisFOrs7w%253D&md5=04225108ab97c18845f7760ac4027185</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2012.01.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2012.01.033%26sid%3Dliteratum%253Aachs%26aulast%3DXia%26aufirst%3DY.%26aulast%3DChoi%26aufirst%3DH.%2BK.%26aulast%3DLee%26aufirst%3DK.%26atitle%3DRecent%2520Advances%2520in%2520Hypoxia-Inducible%2520Factor%2520%2528HIF%2529-1%2520Inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D49%26spage%3D24%26epage%3D40%26doi%3D10.1016%2Fj.ejmech.2012.01.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Harris, A. L.</span><span> </span><span class="NLM_article-title">Hypoxia - A Key Regulatory Factor in Tumor Growth</span> <span class="citation_source-journal">Nature Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">38</span><span class="NLM_x">–</span> <span class="NLM_lpage">47</span><span class="refDoi"> DOI: 10.1038/nrc704</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=10.1038%2Fnrc704" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=11902584" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=1%3ACAS%3A528%3ADC%252BD38XhvF2jtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=38-47&author=A.+L.+Harris&title=Hypoxia+-+A+Key+Regulatory+Factor+in+Tumor+Growth&doi=10.1038%2Fnrc704"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Hypoxia - a key regulatory factor in tumor growth</span></div><div class="casAuthors">Harris, Adrian L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">38-47</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Cells undergo a variety of biol. responses when placed in hypoxic conditions, including activation of signaling pathways that regulate proliferation, angiogenesis and death.  Cancer cells have adapted these pathways, allowing tumors to survive and even grow under hypoxic conditions, and tumor hypoxia is assocd. with poor prognosis and resistance to radiation therapy.  Many elements of the hypoxia-response pathway are therefore good candidates for therapeutic targeting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoO3m4smDSP37Vg90H21EOLACvtfcHk0livpyIvCO-g3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhvF2jtL4%253D&md5=e3f65ce80422e4743d49905e1796fe5c</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnrc704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc704%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DA.%2BL.%26atitle%3DHypoxia%2520-%2520A%2520Key%2520Regulatory%2520Factor%2520in%2520Tumor%2520Growth%26jtitle%3DNature%2520Rev.%2520Cancer%26date%3D2002%26volume%3D2%26spage%3D38%26epage%3D47%26doi%3D10.1038%2Fnrc704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Semenza, G. L.</span><span> </span><span class="NLM_article-title">HIF-1: Upstream and Downstream of Cancer Metabolism</span> <span class="citation_source-journal">Curr. Opin. Genet. Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">51</span><span class="NLM_x">–</span> <span class="NLM_lpage">56</span><span class="refDoi"> DOI: 10.1016/j.gde.2009.10.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=10.1016%2Fj.gde.2009.10.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=19942427" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhslWktr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=51-56&author=G.+L.+Semenza&title=HIF-1%3A+Upstream+and+Downstream+of+Cancer+Metabolism&doi=10.1016%2Fj.gde.2009.10.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">HIF-1: upstream and downstream of cancer metabolism</span></div><div class="casAuthors">Semenza, Gregg L.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Genetics & Development</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">51-56</span>CODEN:
                <span class="NLM_cas:coden">COGDET</span>;
        ISSN:<span class="NLM_cas:issn">0959-437X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Hypoxia-inducible factor 1 (HIF-1) plays a key role in the reprogramming of cancer metab. by activating transcription of genes encoding glucose transporters and glycolytic enzymes, which take up glucose and convert it to lactate; pyruvate dehydrogenase kinase 1, which shunts pyruvate away from the mitochondria; and BNIP3, which triggers selective mitochondrial autophagy.  The shift from oxidative to glycolytic metab. allows maintenance of redox homeostasis and cell survival under conditions of prolonged hypoxia.  Many metabolic abnormalities in cancer cells increase HIF-1 activity.  As a result, a feed-forward mechanism can be activated that drives HIF-1 activation and may promote tumor progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxecD_Xx5HALVg90H21EOLACvtfcHk0liV0P8iUJhuig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhslWktr0%253D&md5=e4ef52f0c940a7c48cf26f09758d0303</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.gde.2009.10.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.gde.2009.10.009%26sid%3Dliteratum%253Aachs%26aulast%3DSemenza%26aufirst%3DG.%2BL.%26atitle%3DHIF-1%253A%2520Upstream%2520and%2520Downstream%2520of%2520Cancer%2520Metabolism%26jtitle%3DCurr.%2520Opin.%2520Genet.%2520Dev.%26date%3D2010%26volume%3D20%26spage%3D51%26epage%3D56%26doi%3D10.1016%2Fj.gde.2009.10.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Won, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Im, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boovanahalli, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwon, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span> </span><span class="NLM_article-title">A Novel Benzimidazole Analogue Inhibits the Hypoxia-Inducible Factor (HIF)-1 Pathway</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">385</span><span class="NLM_x">, </span> <span class="NLM_fpage">16</span><span class="NLM_x">–</span> <span class="NLM_lpage">21</span><span class="refDoi"> DOI: 10.1016/j.bbrc.2009.05.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=10.1016%2Fj.bbrc.2009.05.022" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=385&publication_year=2009&pages=16-21&author=M.+S.+Wonauthor=N.+Imauthor=S.+Parkauthor=S.+K.+Boovanahalliauthor=Y.+Jinauthor=X.+Jinauthor=K.+S.+Chungauthor=M.+Kangauthor=K.+Leeauthor=S.+K.+Parkauthor=H.+M.+Kimauthor=B.+M.+Kwonauthor=J.+J.+Leeauthor=K.+Lee&title=A+Novel+Benzimidazole+Analogue+Inhibits+the+Hypoxia-Inducible+Factor+%28HIF%29-1+Pathway&doi=10.1016%2Fj.bbrc.2009.05.022"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2009.05.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2009.05.022%26sid%3Dliteratum%253Aachs%26aulast%3DWon%26aufirst%3DM.%2BS.%26aulast%3DIm%26aufirst%3DN.%26aulast%3DPark%26aufirst%3DS.%26aulast%3DBoovanahalli%26aufirst%3DS.%2BK.%26aulast%3DJin%26aufirst%3DY.%26aulast%3DJin%26aufirst%3DX.%26aulast%3DChung%26aufirst%3DK.%2BS.%26aulast%3DKang%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DPark%26aufirst%3DS.%2BK.%26aulast%3DKim%26aufirst%3DH.%2BM.%26aulast%3DKwon%26aufirst%3DB.%2BM.%26aulast%3DLee%26aufirst%3DJ.%2BJ.%26aulast%3DLee%26aufirst%3DK.%26atitle%3DA%2520Novel%2520Benzimidazole%2520Analogue%2520Inhibits%2520the%2520Hypoxia-Inducible%2520Factor%2520%2528HIF%2529-1%2520Pathway%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2009%26volume%3D385%26spage%3D16%26epage%3D21%26doi%3D10.1016%2Fj.bbrc.2009.05.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Rapisarda, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uranchimeg, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scudiero, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selby, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sausville, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoemaker, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melillo, G.</span><span> </span><span class="NLM_article-title">Identification of Small Molecule Inhibitors of Hypoxia-Inducible Factor 1 Transcriptional Activation Pathway</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">4316</span><span class="NLM_x">–</span> <span class="NLM_lpage">4324</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2002&pages=4316-4324&author=A.+Rapisardaauthor=B.+Uranchimegauthor=D.+A.+Scudieroauthor=M.+Selbyauthor=E.+A.+Sausvilleauthor=R.+H.+Shoemakerauthor=G.+Melillo&title=Identification+of+Small+Molecule+Inhibitors+of+Hypoxia-Inducible+Factor+1+Transcriptional+Activation+Pathway"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRapisarda%26aufirst%3DA.%26aulast%3DUranchimeg%26aufirst%3DB.%26aulast%3DScudiero%26aufirst%3DD.%2BA.%26aulast%3DSelby%26aufirst%3DM.%26aulast%3DSausville%26aufirst%3DE.%2BA.%26aulast%3DShoemaker%26aufirst%3DR.%2BH.%26aulast%3DMelillo%26aufirst%3DG.%26atitle%3DIdentification%2520of%2520Small%2520Molecule%2520Inhibitors%2520of%2520Hypoxia-Inducible%2520Factor%25201%2520Transcriptional%2520Activation%2520Pathway%26jtitle%3DCancer%2520Res.%26date%3D2002%26volume%3D62%26spage%3D4316%26epage%3D4324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Giaccia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siim, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, R. S.</span><span> </span><span class="NLM_article-title">HIF-1 as a Target for Drug Development</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">803</span><span class="NLM_x">–</span> <span class="NLM_lpage">811</span><span class="refDoi"> DOI: 10.1038/nrd1199</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=10.1038%2Fnrd1199" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=14526383" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnslarsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=803-811&author=A.+Giacciaauthor=B.+G.+Siimauthor=R.+S.+Johnson&title=HIF-1+as+a+Target+for+Drug+Development&doi=10.1038%2Fnrd1199"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">HIF-1 as a target for drug development</span></div><div class="casAuthors">Giaccia, Amato; Siim, Bronwyn G.; Johnson, Randall S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">803-811</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Sensing and responding to fluxes in oxygen tension is perhaps the single most important variable in physiol., and animal tissues have developed a no. of essential mechanisms to cope with the stress of low physiol. oxygen levels, or hypoxia.  Among these coping mechanisms is the response mediated by the hypoxia-inducible transcription factor, or HIF-1.  HIF-1 is an essential component in changing the transcriptional repertoire of tissues as oxygen levels drop, and could prove to be a very important target for drug development, as treatments evolve for diseases, such as cancer, heart disease and stroke, in which hypoxia is a central aspect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGZK-i6A6JQrVg90H21EOLACvtfcHk0li3mUamNErViw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnslarsbw%253D&md5=f7cb7b615106f4716a2293dbfe873ea1</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fnrd1199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1199%26sid%3Dliteratum%253Aachs%26aulast%3DGiaccia%26aufirst%3DA.%26aulast%3DSiim%26aufirst%3DB.%2BG.%26aulast%3DJohnson%26aufirst%3DR.%2BS.%26atitle%3DHIF-1%2520as%2520a%2520Target%2520for%2520Drug%2520Development%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2003%26volume%3D2%26spage%3D803%26epage%3D811%26doi%3D10.1038%2Fnrd1199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Shimizu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruyama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasui, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minegishi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ban, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, H.</span><span> </span><span class="NLM_article-title">Boron-Containing Phenoxyacetanilide Derivatives as Hypoxia-Inducible Factor (HIF)-1alpha Inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1453</span><span class="NLM_x">–</span> <span class="NLM_lpage">1456</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2009.12.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=10.1016%2Fj.bmcl.2009.12.037" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1453-1456&author=K.+Shimizuauthor=M.+Maruyamaauthor=Y.+Yasuiauthor=H.+Minegishiauthor=H.+S.+Banauthor=H.+Nakamura&title=Boron-Containing+Phenoxyacetanilide+Derivatives+as+Hypoxia-Inducible+Factor+%28HIF%29-1alpha+Inhibitors&doi=10.1016%2Fj.bmcl.2009.12.037"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.12.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.12.037%26sid%3Dliteratum%253Aachs%26aulast%3DShimizu%26aufirst%3DK.%26aulast%3DMaruyama%26aufirst%3DM.%26aulast%3DYasui%26aufirst%3DY.%26aulast%3DMinegishi%26aufirst%3DH.%26aulast%3DBan%26aufirst%3DH.%2BS.%26aulast%3DNakamura%26aufirst%3DH.%26atitle%3DBoron-Containing%2520Phenoxyacetanilide%2520Derivatives%2520as%2520Hypoxia-Inducible%2520Factor%2520%2528HIF%2529-1alpha%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D1453%26epage%3D1456%26doi%3D10.1016%2Fj.bmcl.2009.12.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Lee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boovanahalli, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. J.</span><span> </span><span class="NLM_article-title">Aryloxyacetylamino)benzoic Acid Analogues: a New Class of Hypoxia-Inducible Factor-1 Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1675</span><span class="NLM_x">–</span> <span class="NLM_lpage">1684</span><span class="refDoi"> DOI: 10.1021/jm0610292</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0610292" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=1675-1684&author=K.+Leeauthor=J.+H.+Leeauthor=S.+K.+Boovanahalliauthor=Y.+Jinauthor=M.+Leeauthor=X.+Jinauthor=J.+H.+Kimauthor=Y.+S.+Hongauthor=J.+J.+Lee&title=Aryloxyacetylamino%29benzoic+Acid+Analogues%3A+a+New+Class+of+Hypoxia-Inducible+Factor-1+Inhibitors&doi=10.1021%2Fjm0610292"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm0610292&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0610292%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DBoovanahalli%26aufirst%3DS.%2BK.%26aulast%3DJin%26aufirst%3DY.%26aulast%3DLee%26aufirst%3DM.%26aulast%3DJin%26aufirst%3DX.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DHong%26aufirst%3DY.%2BS.%26aulast%3DLee%26aufirst%3DJ.%2BJ.%26atitle%3DAryloxyacetylamino%2529benzoic%2520Acid%2520Analogues%253A%2520a%2520New%2520Class%2520of%2520Hypoxia-Inducible%2520Factor-1%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D1675%26epage%3D1684%26doi%3D10.1021%2Fjm0610292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Boovanahalli, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dat, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. J.</span><span> </span><span class="NLM_article-title">Synthesis of (Aryloxyacetylamino)-Isonicotinic/Nicotinic Acid Analogues as Potent Hypoxia-inducible Factor (HIF)-1alpha Inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">6305</span><span class="NLM_x">–</span> <span class="NLM_lpage">6310</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2007.09.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=10.1016%2Fj.bmcl.2007.09.005" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=6305-6310&author=S.+K.+Boovanahalliauthor=X.+Jinauthor=Y.+Jinauthor=J.+H.+Kimauthor=N.+T.+Datauthor=Y.+S.+Hongauthor=J.+H.+Leeauthor=S.+H.+Jungauthor=K.+Leeauthor=J.+J.+Lee&title=Synthesis+of+%28Aryloxyacetylamino%29-Isonicotinic%2FNicotinic+Acid+Analogues+as+Potent+Hypoxia-inducible+Factor+%28HIF%29-1alpha+Inhibitors&doi=10.1016%2Fj.bmcl.2007.09.005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.09.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.09.005%26sid%3Dliteratum%253Aachs%26aulast%3DBoovanahalli%26aufirst%3DS.%2BK.%26aulast%3DJin%26aufirst%3DX.%26aulast%3DJin%26aufirst%3DY.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DDat%26aufirst%3DN.%2BT.%26aulast%3DHong%26aufirst%3DY.%2BS.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DJung%26aufirst%3DS.%2BH.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DJ.%2BJ.%26atitle%3DSynthesis%2520of%2520%2528Aryloxyacetylamino%2529-Isonicotinic%252FNicotinic%2520Acid%2520Analogues%2520as%2520Potent%2520Hypoxia-inducible%2520Factor%2520%2528HIF%2529-1alpha%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D6305%26epage%3D6310%26doi%3D10.1016%2Fj.bmcl.2007.09.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Kaur, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dat, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gajulapati, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span> </span><span class="NLM_article-title">The First Total Synthesis of Moracin O and Moracin P, and Establishment of the Absolute Configuration of Moracin O</span> <span class="citation_source-journal">Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1879</span><span class="NLM_x">–</span> <span class="NLM_lpage">1881</span><span class="refDoi"> DOI: 10.1039/b823340c</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=10.1039%2Fb823340c" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=1879-1881&author=N.+Kaurauthor=Y.+Xiaauthor=Y.+Jinauthor=N.+T.+Datauthor=K.+Gajulapatiauthor=Y.+Choiauthor=Y.+S.+Hongauthor=J.+J.+Leeauthor=K.+Lee&title=The+First+Total+Synthesis+of+Moracin+O+and+Moracin+P%2C+and+Establishment+of+the+Absolute+Configuration+of+Moracin+O&doi=10.1039%2Fb823340c"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1039%2Fb823340c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb823340c%26sid%3Dliteratum%253Aachs%26aulast%3DKaur%26aufirst%3DN.%26aulast%3DXia%26aufirst%3DY.%26aulast%3DJin%26aufirst%3DY.%26aulast%3DDat%26aufirst%3DN.%2BT.%26aulast%3DGajulapati%26aufirst%3DK.%26aulast%3DChoi%26aufirst%3DY.%26aulast%3DHong%26aufirst%3DY.%2BS.%26aulast%3DLee%26aufirst%3DJ.%2BJ.%26aulast%3DLee%26aufirst%3DK.%26atitle%3DThe%2520First%2520Total%2520Synthesis%2520of%2520Moracin%2520O%2520and%2520Moracin%2520P%252C%2520and%2520Establishment%2520of%2520the%2520Absolute%2520Configuration%2520of%2520Moracin%2520O%26jtitle%3DChem.%2520Commun.%26date%3D2009%26volume%3D14%26spage%3D1879%26epage%3D1881%26doi%3D10.1039%2Fb823340c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Xia, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaur, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span> </span><span class="NLM_article-title">HIF-1a Inhibitors: Synthesis and Biological Evaluation of Novel Moracin O and P Analogues</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">2386</span><span class="NLM_x">–</span> <span class="NLM_lpage">2396</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2011.03.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=10.1016%2Fj.ejmech.2011.03.022" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=2386-2396&author=Y.+Xiaauthor=Y.+Jinauthor=N.+Kaurauthor=Y.+Choiauthor=K.+Lee&title=HIF-1a+Inhibitors%3A+Synthesis+and+Biological+Evaluation+of+Novel+Moracin+O+and+P+Analogues&doi=10.1016%2Fj.ejmech.2011.03.022"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2011.03.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2011.03.022%26sid%3Dliteratum%253Aachs%26aulast%3DXia%26aufirst%3DY.%26aulast%3DJin%26aufirst%3DY.%26aulast%3DKaur%26aufirst%3DN.%26aulast%3DChoi%26aufirst%3DY.%26aulast%3DLee%26aufirst%3DK.%26atitle%3DHIF-1a%2520Inhibitors%253A%2520Synthesis%2520and%2520Biological%2520Evaluation%2520of%2520Novel%2520Moracin%2520O%2520and%2520P%2520Analogues%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2011%26volume%3D46%26spage%3D2386%26epage%3D2396%26doi%3D10.1016%2Fj.ejmech.2011.03.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Naik, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Won, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span> </span><span class="NLM_article-title">Synthesis and Structure–Activity Relationship of (<i>E</i>)-Phenoxyacrylic Amide Derivatives as Hypoxia-Inducible Factor (HIF) 1α Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">10564</span><span class="NLM_x">–</span> <span class="NLM_lpage">10571</span><span class="refDoi"> DOI: 10.1021/jm301419d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301419d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=10564-10571&author=R.+Naikauthor=M.+Wonauthor=B.+K.+Kimauthor=Y.+Xiaauthor=H.+K.+Choiauthor=G.+Jinauthor=Y.+Jungauthor=H.+M.+Kimauthor=K.+Lee&title=Synthesis+and+Structure%E2%80%93Activity+Relationship+of+%28E%29-Phenoxyacrylic+Amide+Derivatives+as+Hypoxia-Inducible+Factor+%28HIF%29+1%CE%B1+Inhibitors&doi=10.1021%2Fjm301419d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm301419d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301419d%26sid%3Dliteratum%253Aachs%26aulast%3DNaik%26aufirst%3DR.%26aulast%3DWon%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DB.%2BK.%26aulast%3DXia%26aufirst%3DY.%26aulast%3DChoi%26aufirst%3DH.%2BK.%26aulast%3DJin%26aufirst%3DG.%26aulast%3DJung%26aufirst%3DY.%26aulast%3DKim%26aufirst%3DH.%2BM.%26aulast%3DLee%26aufirst%3DK.%26atitle%3DSynthesis%2520and%2520Structure%25E2%2580%2593Activity%2520Relationship%2520of%2520%2528E%2529-Phenoxyacrylic%2520Amide%2520Derivatives%2520as%2520Hypoxia-Inducible%2520Factor%2520%2528HIF%2529%25201%25CE%25B1%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D10564%26epage%3D10571%26doi%3D10.1021%2Fjm301419d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Lee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Won, M.</span><span> </span><span class="NLM_article-title">LW6, a Novel HIF-1 Inhibitor, Promotes Proteasomal Degradation of HIF-1alpha via Upregulation of VHL in a Colon Cancer Cell Line</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">982</span><span class="NLM_x">–</span> <span class="NLM_lpage">989</span><span class="refDoi"> DOI: 10.1016/j.bcp.2010.06.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=10.1016%2Fj.bcp.2010.06.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=20599784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVeku7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2010&pages=982-989&author=K.+Leeauthor=J.+E.+Kangauthor=S.+K.+Parkauthor=Y.+Jinauthor=K.+S.+Chungauthor=H.+M.+Kimauthor=K.+Leeauthor=M.+R.+Kangauthor=M.+K.+Leeauthor=K.+B.+Songauthor=E.+G.+Yangauthor=J.+J.+Leeauthor=M.+Won&title=LW6%2C+a+Novel+HIF-1+Inhibitor%2C+Promotes+Proteasomal+Degradation+of+HIF-1alpha+via+Upregulation+of+VHL+in+a+Colon+Cancer+Cell+Line&doi=10.1016%2Fj.bcp.2010.06.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">LW6, a novel HIF-1 inhibitor, promotes proteasomal degradation of HIF-1α via upregulation of VHL in a colon cancer cell line</span></div><div class="casAuthors">Lee, Kyeong; Kang, Jung-Eun; Park, Song-Kyu; Jin, Ying-Lan; Chung, Kyung-Sook; Kim, Hwan-Mook; Lee, Ki-Ho; Kang, Moo-Rim; Lee, Myung-Kyu; Song, Kyung-Bin; Yang, Eun-Gyeong; Lee, Jung-Jun; Won, Mi-Sun</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">982-989</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Hypoxia-inducible factor HIF-1 is responsible for radiation resistance and poor prognosis in cancer therapy.  As part of our drug discovery program, a novel HIF inhibitor, LW6, was identified as a small compd. that inhibits the accumulation of HIF-1α.  We found that LW6 decreased HIF-1α protein expression without affecting HIF-1β expression.  MG132, a proteasome inhibitor, protected HIF-1α from LW6-induced proteasomal degrdn., indicating that LW6 affects the stability of the HIF-1α protein.  We found that LW6 promoted the degrdn. of wild type HIF-1α, but not of a DM-HIF-1α with modifications of P402A and P564A, at hydroxylation sites in the oxygen-dependent degrdn. domain (ODDD).  LW6 did not affect the activity of prolyl hydroxylase (PHD), but induced the expression of von Hippel-Lindau (VHL), which interacts with prolyl-hydroxylated HIF-1α for proteasomal degrdn.  In the presence of LW6, knockdown of VHL did not abolish HIF-1α protein accumulation, indicating that LW6 degraded HIF-1α via regulation of VHL expression.  In mice carrying xenografts of human colon cancer HCT116 cells, LW6 demonstrated strong antitumor efficacy in vivo and caused a decrease in HIF-1α expression in frozen-tissue immunohistochem. staining.  These data suggest that LW6 may be valuable in the development of a HIF-1α inhibitor for cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3Ksyrt_nbn7Vg90H21EOLACvtfcHk0lisQAgMkNK5qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVeku7fK&md5=4d6b427c3fc3e7d106fc9f7200802e9d</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2010.06.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2010.06.018%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DK.%26aulast%3DKang%26aufirst%3DJ.%2BE.%26aulast%3DPark%26aufirst%3DS.%2BK.%26aulast%3DJin%26aufirst%3DY.%26aulast%3DChung%26aufirst%3DK.%2BS.%26aulast%3DKim%26aufirst%3DH.%2BM.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DKang%26aufirst%3DM.%2BR.%26aulast%3DLee%26aufirst%3DM.%2BK.%26aulast%3DSong%26aufirst%3DK.%2BB.%26aulast%3DYang%26aufirst%3DE.%2BG.%26aulast%3DLee%26aufirst%3DJ.%2BJ.%26aulast%3DWon%26aufirst%3DM.%26atitle%3DLW6%252C%2520a%2520Novel%2520HIF-1%2520Inhibitor%252C%2520Promotes%2520Proteasomal%2520Degradation%2520of%2520HIF-1alpha%2520via%2520Upregulation%2520of%2520VHL%2520in%2520a%2520Colon%2520Cancer%2520Cell%2520Line%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2010%26volume%3D80%26spage%3D982%26epage%3D989%26doi%3D10.1016%2Fj.bcp.2010.06.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Semenza, G. L.</span><span> </span><span class="NLM_article-title">Targeting HIF-1 for Cancer Therapy</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">721</span><span class="NLM_x">–</span> <span class="NLM_lpage">732</span><span class="refDoi"> DOI: 10.1038/nrc1187</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=10.1038%2Fnrc1187" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=13130303" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=1%3ACAS%3A528%3ADC%252BD3sXotFCiu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=721-732&author=G.+L.+Semenza&title=Targeting+HIF-1+for+Cancer+Therapy&doi=10.1038%2Fnrc1187"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting HIF-1 for cancer therapy</span></div><div class="casAuthors">Semenza, Gregg L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">721-732</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Hypoxia-inducible factor 1 (HIF-1) activates the transcription of genes that are involved in crucial aspects of cancer biol., including angiogenesis, cell survival, glucose metab. and invasion.  Intratumoral hypoxia and genetic alterations can lead to HIF-1α overexpression, which has been assocd. with increased patient mortality in several cancer types.  In preclin. studies, inhibition of HIF-1 activity has marked effects on tumor growth.  Efforts are underway to identify inhibitors of HIF-1 and to test their efficacy as anticancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9RRo9WvLxN7Vg90H21EOLACvtfcHk0lgoFHazdXwXsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXotFCiu70%253D&md5=099f0fe5908dc1aae0c177a8aa530047</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Fnrc1187&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1187%26sid%3Dliteratum%253Aachs%26aulast%3DSemenza%26aufirst%3DG.%2BL.%26atitle%3DTargeting%2520HIF-1%2520for%2520Cancer%2520Therapy%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2003%26volume%3D3%26spage%3D721%26epage%3D732%26doi%3D10.1038%2Fnrc1187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Lee, K.; Won, M.; Kim, H. M.; Park, S. K.; Lee, K. H.; Lee, C. W.; Kim, B. K.; Ban, H. S.; Chung, K. S.; Naik, R.</span><span> </span><span class="NLM_article-title">Preparation of Adamantly Heterocyclic Compounds as HIF-1α Inhibitors for Treatment of Cancer</span>, Diabeticretinopathy, and Rheumatoid Arthritis Patent WO2013048164A1,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=K.+Lee&author=M.+Won&author=H.+M.+Kim&author=S.+K.+Park&author=K.+H.+Lee&author=C.+W.+Lee&author=B.+K.+Kim&author=H.+S.+Ban&author=K.+S.+Chung&author=R.+Naik&title=Preparation+of+Adamantly+Heterocyclic+Compounds+as+HIF-1%CE%B1+Inhibitors+for+Treatment+of+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DK.%26atitle%3DPreparation%2520of%2520Adamantly%2520Heterocyclic%2520Compounds%2520as%2520HIF-1%25CE%25B1%2520Inhibitors%2520for%2520Treatment%2520of%2520Cancer%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Ban, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naik, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Won, M.</span><span> </span><span class="NLM_article-title">Identification of Targets of the HIF-1 Inhibitor IDF-11774 Using Alkyne-Conjugated Photoaffinity Probes</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">1911</span><span class="NLM_x">–</span> <span class="NLM_lpage">1920</span><span class="refDoi"> DOI: 10.1021/acs.bioconjchem.6b00305</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.bioconjchem.6b00305" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFaisL7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2016&pages=1911-1920&author=H.+S.+Banauthor=R.+Naikauthor=H.+M.+Kimauthor=B.+K.+Kimauthor=H.+Leeauthor=I.+Kimauthor=H.+Ahnauthor=Y.+Jangauthor=K.+Jangauthor=Y.+Eoauthor=K.+B.+Songauthor=K.+Leeauthor=M.+Won&title=Identification+of+Targets+of+the+HIF-1+Inhibitor+IDF-11774+Using+Alkyne-Conjugated+Photoaffinity+Probes&doi=10.1021%2Facs.bioconjchem.6b00305"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Targets of the HIF-1 Inhibitor IDF-11774 Using Alkyne-Conjugated Photoaffinity Probes</span></div><div class="casAuthors">Ban, Hyun Seung; Naik, Ravi; Kim, Hwan Mook; Kim, Bo-Kyung; Lee, Hongsub; Kim, Inhyub; Ahn, Heechul; Jang, Yerin; Jang, Kyusik; Eo, Yumi; Song, Kyung Bin; Lee, Kyeong; Won, Misun</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1911-1920</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We developed a hypoxia-inducible factor-1 (HIF-1) inhibitor, IDF-11774, as a clin. candidate for cancer therapy.  To understand the mechanism of action of IDF-11774, we attempted to isolate target proteins of IDF-11774 using bioconjugated probes.  Multifunctional chem. probes contg. sites for click conjugation and photoaffinity labeling were designed and synthesized.  After fluorescence and photoaffinity labeling of proteins, two-dimensional electrophoresis (2DE) was performed to isolate specific mol. targets of IDF-11774.  Heat shock protein (HSP) 70 was identified as a target protein of IDF-11774.  We revealed that IDF-11774 inhibited HSP70 chaperone activity by binding to its allosteric pocket, rather than the ATP-binding site in its nucleotide-binding domain (NBD).  Moreover, IDF-11774 reduced the oxygen consumption rate (OCR) and ATP prodn., thereby increasing intracellular oxygen tension.  This result suggests that the inhibition of HSP70 chaperone activity by IDF-11774 suppresses HIF-1α refolding and stimulates HIF-1α degrdn.  Taken together, these findings indicate that IDF-11774-derived chem. probes successfully identified IDF-11774's target mol., HSP70, and elucidated the mode of action of IDF-11774 in inhibiting HSP70 chaperone activity and stimulating HIF-1α degrdn. in cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVWcAtICkwsrVg90H21EOLACvtfcHk0lgm4fQzPZfmCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFaisL7F&md5=f7620ba08d26831d0662f282570ab6ff</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Facs.bioconjchem.6b00305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.bioconjchem.6b00305%26sid%3Dliteratum%253Aachs%26aulast%3DBan%26aufirst%3DH.%2BS.%26aulast%3DNaik%26aufirst%3DR.%26aulast%3DKim%26aufirst%3DH.%2BM.%26aulast%3DKim%26aufirst%3DB.%2BK.%26aulast%3DLee%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DI.%26aulast%3DAhn%26aufirst%3DH.%26aulast%3DJang%26aufirst%3DY.%26aulast%3DJang%26aufirst%3DK.%26aulast%3DEo%26aufirst%3DY.%26aulast%3DSong%26aufirst%3DK.%2BB.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DWon%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520Targets%2520of%2520the%2520HIF-1%2520Inhibitor%2520IDF-11774%2520Using%2520Alkyne-Conjugated%2520Photoaffinity%2520Probes%26jtitle%3DBioconjugate%2520Chem.%26date%3D2016%26volume%3D27%26spage%3D1911%26epage%3D1920%26doi%3D10.1021%2Facs.bioconjchem.6b00305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Tehrani, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emami, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asadi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saeedi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirzahekmati, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebrahimi, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahdavi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nadri, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moradi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moghadam, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farzipour, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vosooghi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foroumadi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shafiee, A.</span><span> </span><span class="NLM_article-title">Imidazo[2,1-b]thiazole Derivatives as New Inhibitors of 15-Lipoxygenase</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">759</span><span class="NLM_x">–</span> <span class="NLM_lpage">764</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2014.10.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=10.1016%2Fj.ejmech.2014.10.011" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2014&pages=759-764&author=M.+B.+Tehraniauthor=S.+Emamiauthor=M.+Asadiauthor=M.+Saeediauthor=M.+Mirzahekmatiauthor=S.+M.+Ebrahimiauthor=M.+Mahdaviauthor=H.+Nadriauthor=A.+Moradiauthor=F.+H.+Moghadamauthor=S.+Farzipourauthor=M.+Vosooghiauthor=A.+Foroumadiauthor=A.+Shafiee&title=Imidazo%5B2%2C1-b%5Dthiazole+Derivatives+as+New+Inhibitors+of+15-Lipoxygenase&doi=10.1016%2Fj.ejmech.2014.10.011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.10.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.10.011%26sid%3Dliteratum%253Aachs%26aulast%3DTehrani%26aufirst%3DM.%2BB.%26aulast%3DEmami%26aufirst%3DS.%26aulast%3DAsadi%26aufirst%3DM.%26aulast%3DSaeedi%26aufirst%3DM.%26aulast%3DMirzahekmati%26aufirst%3DM.%26aulast%3DEbrahimi%26aufirst%3DS.%2BM.%26aulast%3DMahdavi%26aufirst%3DM.%26aulast%3DNadri%26aufirst%3DH.%26aulast%3DMoradi%26aufirst%3DA.%26aulast%3DMoghadam%26aufirst%3DF.%2BH.%26aulast%3DFarzipour%26aufirst%3DS.%26aulast%3DVosooghi%26aufirst%3DM.%26aulast%3DForoumadi%26aufirst%3DA.%26aulast%3DShafiee%26aufirst%3DA.%26atitle%3DImidazo%255B2%252C1-b%255Dthiazole%2520Derivatives%2520as%2520New%2520Inhibitors%2520of%252015-Lipoxygenase%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D87%26spage%3D759%26epage%3D764%26doi%3D10.1016%2Fj.ejmech.2014.10.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Yoon, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, Y. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sung, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeon, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, W. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, T. W.</span><span> </span><span class="NLM_article-title">A Novel Synthetic Analog of Militarin, MA-1 Induces Mitochondrial Dependent Apoptosis by ROS Generation in Human Lung Cancer Cells</span> <span class="citation_source-journal">Toxicol. Appl. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">273</span><span class="NLM_x">, </span> <span class="NLM_fpage">659</span><span class="NLM_x">–</span> <span class="NLM_lpage">671</span><span class="refDoi"> DOI: 10.1016/j.taap.2013.10.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=10.1016%2Fj.taap.2013.10.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=24161344" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslyqurfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=2013&pages=659-671&author=D.+H.+Yoonauthor=M.+H.+Limauthor=Y.+R.+Leeauthor=G.+H.+Sungauthor=T.+H.+Leeauthor=B.+H.+Jeonauthor=J.+Y.+Choauthor=W.+O.+Songauthor=H.+Parkauthor=S.+Choiauthor=T.+W.+Kim&title=A+Novel+Synthetic+Analog+of+Militarin%2C+MA-1+Induces+Mitochondrial+Dependent+Apoptosis+by+ROS+Generation+in+Human+Lung+Cancer+Cells&doi=10.1016%2Fj.taap.2013.10.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">A novel synthetic analog of militarin, MA-1 induces mitochondrial dependent apoptosis by ROS generation in human lung cancer cells</span></div><div class="casAuthors">Yoon, Deok Hyo; Lim, Mi-Hee; Lee, Yu Ran; Sung, Gi-Ho; Lee, Tae-Ho; Jeon, Byeong Hwa; Cho, Jae Youl; Song, Won O.; Park, Haeil; Choi, Sunga; Kim, Tae Woong</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology and Applied Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">273</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">659-671</span>CODEN:
                <span class="NLM_cas:coden">TXAPA9</span>;
        ISSN:<span class="NLM_cas:issn">0041-008X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A synthetic Militarin analog-1[(2R,3R,4R,5R)-1,6-bis(4-(2,4,4-trimethylpentan-2-yl)phenoxy) hexane-2,3,4,5-tetraol] is a novel deriv. of constituents from Cordyceps militaris, which has been used to treat a variety of chronic diseases including inflammation, diabetes, hyperglycemia and cancers.  Here, we report for the first time the synthesis of Militarin analog-1 (MA-1) and the apoptotic mechanism of MA-1 against human lung cancer cell lines.  Treatment with MA-1 significantly inhibited the viability of 3 human lung cancer cell lines.  The inhibition of viability and growth in MA-1-treated A549 cells with an IC50 of 5 μM were mediated through apoptosis induction, as demonstrated by an increase in DNA fragmentation, sub-G0/G1-DNA fraction, nuclear condensation, and phosphatidylserine exposure.  The apoptotic cell death caused mitochondrial membrane permeabilization through regulation of expression of the Bcl-2 family proteins, leading to cytochrome c release in a time-dependent manner.  Subsequently, the final stage of apoptosis, activation of caspase-9/-3 and cleavage of poly (ADP ribose) polymerase, was induced.  Furthermore, A549 lung cancer cells were more responsive to MA-1 than a bronchial epithelial cell line (BEAS-2B), involving the rapid generation of reactive oxygen species (ROS), c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein kinase (MAPK) activation.  The pharmacol. inhibition of ROS generation and JNK/p38 MAPK exhibited attenuated DNA fragmentation in MA-1-induced apoptosis.  Oral administration of MA-1 also retarded growth of A549 orthotopic xenografts.  In conclusion, the present study indicates that the new synthetic deriv. MA-1 triggers mitochondrial apoptosis through ROS generation and regulation of MAPKs and may be a potent therapeutic agent against human lung cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaxeXs5b5L67Vg90H21EOLACvtfcHk0lgm4fQzPZfmCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslyqurfK&md5=cce11c4af995c0be97c4f8397d1fbfe2</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.taap.2013.10.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.taap.2013.10.015%26sid%3Dliteratum%253Aachs%26aulast%3DYoon%26aufirst%3DD.%2BH.%26aulast%3DLim%26aufirst%3DM.%2BH.%26aulast%3DLee%26aufirst%3DY.%2BR.%26aulast%3DSung%26aufirst%3DG.%2BH.%26aulast%3DLee%26aufirst%3DT.%2BH.%26aulast%3DJeon%26aufirst%3DB.%2BH.%26aulast%3DCho%26aufirst%3DJ.%2BY.%26aulast%3DSong%26aufirst%3DW.%2BO.%26aulast%3DPark%26aufirst%3DH.%26aulast%3DChoi%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DT.%2BW.%26atitle%3DA%2520Novel%2520Synthetic%2520Analog%2520of%2520Militarin%252C%2520MA-1%2520Induces%2520Mitochondrial%2520Dependent%2520Apoptosis%2520by%2520ROS%2520Generation%2520in%2520Human%2520Lung%2520Cancer%2520Cells%26jtitle%3DToxicol.%2520Appl.%2520Pharmacol.%26date%3D2013%26volume%3D273%26spage%3D659%26epage%3D671%26doi%3D10.1016%2Fj.taap.2013.10.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Varrone, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Consiglio, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Covelli, I.</span><span> </span><span class="NLM_article-title">The Nature of Inhibition of Mitochondrial Malate Dehydrogenase by Thyroxine, Iodine Cyanide and Molecular Iodine</span> <span class="citation_source-journal">Eur. J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1970</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">305</span><span class="NLM_x">–</span> <span class="NLM_lpage">312</span><span class="refDoi"> DOI: 10.1111/j.1432-1033.1970.tb00932.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=10.1111%2Fj.1432-1033.1970.tb00932.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=4314809" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=1%3ACAS%3A528%3ADyaE3cXht1yqsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1970&pages=305-312&author=S.+Varroneauthor=E.+Consiglioauthor=I.+Covelli&title=The+Nature+of+Inhibition+of+Mitochondrial+Malate+Dehydrogenase+by+Thyroxine%2C+Iodine+Cyanide+and+Molecular+Iodine&doi=10.1111%2Fj.1432-1033.1970.tb00932.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Nature of inhibition of mitochondrial malate dehydrogenase by thyroxine, iodine cyanide, and molecular iodine</span></div><div class="casAuthors">Varrone, Stelio; Consiglio, Eduardo; Covelli, Italo</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">1970</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">305-12</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    </div><div class="casAbstract">The mechanism of inhibition of the enzyme activity of mitochondrial malate dehydrogenase by thyroxine, ICN and mol. I was further investigated.  The results obtained excluded formation of a protein/inhibitor stable complex, iodination of the enzyme, or disaggregation of the protein mol. into inactive subunits as explanations for the enzyme inactivation induced by the I-contg. compds.  It was demonstrated that in all cases the enzyme inhibition was dependent on the oxidn. of certain SH groups necessary for the activity.  Direct oxidn. of the thiol groups of the protein by mol. I and ICN can be easily assumed, whereas the chem. mechanism of the thyroxine-induced enzyme inactivation was harder to explain.  However, since neither hormone deiodination nor metal chelation occurred, while thyroxine by itself was also able to oxidize the thiol group of reduced glutathione, a direct effect of thyroxine on the sulfhydryl groups of the enzyme was postulated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq96A5Z8neeUbVg90H21EOLACvtfcHk0ljKZWNXAyvf-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3cXht1yqsLg%253D&md5=87a556ff5423982b9ae1d4668fc4fa09</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1111%2Fj.1432-1033.1970.tb00932.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1432-1033.1970.tb00932.x%26sid%3Dliteratum%253Aachs%26aulast%3DVarrone%26aufirst%3DS.%26aulast%3DConsiglio%26aufirst%3DE.%26aulast%3DCovelli%26aufirst%3DI.%26atitle%3DThe%2520Nature%2520of%2520Inhibition%2520of%2520Mitochondrial%2520Malate%2520Dehydrogenase%2520by%2520Thyroxine%252C%2520Iodine%2520Cyanide%2520and%2520Molecular%2520Iodine%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D1970%26volume%3D13%26spage%3D305%26epage%3D312%26doi%3D10.1111%2Fj.1432-1033.1970.tb00932.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">McGovern, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoichet, B. K.</span><span> </span><span class="NLM_article-title">Kinase Inhibitors: Not Just for Kinases Anymore</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">1478</span><span class="NLM_x">–</span> <span class="NLM_lpage">483</span><span class="refDoi"> DOI: 10.1021/jm020427b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm020427b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhvFeksLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=1478-483&author=S.+L.+McGovernauthor=B.+K.+Shoichet&title=Kinase+Inhibitors%3A+Not+Just+for+Kinases+Anymore&doi=10.1021%2Fjm020427b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Kinase Inhibitors: Not Just for Kinases Anymore</span></div><div class="casAuthors">McGovern, Susan L.; Shoichet, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1478-1483</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Kinase inhibitors are widely employed as biol. reagents and as leads for drug design.  Their use is often complicated by their lack of specificity.  Although binding conserved ATP sites accounts for some of their nonspecificity, some compds. inhibit proteins not known to bind ATP.  It has been found that promiscuous hits from high-throughput screening may act as aggregates.  To explore whether this mechanism might explain the action of widely used nonspecific kinase inhibitors, 15 such compds. were studied.  Eight of these, rottlerin, quercetin, K-252c, bisindolylmaleimide I, bisindolylmaleimide IX, U0126, indirubin, and indigo, inhibited three diverse non-kinase enzymes.  Inhibition was time-dependent and sensitive to enzyme concn.; by light scattering, the compds. formed particles of 100-1000 nm diam.  These observations suggest that these eight kinase inhibitors, at least at micromolar concns., are promiscuous and act as aggregates.  Results obtained from the use of these compds. at micromolar or higher concns. against individual enzymes should be interpreted cautiously.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-JSJ7FPf7e7Vg90H21EOLACvtfcHk0ljKZWNXAyvf-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhvFeksLs%253D&md5=1d7e4e99a27be5ab279744aff92de26d</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm020427b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020427b%26sid%3Dliteratum%253Aachs%26aulast%3DMcGovern%26aufirst%3DS.%2BL.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26atitle%3DKinase%2520Inhibitors%253A%2520Not%2520Just%2520for%2520Kinases%2520Anymore%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D1478%26epage%3D483%26doi%3D10.1021%2Fjm020427b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Rupert, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Segar, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schutte, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scholz, T. D.</span><span> </span><span class="NLM_article-title">Metabolic Adaptation of the Hypertrophied Heart: Role of the Malate/Aspartate and α -Glycerophosphate Shuttles</span> <span class="citation_source-journal">J. Mol. Cell. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">2287</span><span class="NLM_x">–</span> <span class="NLM_lpage">2297</span><span class="refDoi"> DOI: 10.1006/jmcc.2000.1257</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=10.1006%2Fjmcc.2000.1257" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=11113004" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;key=1%3ACAS%3A528%3ADC%252BD3cXos1Kiu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2000&pages=2287-2297&author=B.+E.+Rupertauthor=J.+L.+Segarauthor=B.+C.+Schutteauthor=T.+D.+Scholz&title=Metabolic+Adaptation+of+the+Hypertrophied+Heart%3A+Role+of+the+Malate%2FAspartate+and+%CE%B1+-Glycerophosphate+Shuttles&doi=10.1006%2Fjmcc.2000.1257"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolic adaptation of the hypertrophied heart: role of the malate/aspartate and α-glycerophosphate shuttles</span></div><div class="casAuthors">Rupert, Brian E.; Segar, Jeffrey L.; Schutte, Brian C.; Scholz, Thomas D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular and Cellular Cardiology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2287-2297</span>CODEN:
                <span class="NLM_cas:coden">JMCDAY</span>;
        ISSN:<span class="NLM_cas:issn">0022-2828</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Activation of the malate/aspartate and α-glycerophosphate shuttles (the NADH shuttles) has been identified in glycolytically active newborn myocardium.  The goal of this study was to det. if the NADH shuttles and their regulatory genes are activated in hypertrophied myocardium as substrate utilization shifts away from fatty acids and toward glucose and lactate.  Capacity of the shuttles was detd. in cardiac mitochondria isolated one week, one month, and three months following aortic banding or sham operation.  Myocardial steady-state mRNA and protein levels of regulatory enzymes were also measured.  Despite a significant increase in left ventricular mass and activation of the atrial natriuretic peptide gene, no change in malate/aspartate nor α-glycerophosphate shuttle capacity was found at any of the three time points studied.  Reactivation of the genes encoding the regulatory inner mitochondrial membrane proteins was not found in the hypertrophied myocardium, though these genes were down-regulated one week following aortic-banding.  Apparently, sufficient malate/aspartate and α-glycerophosphate shuttle capacity exists in cardiac mitochondria to accommodate increased shuttle flux as hypertrophied myocardium becomes more glycolytically active.  (c) 2000 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFFtaAzu4wyrVg90H21EOLACvtfcHk0lj_jB6X27tTfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXos1Kiu7w%253D&md5=134973d669ec0bb77f3c30ac53945aea</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1006%2Fjmcc.2000.1257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmcc.2000.1257%26sid%3Dliteratum%253Aachs%26aulast%3DRupert%26aufirst%3DB.%2BE.%26aulast%3DSegar%26aufirst%3DJ.%2BL.%26aulast%3DSchutte%26aufirst%3DB.%2BC.%26aulast%3DScholz%26aufirst%3DT.%2BD.%26atitle%3DMetabolic%2520Adaptation%2520of%2520the%2520Hypertrophied%2520Heart%253A%2520Role%2520of%2520the%2520Malate%252FAspartate%2520and%2520%25CE%25B1%2520-Glycerophosphate%2520Shuttles%26jtitle%3DJ.%2520Mol.%2520Cell.%2520Cardiol.%26date%3D2000%26volume%3D32%26spage%3D2287%26epage%3D2297%26doi%3D10.1006%2Fjmcc.2000.1257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5MDH" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5MDH','PDB','5MDH'); return false;">PDB: 5MDH</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2DFD" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2DFD','PDB','2DFD'); return false;">PDB: 2DFD</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i85"><a href="/doi/suppl/10.1021/acs.jmedchem.7b01231">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_41051"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b01231">10.1021/acs.jmedchem.7b01231</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Protein–protein Blast of MDH1 and MDH2, structural and sequence alignment of the active site regions from MDH1 and MDH2, molecular docking study of compounds, effects of compounds on intracellular oxygen tension, effects on mitochondria complex II, III, and IV activity, body weight change in HCT116 xenograft model, in vivo antitumor effect of compound <b>5i</b> and <b>15a</b> in HCT116 xenograft model, and in vitro water solubility of <b>14b</b> and <b>16c</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01231/suppl_file/jm7b01231_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01231/suppl_file/jm7b01231_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01231/suppl_file/jm7b01231_si_001.pdf">jm7b01231_si_001.pdf (902.44 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01231/suppl_file/jm7b01231_si_002.csv">jm7b01231_si_002.csv (3.8 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b01231&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-20%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b01231%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b01231" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679963777aeb24fd","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
